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Ageing is associated with changes in cellular and molecular processes including the 
alteration of stem cell pools. In particular, biological and functional changes observed in 
ageing neural stem cells (NSCs), are linked to age-related cognitive decline. Recently, the 
systemic environment has been shown to alter both NSC regulation and age-related 
cognitive decline. Interestingly, a well-documented and naturally occurring way of altering 
the composition of the systemic environment is through diet and nutrition. Studies have 
found an overabundance of nutrients to be detrimental for human and animal health; the 
presence of specific nutrients as well as the overall increase in calorie or protein intake was 
shown to overstimulate conserved molecular pathways and to reduce lifespan. Conversely, 
dietary restriction was found to be the most efficient way of extending an organism’s 
lifespan. 
 
In this study, we examined nutrient sensing pathways in relation to their function in NSCs, 
ageing and cognition. We focus on the Sirtuin, mTOR and Insulin / Insulin like growth factor-
1 pathways and employ both in vitro and epidemiological methods to assess their 
contribution to age-related phenotypes. Using a human hippocampal progenitor cell line 
(HPC) we modelled ageing through treatment with ageing human serum and via 
pharmacological interventions combined with increased passage number. A semi-
automated imaging platform was used for the immunocytochemical quantification of NSC 
proliferation, differentiation, damage and apoptosis. Further to this, candidate gene 
selection was preformed through literature search and validated by qPCR to measure gene 
expression alterations within our ageing models. Results from the in vitro experiments, 
were used to inform the selection of 9 genes belonging to nutrient-sensing pathways as 
candidate genes for a role in NSC regulation. Next, we investigated the effects of lifestyle 
and candidate-gene genotype on cognition using 1633 participants from the adult 
longitudinal population-based TwinsUK cohort.  
 
We report that treatment with human serum is able to induce changes in the HPC model 
that relate to both the serum-donor’s hippocampal volumes and their cognitive 
performance. In addition, we report interesting associations between candidate-gene 
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expression and NSC regulation. Our data also revealed increasing passage number causes 
significant alterations in nutrient-sensing genes and emphasised FOXO3A, NAMPT, PTEN, 
GRB10 and mTOR as interesting candidates for further ageing research. Finally, 
epidemiological analysis showed a significant effect of lifestyle on cognition and highlighted 
associations between SNPs in SIRT1 and ABTB1 and cognitive performance.  
The results outlined in this thesis support an important role for nutrient-sensing pathways 
in human NSCs ageing. In addition, we provide support for the use and further 
development of novel in vitro models to investigate NSCs ageing and to validate existing 
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1 General Introduction 
Large portions of this introduction have been published as a review entitled “Emerging 
Molecular Pathways Governing Dietary Regulation of Neural Stem Cells during Aging” of 
which I am first author (de Lucia et al., 2017). 
 
1.1 Biogerontology 
Socio-economic development and advances in medicine and healthcare over the past 
century have led to greatly increased life expectancies across the globe. As well as a 
decrease in infant mortality and developments in the treatment and prevention of midlife 
killers such as cancer, there has also been a decrease in the number of deaths in later life: 
with deaths between the age of 60 and 80 decreasing by 1.5% a year for the last 30 years 
(Banerjee, 2015; Mathers et al., 2015).  An increase in longevity however, has resulted in 
an ageing population with the number of the people aged over 80 expected to triple by 
2050 (United nations, 2017). This social transformation has a variety of social and economic 
implications, one of the most concerning being the relative shrinking of the workforce able 
to provide for a possible increase in healthcare costs. While deaths in later age are 
decreasing, ageing is still accompanied by frailty and susceptibility to disease which, if left 
unchanged will require adaptations to health infrastructure and will have deep economic 
repercussions (Maestas et al., 2016). Ageing is the number one risk factor for the majority 
of diseases currently affecting the developed and developing world and has therefore 
become one of the greatest challenges of modern medicine (Niccoli and Partridge, 2012).  
The area of study addressing this issue, known as biogerontology, is committed to 
investigating the underlying mechanisms of ageing, to explore whether they can be 
intervened upon to delay or perhaps even halt the progression of age-related conditions 
such as cardiovascular disease, cancer and neurodegeneration (Verburgh, 2015). The field 
hypothesises that by delaying the biological aspects of ageing there will be a concomitant 
delay in age-associated chronic diseases due to the shared physiological risk factors 
(Schubert et al., 2018). An improved understanding of ageing mechanisms could therefore 
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lead to the development of strategies to increase “healthspan” - the period of time free 
from debilitating disease (Brandhorst et al., 2015; Franklin and Tate, 2008). 
Ageing is defined as the time-dependent functional decline that affects most living 
organisms (López-Otín et al., 2013). It is characterised by a loss of fitness at both an 
organismal and cellular level and is usually attributed to a time-dependent accumulation 
of damage (Gems and Partridge, 2013; Kirkwood, 2005). The seminal review in the ageing 
field by López-Otín et al. identified and assigned the cellular and molecular hallmarks of 
ageing to 9 categories: genomic instability, telomere attrition, epigenetic alterations, loss 
of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular 
senescence, stem cell exhaustion and altered intercellular communication. For a hallmark 
to be included, it must manifest during ageing, its experimental aggravation should 
accelerate ageing and its experimental amelioration should delay the ageing process 
(López-Otín et al., 2013).  
 
This categorisation has helped identify ageing as a biological process that, whilst dependent 
on the passing on time, is also greatly affected by other factors. Ageing in fact, is 
characterised by distinct inter-individual differences (Papenberg et al., 2015). This 
heterogeneity is a particularly challenging aspect of ageing research, but, at the same time, 
has highlighted an important role for both genetics and lifestyle in determining an 
individual’s ageing rate. Observations like these, have given rise to the concept of biological 
and chronological age: the former being the advancement of the strictly biological ageing 
process and the latter being the passing of time (Ries and Pöthig, 1984).  A typical 
phenotype of ageing where the discrepancy between biological and chronological ageing 
is evident is cognitive decline. While some individuals retain intact cognitive performance, 
others of a similar age may already display drastic deterioration (Papenberg et al., 2015). 
Recent studies, aimed at identifying the driving mechanisms behind cognitive ageing and 
the phenotypic heterogeneity with which it presents have emphasised an important role 
for neural stem cells (NSCs) and nutrient-sensing pathways (Papenberg et al., 2015; Romine 
et al., 2015; Yang et al., 2015). In this literature review we outline the current knowledge 
on the role of the hippocampus, NSCs and nutrient-sensing pathways in age-related 
cognitive decline as well as the gaps in research in these areas. 
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1.2 The ageing brain: focus on the hippocampus 
Increasing age is usually accompanied by a decline in fluid cognitive abilities but a 
preservation of crystallised intelligence. Fluid intelligence is the capacity to reason that is 
independent from past knowledge while crystallised intelligence is based on an individual’s 
knowledge and past experiences.  Accordingly, attention, executive control, reaction and 
processing speed all show considerable decline with age while long-term semantic memory 
remains intact (Ghisletta et al., 2012; Samanez-Larkin and Knutson, 2015). In addition, a 
decline in episodic memory, a function that requires hippocampus, is one of the most 
common age-related cognitive-deficits (Burgess et al., 2002). In line with this, a conserved 
feature of age-related cognitive decline across mammalian species is reduced spatial 
memory; a cognitive ability known to be highly-dependent on the hippocampus (Yankner 
et al., 2008). Besides these observations, other factors have highlighted the hippocampus 
as a structure greatly affected by ageing processes. Human fMRI studies for example, have 
shown altered functional activation of the hippocampus in aged adults (Logan et al., 2002; 
Malberg, 2004). In addition, rodent and primate studies assessing neuronal activity via fMRI 
and in situ hybridisation have also shown a specific susceptibility of hippocampal 
subregions to ageing in both species (Small, 2014). Furthermore, several imaging studies 
have reported that the hippocampus undergoes volumetric reductions with age (Daugherty 
et al., 2016; Peters, 2006; Shing et al., 2011). The hippocampus is therefore often the focus 
of cognitive-ageing research.  
 
The hippocampal formation is a bilateral region found in the medial temporal lobes. As 
initially suggested by Ramón y Cajal in 1911, it is a circuit made up of several interconnected 
regions, each with distinct neuron types. It is formed of the subiculum, the dentate gyrus 









Figure 1 - The human hippocampus. Diagrams showing the location and structure of the hippocampal 
formation. A) Images created using the Allen Human Brain Atlas (2010), the hippocampus is shown in green. 
On the left is a sagittal section and on the right, is a coronal section. Boxes on the top right of each image 
show the facing direction. B) Shows the hippocampal subfields relative to the hippocampus orientation in A. 
The 6 substructures of the hippocampal formation are colour coded to the legend on the left. DG- Dentate 
Gyrus, CA - Cornu Ammonis, Sub – subiculum. 
 
These subregions are connected via multi-synaptic circuits that signal to and from the 
entorhinal cortex; a circuitry that is thought to be responsible for the hippocampus’ role in 
episodic memory. The entorhinal cortex also acts as an interface between the hippocampus 
and the neocortex. This hippocampal-neocortical network has been shown to be 
fundamental for the consolidation of long-term memories (Squire et al., 2004). 
Interestingly, the histological specialization of the hippocampal formation is indicative of 
highly functionally-specialised subregions. While this remains to be elucidated in humans, 
animal studies have demonstrated a first specialization across the anterior-posterior axis: 
the posterior (i.e. dorsal in rodents) hippocampus is mainly involved in memory and 
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cognitive processing while the anterior (i.e. ventral) hippocampus is involved in emotional 
processing. Further to this, subfield -specific specialisations have also been identified. 
Studies have suggested that the CA1 is responsible for late retrieval, recognition and 
consolidation while the CA3 and the DG are primarily responsible for early retrieval and 
encoding (Hasselmo, 2005; Hunsaker and Kesner, 2008; Mueller et al., 2011; Wan et al., 
1999). Besides these functions the DG also enables pattern separation, which is the ability 
to differentiate between pre-existing information and similar but novel information. 
Interestingly, the DG is also one of the only two known regions of the adult mammalian 
brain capable of generating newborn neurons throughout adulthood. 
 Adult neurogenesis 
Adult neurogenesis is the birth of new neurons from NSC during adulthood. Despite early 
neuroscientists claiming the adult brain was incapable of regeneration, this remarkable 
process has now been identified in several species and brain regions (Deng et al., 2010; 
Ramon y Cajal, 1928; Zupanc, 2001). Extensive rodent studies have demonstrated the 
presence of two neurogenic niches in the mammalian brain: the subventricular zone (SVZ) 
of the lateral ventricles and the subgranular layer (SGL) of the hippocampus (Altman and 
Das, 1965b; Doetsch and Hen, 2005). 
 
In line with this, human studies in the late 90s demonstrated that new neurons are indeed 
born in the adult human hippocampus by using bromodeoxyuridine (BrdU) to track 
proliferative cells in cancer patients (Eriksson et al., 1998). More recently, elegant studies 
by the Frisen group provided further support for the presence of mammalian adult 
hippocampal neurogenesis (AHN). These studies made use of the varying levels of 14C 
isotope in the atmosphere following above ground nuclear bomb testing to carry out 
carbon dating of neurons in post-mortem human tissues and demonstrated neurons in the 
same human brain were created at different points in time (Ernst et al., 2014; Spalding et 
al., 2013). Interestingly, results from this work suggested there is only a negligible level of 
neurogenesis in the human olfactory bulb, a surprising result given the extent of SVZ 
neurogenesis in rodents. This technique also provided an insight into the dynamics of adult 
neurogenesis allowing the authors to calculate the average total hippocampal neuron 
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turnover rate which was estimated at 35% and the average turnover of the DG neurons 
specifically, which was estimated to be close to 100%.  These findings showed, for the first 
time, the considerable differences between human and mouse neurogenesis highlighting 
the need for human-based studies. Indeed, as well as the differences in olfactory bulb 
neurogenesis, the turnover rate of DG neurons was estimated at only 10% in rodents while 
the rate of AHN decline in response to age appeared far greater in mice than in humans 
(Bergmann et al., 2015; Imayoshi et al., 2008; Spalding et al., 2013).  
 
In line with this, throughout the last decade, there has been an ever-growing body of 
evidence supporting the notion of human AHN (Boldrini et al., 2018; Galán et al., 2017; 
Kempermann et al., 2018; Knoth et al., 2010; Liu et al., 2008; Mathews et al., 2017). In this 
period, human AHN has only been contested by a limited number of publications claiming 
AHN falls to undetectable levels shortly after birth and the only remaining proliferating cells 
in the “neurogenic niches” are glial cells (Dennis et al., 2016a; Sorrells et al., 2018). Given 
that other studies adopting similar immunohistochemical techniques were able to show 
the presence of markers of adult neurogenesis in human post-mortem tissues, the most 
likely explanations for these discrepancies methodological differences. Recent papers have 
in fact suggested the lack of stereological methodology, large post-mortem delay and 
lenient participant inclusion criteria may explain these discrepancies (Boldrini et al., 2018; 
Lucassen et al., 2019). These findings however, have highlighted the need for the 
development of more robust techniques for assessing adult neurogenesis and for 
undoubtedly proving its existence throughout human lifespan (Kempermann et al., 2018; 
Lee and Thuret, 2018). 
 
Such techniques would also allow the field to robustly replicate rodent studies assessing 
the functional relevance of AHN in humans. The animal literature in fact, has already 
highlighted important roles for AHN in learning and memory suggesting therapies targeting 
this process may prove beneficial for a number of diseases  (Altman and Das, 1965a; Pencea 
et al., 2001; Spalding et al., 2013). The high excitability of the newborn neurons and their 
susceptibility to long-term potentiation (Schmidt-Hieber et al., 2004) make them perfect 
candidates as biological building blocks of learning and memory; the notion that the level 
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of AHN positively correlates with hippocampal-dependent learning tasks has been 
extensively proven. For example: experiments with methylazoxymethanol, a methylation 
agent capable of blocking neurogenesis showed rats with no neurogenesis had impaired 
trace-fear conditioning (Shors et al., 2002). In addition, experiments looking at co-
localization of c-fos, a gene involved in memory formation, and BrdU incorporation in the 
hippocampus also supported this important function for newborn neurons (Tashiro et al., 
2007). Furthermore, Clelland and colleagues showed newborn neurons are required for 
performance on pattern separation tasks showing AHN in particular is responsible for the 
DG’s role in pattern separation (Clelland et al., 2009). Interestingly, an elaborate gene 
construct allowing for inducible ablation of newly generated neurons via the use of 
diphtheria toxin and the Cre-Lox system allowed Arruda-Carvalho and colleagues to show 
AHN may also be involved in destabilising existing memories (Arruda-Carvalho et al., 2011).  
As discussed above, the currently used techniques for detecting human AHN rely mostly on 
the expression of markers in post-mortem tissue thereby hindering intervention and 
longitudinal studies. Extensive data from animal models has identified the stages required 
for the maturation of NSCs to post-mitotic neuron and the pertinent markers associated to 
each stage. Briefly, the maturation process is believed to involve 6 stages. During the first 
stage, type-1 cells with unlimited regenerative capacities undergo division giving rise to 
transiently amplifying progenitor cells known as type-2a. These proliferate for the next 3 
stages and gradually lose their proliferative capabilities while acquiring neuronal 
differentiation characteristics, giving rise to progenitor cell type-2b and type-3.  During the 
5th stage, the progenitor cells differentiate into transient postmitotic cells and eventually 
mature into fully developed neurons during stage (Kempermann et al., 2004a). This process 
and the markers associated to each stage are reported in Figure 2. 
 




Figure 2 - Developmental stages of neural stem cell maturation  The process of maturation from neural stem 
cell to mature granule cell (GC) can be subdivided in 6 stages each giving rise to a specific cell type (reported 
at the top of the image). The coloured blocks report the currently available markers to identify each cell type. 
Gradients represent the gradual decrease or increase in expression as the maturation process progresses. 
Glial Fibrillary Acidic Protein (GFAP), Proliferating Cell Nuclear Antigen (PCNA), Prospero Homeobox 1 
(PROX1), Doublecortin (DCX), Microtubule Associated protein 2 (MAP2), Neuronal Nuclei (NeuN). Figure 
adapted from (Knoth et al., 2010). 
 
Transplantation studies investigating AHN have shown that for NSCs to undergo the 
process outlined above, a uniquely permissive environment coined the ‘neurogenic niche’ 
is required (Seidenfaden et al., 2006; Shihabuddin et al., 2000). In both the human and 
rodent hippocampus, this is located between the granule cell layer of the DG and the 
CA3/CA4 region. It contains NSCs as well as their immediate progeny (type-2 and type-3 
cells), immature neurons and several glial cell-types. The niche can promote neurogenesis 
by enabling cell to cell contact and by housing a number of astrocyte and microglia 
responsible for regulating the balance between gliogenesis and neurogenesis (Carpentier 
and Palmer, 2009). In addition, studies have shown the niche and the surrounding 
vasculature emanate signals able to determine the fate and differentiation rate of NSC 
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(Koutsakis and Kazanis, 2016). Neurogenesis is in fact considered a highly dynamic process 
able to respond to positive environmental stimuli such as physical exercise (Bolijn and 
Lucassen, 2015), enriched environments, learning (Monteiro et al., 2014) and certain 
dietary regimens like calorie restriction (Morgan et al., 2017) as well as to negative stimuli 
like sleep deprivation, social isolation  and stress (Lucassen et al., 2015; Snyder et al., 2011).  
 
The most dramatic and well-studied negative regulator of neurogenesis is ageing which has 
been linked to decreased proliferation, survival and differentiation of NSCs in both rodent 
(Ben Abdallah et al., 2010; Driscoll et al., 2006; Heine et al., 2004; Kuhn et al., 1996).and 
primate models (Gould et al., 1999; Ngwenya et al., 2006) In humans, the sharp age-related 
decline in performance in episodic memory and thereby on hippocampus-dependent tasks 
such as pattern separation, is highly suggestive of age-related neurogenic-impairments 
(Plancher et al., 2010). This has been supported by immunohistochemical studies showing 
a decline in the number of DCX-positive neurons and in that of proliferative markers such 
as Ki67 in older individuals when compared to younger individuals (Knoth et al., 2010). 
Though the presence of DCX positive cells is not irrefutable proof of fully integrated and 
functional neurons, the carbon dating experiments by Spalding and colleagues showed that 
the hippocampal neuron exchange rate does decline in a similar age-dependent manner to 
the DCX expression shown by Knoth et al. (Spalding et al., 2013).  
 Effects of ageing on neural stem cell function and neurogenesis 
Stem cells in general have been closely linked to ageing owing to their reduced regenerative 
ability related to the decline of tissues that accompanies age (Behrens et al., 2014; Signer 
and Morrison, 2013). Impaired function of satellite stem cells in muscle and epidermal stem 
cells of the skin, for example, are key processes underlying reduced regeneration as a result 
of ageing in these tissues (Castilho et al., 2009; Day et al., 2010).  
 
Similarly, NSC dysfunction is thought to be strongly associated to the cognitive impairments 
that accompany ageing. As introduced above, the marked decline in NSC activity in the 
ageing rodent DG manifests in reduced proliferation that eventually leads to the depletion 
of the progenitor pool (Romine et al., 2015; Yang et al., 2015). This decline partly 
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contributes to the age-linked decline in cognitive abilities, particularly those dependent on 
the hippocampus (Park et al., 2013; Romine et al., 2015; Yang et al., 2015). In the SVZ, there 
is a similar marked decline in NSC function which contributes to impoverished olfaction 
during rodent ageing (Enwere et al., 2004). Studies in model species have shown that 
deregulated hippocampal neurogenesis, is an important component of neurodegenerative 
conditions such as Alzheimer’s (López-Toledano, Michael L et al., 2004; López-Toledano et 
al., 2007; Winner et al., 2011), further linking declines in NSC function to the deterioration 
of the ageing brain. Interestingly, a recent study suggested human neurogenesis remains 
unaffected by age in the absence of disease but that alterations in angiogenesis, quiescence 
and neuroplasticity may be responsible for the ageing phenotypes (Boldrini et al., 2018). 
Together, these studies suggest ageing exerts some of its detrimental effects in the CNS by 
directly interfering with multiple cellular and molecular processes that govern the 
regulation of the NSC population. This notion is summarized in Figure 3. As ageing has such 
severe effects on the decline of NSC and the development of neurodegenerative 
conditions, this prompts the field to consider whether we can target the maintenance of 
the NSC population to slow cognitive ageing and neurodegenerative disease progression. 
If so, what are the key mechanisms to target? 
 
Interestingly, studies investigating the role of ageing on NSCs have also highlighted the 
possible role of the systemic milieu in regulating the neurogenic niches of the CNS; through 
the use of heterochronic parabiosis, Villeda and colleagues showed that the systemic 
environment of a young mouse was able to rescue the cognitive deficits of an aged mouse 
following the fusion of young-old circulatory systems (Villeda et al., 2011, 2014). This 
rejuvenating effect is also observed following intravenous infusion of young plasma into 
old mice, and was underpinned by a marked reversal of age-related decline in hippocampal 
neurogenesis (Villeda et al.2011) and upregulation of genes linked to synaptic plasticity 
(Villeda et al.2014).Villeda and colleagues however, only showed variation in proliferation 
and in neuroblast number using BrdU and doublecortin (DCX) respectively. Though this is 
strongly indicative of adult hippocampal neurogenesis, markers identifying more mature 
neurons as well as marker colocalization would have provided stronger evidence for the 
involvement of neurogenesis. For example, DCX and PSA-NCAM colocalization has been 
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suggested as a more reliable marker of neurogenesis (Boldrini et al., 2018; Sorrells et al., 
2018). In addition, though the authors show a variation in performance in hippocampal 
dependent tasks such as fear conditioning and spatial awareness, the exact contribution of 
neurogenesis to these tasks remains to be elucidated (Merrill et al., 2003). Nevertheless, 
these studies were seminal in identifying the systemic environment as an important 
regulator of hippocampal and possibly neurogenic function. 
 
In line with the above studies, enhanced neurogenesis in the SVZ was observed by 
Katsimpardi and colleagues following heterochronic parabiosis, resulting in improved 
odour discrimination, another task thought to rely on adult neurogenesis in rodents 
(Katsimpardi et al., 2014). Notably, these studies have demonstrated the role for candidate 
chemokines (e.g. CCL11,(Villeda et al., 2011)) and growth factors (e.g. GDF11 e.g. (Loffredo 
et al., 2013)) whose circulating levels fluctuate in ageing mice and appear to exert their 
effects, at least in part, by altering NSC function.  Complementary to this, studies looking 
at other populations of stem cells have observed a similarly rejuvenating effect of the 
youthful milieu on the typical age-related declines in stem cell function throughout the 
body as well as vice-versa, whereby the old milieu inhibited stem cell function (Conboy and 
Rando, 2012). These data suggest that by altering the composition of the systemic 
environment, one could affect the regulation of the NSCs; a well-documented, naturally 
occurring way of achieving this is through diet and nutrition (Stangl and Thuret, 2009). 
Here, we define diet as encompassing dietary paradigms such as calorie restriction (CR), 
intermitted fasting (IF), dietary restriction (e.g. of specific components such as protein) (DR) 
and time restricted feeding (TRF) whereas nutrition involves the intake and/or 
supplementation of foods containing pro-neurogenic agents such as polyphenols (Valente 
et al., 2009), polyunsaturated fatty acids (PUFAs) (Kawakita et al., 2006; Valente et al., 
2009) and vitamins/minerals (Bonnet et al., 2008; Corniola et al., 2008; Zhao et al., 2008).  
 
As stem cells in general are designed to act in response to their environment and, and as 
reported above, are responsive to differing compositions of the systemic environment, it 
follows that diet can greatly influence their function (Murphy and Thuret, 2015). Several 
authors have reviewed the effect of diet on stem cells in general (Mihaylova et al., 2014; 
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Ochocki and Simon, 2013; Rafalski et al., 2012), for the purpose of this review we will focus 
on the relatively unexplored field of the effects of diet and ageing on NSCs. Nutritionists 
have found that an overabundance of nutrients is detrimental to several aspects of human 
and animal health (Keenan et al., 1994; Nagai et al., 2012). This results from an 
overstimulation of nutrient sensing molecular pathways, which eventually become 
insensitive to the stimuli (Blagosklonny, 2008; Gems and de la Guardia, 2013). CR, IF and 
DR have been reported to have opposite effects on these pathways and present a means 
to improved health and lifespan (Brandhorst et al., 2015; Fontana and Partridge, 2015; 
Solon-Biet et al., 2014, 2015). Figure 3 is a schematic of how ageing, diet and the systemic 
environment interact to act upon these pathways. Notably, these effects are conserved 
across species as they have been observed in simple organisms such as yeast, C. elegans, 
and drosophila through to rodents and humans (Fontana et al., 2010). We will now review 
the impacts of dietary and nutritional regulation of NSC activity and function, with focus on 
the aforementioned nutrient sensing pathways and their effects on longevity.   
 




Figure 3 - Diagram summarizing the proposed relationship between ageing, nutrition and neural stem 
cells.  Ageing and dietary modulation such as calorie restriction (CR) can alter the composition of the 
systemic environment, which affects epigenetic regulation and several nutrient-sensing pathways, including 
the mTOR, Sirtuin and Insulin and Insulin like signalling (IIS) pathways. These in turn alter neural stem cell 
(NSC) regulation and can predispose to disease and cognitive decline. 
 
1.3 Impact of diet on neural stem cells 
Dietary paradigms such as CR and IF are the most widely employed means of assessing the 
impacts of diet upon stem cell function and longevity. A 30-40% reduction in calorie intake, 
the typical regimen for CR, has often been brought about by alternate-day feeding – a form 
of IF. As such, the field must pay great attention as to whether they are assessing the 
impacts of DR or IF, unpublished work from our lab shows that the positive impacts of IF 
on hippocampal neurogenesis and cognitive performance can be derived independent of 
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calorie intake, suggesting that it is the period of fasting that that is acting on the NSC pool. 
Nutritional content, such as the amount of polyphenols and PUFAs, among other specific 
nutrients, has also been reported to impact on NSC function during ageing (Fernández-
Fernández et al., 2012; Valente et al., 2009). 
 
Reducing calorie intake in rodents was shown to counteract age-related cognitive decline 
as well as increase the number of newly generated neurons in the hippocampus (Ingram et 
al., 1987; Lee et al., 2000, 2002).  In line with this, Hornsby et al showed that CR increased 
the number of mature newborn neurons in the rodent dentate gyrus and that these effects 
were mediated by the receptor for the orexigenic hormone, acyl-ghrelin (Hornsby et al., 
2016). Furthermore, Kumar and colleagues suggest DR may aid in fighting excitotoxic injury 
as an increase in progenitors is seen in the SVZ, SGL, hypothalamus and cortex of adult rats 
(Kumar et al., 2009). In contrast, Bondolfi and colleagues found that CR did not affect the 
rate of proliferation but affected the survival of new–born glia in the mouse hippocampus 
(Bondolfi et al., 2004). Given that CR and IF (typically involving some degree of CR) have 
been shown to positively impact on NSC function, it follows that excessive calorie intake, 
as in the case of obesity and other models of metabolic disorders, will negatively affect NSC 
activity and may decrease adult hippocampal neurogenesis (Bondolfi et al., 2004; Kitamura 
et al., 2006). Furthermore, obesity was a detrimental factor in studies investigating post-
stroke recovery in humans, showing that a history of increased calorie intake impairs brain 
repair (Kalichman et al., 2007). Interestingly, CR was also proven beneficial in elderly 
humans as shown by improved verbal memory scores (Witte et al., 2009). It must be 
considered however, that in elderly, sometimes frail individuals, restricting of calories may 
be too dangerous, older populations may therefore benefit from more targeted 
pharmacological interventions to modulate NSCs activity based on CR/IF and DR mimetics. 
 
Though it may seem counter-intuitive that reducing calories may be beneficial to stem cells 
in particular, this can be explained by our historical food supply not being readily available 
and abundant at all times. Humans have evolved to cope with periods of reduced calorie 
intake, resembling the effect achieved by CR and IF experiments. A possible biological 
explanation for this relies on the benefits of refeeding after a fasting period, suggesting 
  1. General Introduction 
32 
 
that when an organism is “fasting” it can focus on preparing resources to act quickly and 
effectively when nutrients do become available (Reed et al., 1996). With respects to the 
NSCs of the DG in particular, their activity is possibly enhanced in the absence of nutrients 
owing to the necessity of “hunting behaviour” and the requirement for cognitive flexibility 
that must accompany it: improved cognition may be a means to ensure food is found 
(Mattson, 2012).  
1.4 The role of nutrient-sensing pathways in neural stem cell regulation and ageing 
Owing to the compelling research relating diet to longevity and to NSCs, the field is now 
trying to delineate the molecular pathways behind this relationship. Though many 
pathways are involved in NSC regulation and an equally vast amount is involved in nutrient-
sensing and ageing, there is a relatively small proportion identified as relating the three. 
Thus far, the best characterized, and therefore most promising starting point for imminent 
studies, are the mTOR, Insulin and Insulin-like growth factor signalling (IIS) and Sirtuin 
pathways. In this section, we will focus on the available data supporting a role for these 
pathways in ageing, nutrient sensing and NSC regulation. See Figure 4 for a summary of key 
NSC related functions affected by these pathways.




Figure 4 - Schematic summarizing the key effects of the Insulin/ Insulin-like Growth factor (IIS) (in purple), mTOR (in green), sirtuin (in blue) and epigenetic (in orange) 
pathways on neural stem cell (NSC) function as a result of diet and ageing. Solid arrows represent relationships between the molecular pathways (represented by the four 
rectangles in the center) and NSC function (represented by the outer, rounded rectangles) or related phenotypes (dotted rounded rectangles) discussed in this review. The 
dotted arrows connect possible molecular mechanisms behind the observed phenotypes reported in this review. Red arrows represent an effect caused by the inhibition of 
the pathway they stem from. Boxes with gradient colouring represent functions affected by multiple pathways 




The mammalian target of rapamycin (mTOR) is a classical dietary and nutrient sensing 
pathway. mTOR is a serine/threonine kinase. It combines with several accessory proteins 
including RAPTOR or RICTOR to form mTOR complex 1 (mTORC1) and mTOR complex 2 
(mTORC2) respectively. The two complexes carry out different functions with mTORC1 
being responsible for cell growth and metabolism while mTORC2 regulates cytoskeleton 
organization. Importantly, mTOR is the catalytic subunit of the complex and is inhibited by 
the presence of rapamycin, this inhibition however only occurs when mTOR is bound to the 
RAPTOR protein (Magri and Galli, 2013). mTOR activity is altered by energy and amino acid 
availability as well as growth factors, making it a key molecule within nutrition studies 
(Magri and Galli, 2013). mTOR is also involved in a feedback loop with insulin where insulin 
(discussed below) activates mTOR and mTOR phosphorylates the S6 kinase, which in turn 
inhibits insulin signalling (Blagosklonny, 2008). In the liver, branched chain amino acids 
(BCAA) in particular signal for mTOR activation, showing that protein intake and specific 
amino acids alter the total activation of mTOR (measured as phosphorylated mTOR / total 
mTOR) and ultimately longevity (Solon-Biet et al., 2014). 
 
As well as functions in nutrient sensing, the mTOR pathway has also been linked to 
longevity (Blagosklonny, 2010). Its inhibition via ethylaxanthine and rapamycin was shown 
to improve longevity in yeast (Wanke et al., 2008) and mice (Fok et al., 2014; Harrison et 
al., 2009) respectively, leading to plans to test the compound in larger and longer-lived 
mammals such as companion dogs (Check Hayden, 2014).  Recently, the mechanism of 
action behind rapamycin’s role in longevity was suggested to involve a decrease in reactive 
oxygen species, as shown by experiments in the rodent liver (Martínez-Cisuelo et al., 2016). 
Notably, rapamycin treatment was shown to exert its beneficial effects even if started at 
advanced age, a factor, which usually greatly impairs the efficacy of life-extending 
interventions (Harrison et al., 2009). In addition, Tan and colleagues highlighted increased 
PI3K/Akt/mTOR pathway activation during ageing as the molecular mechanism responsible 
for replicative senescence in vascular smooth muscle cells (Tan et al., 2016). This pathway 
has been the focus of ageing research and is shared by both the mTOR and the insulin-like 
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growth factor signalling (IIS) pathways as explained in section 1.4.2. Several consequences 
of mTOR activation increase the risk of premature ageing and disease, these include 
decreased autophagy accompanied by an increase in protein production eventually causing 
an increase in protein agglomeration as well as an increase in inflammation(Verburgh, 
2015). Furthermore, chronic mTOR activation causes increased proliferation of several 
types of stem cells eventually leading to progenitor pool depletion. Adequate mTOR 
regulation could thus be key in maintaining these populations throughout ageing (Paliouras 
et al., 2012; Sato et al., 2010) Though there is a limited number of studies investigating the 
role of mTOR within the NSC population, there have been several encouraging findings 
supporting key functions for this nutrient sensing pathway in NSC regulation and ageing.  
 
Firstly, both protein deposition and inflammation are key hallmarks of neurodegenerative 
conditions suggesting that mTOR hyperactivity may contribute to disease progression 
within the CNS (O’ Neill, 2013). These observations are consistent with the evidence 
supporting ageing as a consequence of overstimulation of signalling pathways, driven by 
the overabundance of nutrients. Furthermore, mTOR has also been shown to be key in 
dictating the proliferation rate of the adult SVZ NSC population; its inhibition in fact, caused 
progenitor pool depletion (Paliouras et al., 2012). In addition, Han and colleagues have also 
reported that, during embryonic development, mTOR carries an important role for 
neuronal differentiation: enhancing mTOR activity via insulin caused an increase in the 
number of neurons, which was counteracted by rapamycin. Intriguingly, in the presence of 
rapamycin the decrease in neuronal numbers was attributed to increased autophagy rather 
than apoptosis (Han et al., 2008).  These findings also suggested the possibility of similar 
mechanisms taking place in adult NSCs. Indeed, Yu and colleagues showed that increased 
autophagic death also occurred in adult hippocampal NSC following insulin withdrawal and 
was accompanied by a decrease in cell density, these effects were also exacerbated by the 
presence of rapamycin, implicating mTOR activity (Yu et al., 2008). The authors state that 
in an aged environment there is decreased insulin signalling and thus increased autophagy, 
which may reduce the survival of stem cells. Contrary to this, the authors remark that 
autophagy can enhance cell survival, given its beneficial effect in clearing unwanted and 
malfunctioning cells, an essential mechanism in the context of ageing (Cuervo, 2008). 
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Elevated autophagy in response to reduced insulin signalling may thus not be a solely 
negative effect but further research is required to better delineate the modulatory role of 
mTOR activity in NSC during ageing (Gems and de la Guardia, 2013).  
The limited number of studies (See Table 1) however, highlights the need for further 
investigations into the exact mechanisms of mTOR regulation in adult NSCs, with the 
ultimate aim of determining whether modulation of this pathway can bring preserve the 
NSC pool during ageing.  The key effects of the mTOR pathway on NSCs elucidated this far 
are depicted in Figure 4. 
 Insulin 
Insulin and Insulin-like growth factor (IGF) are two hormones closely linked to nutrition, as 
they respond to increased glucose. Insulin is released by the β cells of the pancreas and 
acts upon transmembrane tyrosine kinase receptor to activate downstream signalling 
pathways and cause glucose uptake by liver and muscle cells (van Heemst, 2010). Other 
members of the IGF family are under the control of growth hormone (GH) release by the 
pituitary gland. They also act upon tyrosine kinase receptors and activate downstream 
pathways that are often shared with insulin, coining the term insulin/ insulin-like growth 
factor signalling (IIS) pathway. Stimulation of the IIS pathway results in the activation of the 
PI3K/Akt pathway, a pathway shared with mTOR signalling, which ultimately leads to the 
inactivation of the FoxO transcription factors(van Heemst, 2010). While both insulin and 
IGF respond to carbohydrate presence, they usually carry out slightly different roles with 
insulin being primarily occupied with glucose metabolism and IGF with growth and survival 
(Rafalski and Brunet, 2011). Besides being activated by carbohydrates such as glucose, the 
IIS pathway is also stimulated by proteins and is involved in a feedback loop with mTOR as 
described in section 1.4.1 (Blagosklonny, 2008).  
 
IIS is also extensively implicated in longevity (Bartke et al., 2013; Kimura et al., 1997); 
overactivation, like for mTOR, leads to decreases autophagy and ultimately to the 
shortening of lifespan (Verburgh, 2015). The decrease of the IIS pathway in C. elegans by 
Kimura and colleagues was one of the first experiments to show an increase in lifespan 
relating to diminished insulin signalling (Kimura et al., 1997). This was confirmed by several 
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other studies, with Blüher and colleagues showing that the knock-out of a fat specific 
insulin receptor resulted in an increase in lifespan of 18% (Blüher et al., 2003) and Taguchi 
et al finding that the knock-out of downstream substrates of the IIS pathway caused a 32% 
increase in female mice lifespan (Taguchi et al., 2007). Furthermore, serum IGF-1 levels in 
31 different mouse strains negatively correlated to average lifespan (Yuan et al., 2009). 
Some encouraging evidence has also been found relating IIS to human longevity; IIS related 
polymorphisms correlate to lifespan (Bonafè et al., 2003; Kojima et al., 2004) and several 
centenarians were found to have loss of function mutations in the IGF-1 receptors (Suh et 
al., 2008). Conversely, people affected by acromegaly, characterized by increased GH 
release, experienced a 2-3 fold increase in death rate (Clayton, 2003; Suh et al., 2008; 
Verburgh, 2015). More recently, reduced growth hormone secretion, and thus indirectly IIS 
activity, was shown to correlate with human familial longevity (van der Spoel et al., 2016) 
and genome wide meta-analysis studies linked several gene loci to longevity and to levels 
of circulating IGF-related proteins (Teumer et al., 2016).  These studies show that this 
pathway and its role in lifespan is conserved in more complex organisms. Several rodent 
studies have suggested insulin and IGF may link nutrition to organism longevity through key 
functions in tissue-specific stem cell maintenance. Mechanisms such as autophagy, 
compromised by IIS overstimulation, carry out key functions within the stem cell 
population.  FoxO3A was proven essential for efficient clearing of age-related cellular 
debris which is known to prevent malfunctioning of stem cells and to lead to improved 
longevity (Cuervo, 2008; Warr et al., 2013). The IIS pathway also appears to have important 
functions on the regulation of NSCs specifically, with studies implicating it in both 
development and adulthood. 
 
IGF-1 overexpression alone and IGF-1 and insulin overexpression on embryonic NSC for 
example, highlighted that insulin pushes towards increased differentiation while IGF-1 
pushes towards a proliferative phenotype (Arsenijevic et al., 2001). Furthermore, studies 
have shown that overexpression of IGF-1 leads to increased brain size due to increased 
myelination (Carson et al., 1993). Finally, Igf-1 null mice presented with decreased 
proliferation and differentiation of oligodendrocyte lineage (Ye et al., 2002).  
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Whether these effects persist into adulthood requires further investigation. Recently 
however, Chaker and colleagues showed that the inhibition of IGF-1 signalling in rodent 
adult olfactory bulb NSCs was able to hinder age-related stem cell decline and preserve the 
production and integration of new-born neurons (Chaker et al., 2015). IGF-1 was also 
shown to stimulate proliferation of adult hippocampal NSC both in vivo and in vitro while 
blocking the PI3K/Akt pathway stopped the proliferative effects of IGF-1 on NSCs (Åberg et 
al., 2000, 2003). This was later supported by  Chigogora and colleagues finding a correlation 
between IGF-1 levels and an elevated risk of human depression (Chigogora et al., 2016), a 
disorder known to involve neurogenic and possible NSC deregulation (Hill et al., 2015). 
Furthermore, the deletion of the FoxO family members results in increased brain size and 
proliferation during development but also in a depletion of the progenitor pool and 
ultimately a decrease of SVZ adult neurogenesis (Paik et al., 2009; Renault et al., 2009). 
FoxO3 in particular seems to regulate quiescence of the adult SGL and SVZ NSC population 
and to have a role in oligodendrocyte regulation. FoxO transcription factors are also 
sensitive to oxygen changes making them ideal effectors between oxidative stress, a known 
aspect of ageing, and stem cell maintenance (Renault et al., 2009). Besides these studies, 
several others have reported pro-neurogenic effects of insulin when investigating the 
mTOR pathway as discussed in section 1.4.1.  
 
Interestingly, IGF-II is produced by choroid plexus and released in the cerebrospinal fluid 
(CSF), allowing it to come in contact with the neurogenic niches. NSCs in the SVZ extend a 
process through the ventricular wall and come in contact with the CSF directly, thereby 
allowing its composition to directly alter their regulation. Increased presence of CSF IGF-II 
during development for example, promotes neurogenesis (Lehtinen et al., 2011; Ziegler et 
al., 2015). IGF-II is also involved in hippocampal neurogenesis in adulthood (Bracko et al., 
2012). In vitro and vivo studies showed IGF-II involvement in promoting NSC maintenance 
(Ziegler et al., 2012). Studies have also linked IGF-II dependent mechanisms to 
hippocampal-dependent memory retention (Chen et al., 2011) and more specifically to 
age-related cognitive decline (Steinmetz et al., 2016) in rodents, further supporting a link 
between IGF-II and NSCs function and  presenting a key target for further researching 
seeking to preserve AHN during ageing (See Table 1).  




The overall effects of this pathway on NSC regulation however, remain inconclusive due to 
a limited number of concordant studies (Åberg et al., 2003; Itoh et al., 2012); some studies 
have reported increased IIS resulting in a beneficial increase in adult neurogenesis, for 
example during GH and IGF-1 mediated increases in neurogenesis as a result of exercise 
(Berg and Bang, 2004) or following a blueberry supplemented diet in rodents (Shukitt-Hale 
et al., 2015). In contrast, CR, which is known to directly target and diminish IIS, has also 
been proven beneficial for both cognition and longevity in rodent models of Alzheimer’s 
disease (Parrella et al., 2013). Figure 4 summarizes some of the NSC functions affected by 
the IIS pathway. As for mTOR, this highlights the need of a fine-tuned balance between IIS 
activation and inhibition throughout the lifespan. It is likely that several other factors such 
as oxidative state of the cell, biological age and brain region all play a role in this balance 
and can propel towards a positive or negative effect of the IIS pathway. 
 Sirtuins 
Sirtuins are a group of deacetylases initially shown to extend lifespan in yeast by regulating 
mitochondrial function and cellular redox state (Aguilaniu et al., 2003). Deacetylases are 
key regulatory proteins as they can control the expression of several genes. Furthermore, 
sirtuin activity is NAD-dependent, making them likely candidates for the molecular link 
between metabolism and ageing owing to their ability to respond to the cell’s energy 
status. Indeed, Sir2 activation in yeasts mimics CR-induced longevity, which in turn was 
shown to depend on the Sirtuin pathway (Lin et al., 2000). Increased lifespan as a result of 
sirtuin overexpression was also confirmed in other organisms such as Drosophila and C. 
elegans (Guarente, 2007). Similarly, the mammalian components of the sirtuin family, 
SIRT1 and SIRT4 have also been implicated in CR diet-regulated processes, showing that the 
link between metabolism and ageing could be conserved across species (Guarente, 2007). 
Research into Sirtuins also highlighted the importance of NAMPT, the rate limiting enzyme 
in mammalian NAD+ synthesis; ageing is accompanied by chronic DNA damage which leads 
to NAD+ depletion, Sirt1 inactivation and thus mitochondrial dysfunction (Guarente, 2014). 
Overexpression of NAMPT can rescue NAD+ levels and counteract these changes as shown 
by interesting studies investigating its effects on the accelerated ageing disorder, Cockanye 
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syndrome (Guarente, 2014; Scheibye-Knudsen et al., 2014; van der Veer et al., 2007). The 
importance of NAD+ and sirtuins in ageing was also supported by recent studies by Song 
and colleagues showing that NAMPT inhibition is sufficient to induce senescence in human 
fibroblasts(Song et al., 2015).  
 
The above studies however did not focus on the effects of NAMPT on NSCs. Interestingly, 
a recent study showed that NAMPT ablation recapitulated aspects of NSC ageing such as 
decreased NSC proliferation in rodents (Stein and Imai, 2014), suggesting that NAMPT and 
the sirtuin pathway play key roles in NSC ageing as well. Studies are now beginning to 
integrate the role of sirtuins, ageing and diet or nutrition on the CNS specifically. For 
example, increased Sirt1 levels in murine brains due to CR were shown to increase anxiety 
and decrease exploratory drive (Libert et al., 2011). Whilst NSC function was not assessed 
in these studies, these conditions are known to involve deregulation of hippocampal 
neurogenesis (Hill et al., 2015; Libert et al., 2011) making it a plausible underlying 
mechanism. These studies also highlighted a possible disadvantage of increased Sirt1 
activity and CR.  In line with this, when the effect of SIRT1 deletion was investigated in prion 
disease, a condition in which neurogenic deregulation is also implicated (Gomez-Nicola et 
al., 2014), it was found to delay disease onset and to prolong the healthy portion of the 
affected animals. This was mimicked by CR (Chen et al., 2008). In contrast, others have 
shown that sirtuins can have neuroprotective functions in response to neuronal damage 
and neurodegenerative conditions; firstly, SIRT1 is upregulated in mouse models of 
Alzheimer’s disease and amyotrophic lateral sclerosis and shown to enhance neuronal 
survival both in vitro and in vivo (Kim et al., 2007).  Furthermore, SIRT1 was also found 
responsible for neuroprotective effects in murine models of axonal injury (Araki et al., 
2004). SIRT1 overexpression was found to replicate the beneficial effects of CR in the 
context of several neurodegenerative conditions in various animal models (Gräff et al., 
2013). 
 
As many neurodegenerative conditions experience changes in neurogenesis, it is likely Sirt1 
conveys some of its effects by influencing NSC function. SIRT1 activation in particular was 
linked to changes in neurogenesis in the perinatal SVZ; oxidizing conditions were found to 
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activate SIRT1 and push the progenitor pool towards astrocytic differentiation whereas a 
reducing environment would promote neuronal differentiation(Prozorovski et al., 2008). 
Similarly, blocking Sirt1 activity disengaged redox changes from SVZ NSC fate(Prozorovski 
et al., 2008). Rafalski et al. in contrast, showed that Sirt1 inactivation pushed NSCs towards 
an oligodendrocyte lineage. (Rafalski et al., 2013). Following Prozorovski’s results, it is 
possible that the neuroprotective effect of SIRT1 activation, in part, is explained by 
improved CNS support from an increased number of astrocytes (See Table 1). An 
interesting avenue would be to investigate whether this finding is replicated in the DG and 
how this SIRT1-mediated modulation of the NSC pool changes with age. 
 
Finally, these findings are now being investigated in human populations, Libert and 
colleagues for example showed that rare human SIRT1 variants are associated with anxiety 
and mood disorders (Libert et al., 2011). Interestingly, Sirt1 is also one of the two genes 
recently implicated in major depressive disorder by whole-genome sequencing findings 
(Cai et al., 2015). Though dietary interventions such as CR seem to be the most potent 
effectors of Sirtuin activation, some nutrients, like polyphenols have also been identified 
to directly activate components of this family (Howitz et al., 2003). Together the studies 
reported above, suggest the relationship between Sirt1, CR and ageing is regulated by 
intricate mechanisms, which become even more complex when acting upon different types 
of NSCs. The key NSC’s functions acted upon by the sirtuin pathway are reported in Figure 
4.
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Table 1 -  Table summarizing studies showing supporting evidence for the role of mTOR, IIS and Sirtuin pathways in NSCs function. NSC- Neural Stem Cells, IIS -Insulin and 
Insulin-like Signalling, DG- Dentate Gyrus, SVZ- Sub Ventricular Zone, KO- Knockout.
Pathway Model NSC Intervention Supporting Evidence Study 
mTOR / IIS Rat In Vitro Embryonic 
Increased insulin 
levels 
Increase in differentiated neurons, which was counteracted by 
rapamycin 




DG Insulin withdrawal Increased neuronal death, exacerbated by rapamycin (Yu et al., 2008) 
IIS Mouse In Vitro SVZ and DG FoxO3 knockout Decreased number of NSC and self-renewal ability (Renault et al., 2009) 
mTOR / IIS Rat In Vivo Cortex 
Treated with EGCG + 
TBI 
Reduced NSC cell death around damaged area (Itoh et al., 2012) 
IIS Rat In Vitro DG Increased IGF-1 Decreased differentiation and increased proliferation of NSCs (Åberg et al., 2003) 
IIS Mouse In Vitro Striatal Increased insulin  Increases NSCs differentiation (Arsenijevic et al., 2001) 
IIS Mouse In Vivo Perinatal IGF-1 overexpression Increase in number of neurons and of oligodendrocytes. (Carson et al., 1993) 
IIS Mouse In Vivo Perinatal IGF-1 KO Decreased proliferation and differentiation of oligodendrocytes (Ye et al., 2002) 
IGF-1 Mouse In vivo SVZ IGF-1R KO Reduced age related depletion of NSC (Chaker et al., 2015) 
IGF-II Mouse In Vitro Perinatal IGF-II treatment Increased NSC expansion and promoted self-renewal  (Ziegler et al., 2012) 
IGF-II Mouse In Vitro DG 
Sh-RNA knockdown 
of IGF-II 
Impaired proliferation (Bracko et al., 2012) 
Sirtuins Mouse In Vitro Perinatal SVZ 
Oxidation or Sirt1 
activation 
Enhanced astrocytic lineage 
(Prozorovski et al., 
2008) 
Sirtuins Mouse In Vitro Perinatal SVZ 
Reducing 
environment 
Enhanced neuronal lineage 
(Prozorovski et al., 
2008) 
Sirtuins Mouse In Vitro Perinatal SVZ 
Sh-RNA knockdown 
of Sirt1 
Disengaged neural fate from redox conditions 
(Prozorovski et al., 
2008) 
Sirtuins Mouse In Vivo SVZ and DG  Inactivation of Sirt1 Increased oligodendrocyte differentiation and myelination (Rafalski et al., 2013) 
Sirtuins/ 
NAMPT 
Mouse In Vivo DG 
Measuring /ablating 
NAMPT 
NAMPT levels decrease with age, its ablation reduces NSC 
proliferation and oligodendrogenesis 
(Stein and Imai, 2014) 
Epigenetics Mouse In Vitro Embryonic Dnmt1 knockout Increased astrocytic differentiation (Fan et al., 2005) 
Epigenetics Mouse In Vitro Perinatal SVZ Dnmt3 knockout Impaired neuronal differentiation (Wu et al., 2010) 




Epigenetics is at the forefront of ageing research, a position supported by the recent 
establishment of an ‘epigenetic clock’ by Steve Horvath, and has clear functions in adapting 
the organism’s responses to its environment. These attributes make it a key mechanism 
mediating cellular and molecular responses to diet and ageing processes (Rea et al., 2015). 
Epigenetic modulation comprises many mechanisms and is usually identified as the driving 
force behind changes in gene expression, which are not due to DNA sequence mutations. 
Such a process clearly has very important functions in stem cell regulation of different 
tissues as it can confer lineage-determining decisions as well as maintain quiescence.  
Epigenetics also plays an important role in ageing; twin studies showed that genetic 
background only has a 25% influence on longevity (Herskind et al., 1996) suggesting that 
the remaining effects would be dictated by the environment, which usually ensues its 
effects through epigenetics. A role for epigenetics is also supported by the notion that the 
effect of genetic variations on cognition and brain structure increases with age, recently 
reviewed by (Papenberg et al., 2015). One of such environmental factors able to cause 
epigenetic changes is likely to be diet.   A line of thought believes that as epigenetic changes 
are less permanent, it would be more efficient to target and reverse them rather than 
targeting any genetic mutations which may arise as a result of ageing (Beerman and Rossi, 
2015; Rando and Chang, 2012). By restoring a “young” epigenetic environment one may be 
able to reverse age-related deficit; in a similar manner to the aforementioned 
heterochronic parabiosis studies (Villeda et al., 2014). Another factor supporting the notion 
that targeting epigenetics may be an efficient way to reverse ageing comes from studies 
showing that only a small number of loci are altered consistently throughout ageing, 
allowing for targeted interventions rather than global ones (Beerman and Rossi, 2015). 
Furthermore, epigenetic changes could be used as ageing biomarkers, providing important 
information on the ageing rate of an organism, with the potential to enable more precise 
preventive strategies. It is therefore important for us to understand how age and nutrition 
affect epigenetics and how this causes alterations in NSC regulation, disease progression 
and longevity. For the remainder of this section we will evaluate the evidence for such a 
relationship. 
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 Epigenetics and nutrition 
There are several studies showing perinatal or in utero nutrition can have vast effect on 
health later in life, mainly related to cardiovascular disease, diabetes and obesity (Choi and 
Friso, 2010). Interestingly, these effects were also witnessed in the offspring of the affected 
animals suggesting that epigenetic changes could be passed through generations. The 
involvement of epigenetics was also confirmed via methylome analysis, though a causal 
link is yet to be shown (Fontana and Partridge, 2015; Radford et al., 2014). Such 
mechanisms are set in place to ensure adaptation for the foetus to its environment – CR 
and DR prepares a foetus to food scarcity whilst over nutrition primes for a nutrient 
abundant environment. Studies have suggested it may be the mismatching of predicted 
and actual nutrient availability to cause some of the detrimental health effects later in life 
(Perera and Herbstman, 2011).  
 
While epigenetic changes occurring during the malleable stages development in response 
to nutrition have been extensively studied, those happening during adulthood are less 
known. The evidence from developmental studies reported above, however shows that 
mechanisms are set in place for epigenetics to respond to dietary and nutritional cues 
through the lifespan. Indeed, diet can alter epigenetics in several ways, these include the 
donation of methyl groups and the regulation of several enzymes (Mathers and Ford, 
2009). As well as the alterations in response to CR and DR, other dietary alterations can 
have effects on epigenetics, such as the intake of specific nutrients. Studies on agouti mice 
showed a methyl-supplemented diet was able to cause DNA hypermethylation, making it 
likely for diet-acquired methyl donors like choline and methionine (an essential amino acid) 
to have similar effects (Niculescu et al., 2006; Waterland et al., 2007; Waterland and Jirtle, 
2003). Furthermore, the trace mineral zinc interacts with histone deacetylase regulation 
(HDAC) and causes their inhibition (Myzak et al., 2006) whilst resveratrol, a dietary phenol, 
activates the HDAC SIRT1 (Rafalski and Brunet, 2011). Vitamin D also appears to form an 
important link between nutrition, ageing and epigenetics as its varying concentrations can 
delay the ageing phenotype in mice and its mechanism of action is known to involve histone 
acetylases (HATs) and HDACs (Tuohimaa, 2009).  
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 Epigenetics, ageing and neural stem cells 
Several years ago it was found that cellular methyl content declines with increasing age in 
mammals (Wilson and Jones, 1983). This loss is likely to contribute to genomic instability, 
which is a hallmark of ageing cells. Recently, Horvath and colleagues showed the existence 
of an epigenetic clock and developed a predictor able to estimate the methylation age of 
most tissues or cell types, suggesting that specific epigenetic changes occur as a result of 
age (Horvath, 2013). 
 
Though there are a number of possible epigenetic marks, methylation is the mark 
considered to be the most stable one and thus the most likely candidate for encoding 
ageing and nutritional changes. Methylation changes as a result of age can be divided into 
two main categories: those resulting from loss of fidelity when copying methylation marks 
and those arising from abnormal addition or removal of methylation marks. Further to this, 
a decrease in the activity and expression of the DNA methyltransferase DNMT1 was found 
with increasing age (Cooney, 1993). Interestingly, DNMT1 controls stem cell balance and 
lineage decisions in several tissues; its knock out in embryonic NSCs, for example, causes a 
preferential push towards astroglial differentiation(Fan et al., 2005). DNMT1 loss in general 
causes an ageing phenotype highlighting it as a key molecule governing ageing processes 
(Beerman and Rossi, 2015). In contrast, some housekeeping genes that are usually 
unmethylated seem to become methylated with age. This may be due to an increase in 
DNMT3 activity; DNMT3 is a methyltransferase responsible for de novo methylation, a 
process shown to be key in regulating stem cells as it halts self-renewal to allow 
differentiation. A DNMT3 knock out in mouse in fact showed impaired post-natal SVZ and 
SGL NSC differentiation (Wu et al., 2010) (See Table 1). 
 
An important methylation mark, studied in the field of ageing and NSCs, is the methylation 
of lysine 27 on histone 3 (H3K27). The differing methylation of this mark in fact can regulate 
adult NSC differentiation; when this mark has a single methylation, transcription is enabled, 
when the mark has 2 or 3 methyl groups gene transcription is repressed (Zhang et al., 2014). 
Another epigenetic mark often involved in ageing is histone acetylation; several histone 
acetylases (HATs) are key in regulating the NSC pool by affecting both proliferation and 
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differentiation of the neural progenitors. Sirtuins as detailed above are part of this family. 
There is also evidence of different epigenetic marks influencing one another – i.e. DNA 
methylation being restricted by acetylation marks (Beerman and Rossi, 2015). See Figure 4 
for a representation of this interconnection. Mathers and Ford suggest that changes in 
methylation do not occur in every cell in a tissue. They explain how this leads to promoter 
methylation heterogeneity and thus to divergent gene expression and cellular response 
across different tissues with increasing age (Mathers and Ford, 2009). Together these 
studies show that epigenetic mechanisms are pivotal to a permissive or restricting 
environment for gene transcription in response to environmental cues and are therefore 
likely molecular effectors of nutrient intake and its ensuing effect on NSC regulation.  
 
Finally, as well as sharing common downstream mechanisms, ageing and nutrition can also 
affect one another; for example, nutrient intake may change as a result of age which could 
then cause the age-related epigenetic changes. A reduction of fruit and vegetable intake 
for instance, would reduce the intake of zinc and thus affect HDAC function (Mathers and 
Ford, 2009). Given the prominent role played by NSCs during ageing, an exciting avenue 
would be to explore epigenetic changes in these cells in response to diet. 
1.6 Conclusions 
In conclusion, though much progress has been made in establishing the role played by 
nutrition in longevity, and on stem cells more broadly, its role in NSCs regulation is still to 
be elucidated. Whilst the positive impacts of CR and IF continue to be detailed in model 
systems, more targeted pharmacological approaches may be beneficial for use in frail and 
elderly populations. This highlights the need for a more thorough understanding of the 
molecular pathways involved in these dietary paradigms. Further to this, much more 
research into the genetic - and epigenetic - influences of diet and nutrition is required, to 
refine populations that potentially stand to gain the most from such interventions.     
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1.7 Summary of introduction 
In the above review, we discussed the importance of ageing research given the changing 
population structure. We focussed on the impact of the hippocampus and of neurogenesis 
on cognitive ageing and emphasised the role played by lifestyle and genetics on the rate of 
cognitive decline. We outlined the current knowledge on how mTOR / IIS pathway 
inhibition and sirtuin activation may enhance longevity and CNS function, an effect 
achieved at least in part, through their impact on NSC function. We also highlight epigenetic 
modification as important contributors to the ageing process and as mediators for the 
effect of diet on longevity and NSCs.  
 
Importantly, we emphasise the need for more human-based studies to assess whether 
similar mechanisms occur in both animal and human NSC regulation and suggest that a 
combination of diet and genetics may contribute to the surprising heterogeneity of the 
ageing process in humans and thereby to the discrepancies between chronological and 
biological age. 
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1.8 Thesis aims and hypotheses 
We hypothesise that biological ageing is a malleable process which can be accelerated and 
delayed. We also hypothesise that nutrient-sensing pathway alterations are key mediators 
of this process and that they are especially important in the regulation on NSCs in response 
to ageing. Finally, we hypothesise that genetic polymorphisms in genes within these 
pathways, together with environmental factors such as lifestyle impact human cognition. 
  
This thesis aims to evaluate the modulation of nutrient-sensing genes in human NSC 
regulation and cognition.  
 
In particular, this thesis will address the following: 
1) Test whether an aged systemic environment can alter the gene expression of 
candidate nutrient-sensing genes or affect the proliferation and differentiation rates 
of an in vitro model of hippocampal neurogenesis. 
 
2) Establish a controlled cellular model of hippocampal progenitor cell ageing to assess 
whether it induces alterations in the proliferation and differentiation rates of human 
progenitor cells and whether it leads to alterations in the expression level of 
candidate nutrient-sensing genes. 
 
3) Assess the role of diet, exercise and genetic polymorphisms of candidate nutrient-
sensing genes on cognitive performance in an ageing human cohort. 
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2 Materials and Methods  
This chapter reports the common materials and methods used throughout this thesis. We 
introduce the cell line used for all in vitro experiments and detail cellular and molecular 
analysis techniques employed throughout this thesis. The specific methods used within 
each chapter are outlined in chapter-specific materials and methods sections. 
 
2.1 Human hippocampal progenitors culture -  In Vitro model of hippocampal 
neurogenesis 
 Immortalisation 
The human hippocampal progenitor cells (HPC) cell line HPC0A07/03A (ReNeuron Ltd., 
Surrey, U.K., hhtp://reneuron.com ) was used for all cellular experiments in this project and 
was previously described in (Anacker et al., 2011) and (Johansson et al., 2008). Briefly, 12-
week-old foetal female tissue was obtained in accordance with UK and USA ethical and 
legal guidelines following normal terminations. A small population of neural stem cells from 
the hippocampal region was dissected under microscopic control and grown to 50-60% 
passage (P) 0 confluency as a primary culture. The cells were then infected with the 
retroviral vector pLNCX-2 encoding the c-mycERTAM gene construct and neomycin selection 
was employed to generate a conditionally immortalised cell line. This construct produces a 
version of the oncogene c-myc, which is responsible for growth, where its c-terminus is 
fused to a modified oestrogen receptor and its activity is therefore determined by receptor 
activation(Pollock et al., 2006). As this receptor is selectively activated by the synthetic drug 
4-hydroxy-tamoxifen (4-OHT) at 100nM, c-Myc activity and consequently cell proliferation 
is dependent on the presence of 4-OHT.  This attribute can be used to control proliferation 
and differentiation of the progenitors in an in vitro system by the addition and removal of 
4-OHT and growth factors as illustrated in Figure 5. In the absence of growth factors and 4-
OHT the progenitors differentiate into neurons, astrocytes and oligodendrocytes 
(Johansson et al., 2008). 
 




Figure 5 - Schematic of transgene function in the HPCOA07/03A cell line by ReNeuron. The cell line contains 
the c-Myc oncogene under the control of the estrogen receptor (ER); c-MycER.  In the presence of 4-OHT 
(synthetic version of estrogen), c-MycER dimerizes and translocates to the nucleus, this allows promoter 
binding which leads to the activation of downstream pathways leading to cell proliferation, provided FGF2 
and EGF are also present. In the absence of 4-OHT, the cells are unable to proliferate and begin differentiating 
(Pollock et al., 2006). 
 Cell bank 
For most experiments, cells used in this project originated from common Thuret lab cell 
bank created from a passage 8 vial obtained from ReNeuron. Briefly, the passage 8 vial was 
thawed and passaged exponentially until passage 13. Approximately 100 passage-13 vials 
containing 2 million cells each were frozen in Mr FrostyTM (Thermo Fisher) and stored in 
liquid nitrogen. Several intermediate passages were also frozen and stored as safety 
measures. 
 Cell culture conditions 
HPC0A07/03A cells were grown in reduced modified media (RMM) supplemented with 
factors outlined in Table 2 and in the absence of any serum besides when specifically stated 
as part of treatments. Cells were passaged using Accutase (A1110501, Sigma) and cultured 
on tissue culture flasks (Nunclon, Denmark) coated with 20ug/ml mouse laminin (L2020 
Sigma) at 37 ˚C, 5% CO2 and saturated humidity. HPC03A/07 cells normally proliferate with 
a doubling time of 48-72 hours (Johansson et al., 2008), medium was changed fully 24 hours 
after passaging. 
 






Catalogue Number / Supplier 
Dulbecco’s modified eagle’s medium 
nutrient mixture f-12 ham 
N/a D6421 500ml, Sigma 
Human albumin solution 0.03 % 20, Zenalb 
Apo-transferrin 100 μg/ml T1147, Sigma 
Putrescine DIHCL 16.2 μg/ml P5780, Sigma 
Human recombinant insulin 5 μg/ml I9278-5ml, Sigma 
Progesterone 60 ng/ml P8783, 1 mg Sigma 
L-glutamine 2 mM G7513, 100ml Sigma 
Sodium selenite 40 ng/ml S9133-1MG, Sigma 
Additional factors for growth and proliferation media 
Epidermal growth factor (EGF) 10 ng/ml AF 100-15-500, Peprotech 
Basic fibroblast growth factor (bFGF) 20 ng/ml EC 100-18B, 50ug Peprotech 
4-hydroxytamoxifen (4OHT) 1:10 000 H7904, 5mg Sigma 
Table 2 - Components of reduced modified cell culture medium (RMM) used for all cultures 
 
 Proliferation assay 
Progenitor cells were seeded on 96-well plates (Nunclon, Denmark) at a density of 1.2x104 
cells per well in 3 technical replicates for cellular work or in 6-well plates (Nunclon, 
Denmark) at a density of 3x105 for molecular work. Cells were cultured in proliferation 
media (RMM including EGF, bFGF and 4-OHT (See Table 2) for 24 hours, at which point the 
media was replaced by proliferation media containing the appropriate treatment for the 
experimental condition (See Figure 5) for a duration of 48 hours.  In conditions where 
treatment consisted in the addition of human serum from young or old persons this was 
delivered at a concentration of 1% in proliferation media and supplemented with 1% 
Penicillin-Streptomycin (P/S, Life Technologies). 
 
72 hours after seeding cells in 96-well plates were washed in Phosphate Buffered Saline 
(PBS), fixed with 4% paraformaldehyde (PFA) for 20 minutes at room temperature and 
stored at 4˚C in preparation for immunohistochemistry. Cells in 6-well plates were either 
harvested for RNA work by adding 1ml of TRIzol (12044977, Ambion) per well and scraping. 
 




Figure 6 - Schematic of proliferation and differentiation assays. A shows the timescale of the experiments, 
the treatment timepoints and growth factors used. B displays how the above timeline can be divided to yield 
proliferation or differentiation assays. Cells are cultured in media containing growth factors (EGF, bFGF and 
4-OHT) for the duration of the proliferation assay (first 72 hours) at which point the plates can be fixed / 
harvested to complete the proliferation assay. Alternatively, to begin the differentiation assay, plates 
undergo 2 full media changes with differentiation media (lacking EGF, bFGF and 4-OHT) and are cultured for 
a further 7 days in differentiation media containing treatment.    
 Differentiation assay 
Progenitor cells were seeded, cultured and treated as for the proliferation assay for the 
first 72 hours. After the proliferation assay, instead of harvesting or fixing, cells were 
washed in differentiation media (RMM lacking EGF, bFGF and 4-OHT) 2 times at 30-minute 
intervals and finally treated with the appropriate treatment in differentiation media after 
a subsequent 30 minutes. Cells were then cultured for a further 7 days and harvested for 
RNA and DNA or fixed as described for the proliferation assay see Figure 6 for experimental 
schematic. 
 Treatments 
Unless specified, treatments were carried out at the 24-hour time point in proliferation and 
at the 72-hour timepoint at the start of differentiation at the concentrations outlined in 
Table 3. Serum treatment concentration was selected Dr. Tytus Murphy who carried out a 
dose-response curve testing concentrations between 0.1% and 10%. 1% serum was 
selected as the most efficient concentration that did not cause overconfluence, had a 
significant proliferative effect compared to media-only controls and made the most 
efficient use of a limited resource (serum from cognitively healthy older participants). 






Tert-Butyl Hydroperoxide (tBHP) 0.01µM 
Hydroxyurea (HU) 1mM 
Combination: tBHP And HU 0.01 µM and 1mM 
Table 3 - Standard treatment concentrations 
2.2 Cellular analysis 
 Immunostaining 
PFA-fixed cells were blocked for 60 minutes at room temperature in blocking solution 
consisting of phosphate buffered saline (PBS) containing 5% normal donkey serum (D9663, 
Sigma), 0.3% Triton-X (93443, Sigma).  Primary antibodies were diluted appropriately 
(Table 4) in blocking solution, 30µl of antibody in blocking solution was added to each well 









1:500 Ab15580, abcam 
Marker of proliferation: labels cells in 




1:800 9449, CellSignalling 
Marker of proliferation: labels cells in 











1:500 Ab5603, Abcam 














Marker of DNA repair (Histone) 
Rabbit anti-
DCX 
1:500 Ab11267, Abcam Marker of neuronal precursors 
Mouse anti-
Map2 
1:500 Ab11267, Abcam 
Microtubule associate protein 2, 
marker of immature neurons 
Rabbit anti-
NRF2 
1:500 Ab31163, Abcam 
Transcription activator involved in 
gene up-regulation in response to 
oxidative stress 
Table 4  - Table showing the primary antibody used, their dilution, catalogue numbers and function. 
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The following day, the HPCs were washed in PBS and incubated in blocking solution for 30 
minutes at room temperature, followed by 30µl/well of appropriate secondary antibody 
diluted in blocking solution for 2 hours at room temperature (Table 5). The cells were then 
washed 3 times and incubated with 50µl/well of 300µM DAPI (Sigma, D9542-5mg) in PBS 
solution for 5 minutes at room temperature. Well were washed 3 more times and stored 
in PBS supplemented with 0.05% sodium azide. Representative images of each marker for 
proliferation and differentiation assay are reported in Figure 8 and  
Figure 9 respectively. 
 
Secondary antibody Dilution Catalog # / Supplier 
555 Donkey Anti-rabbit IgG 1:500 A-31572, Life Technologies 
488 Donkey Anti-mouse IgG 1:500 A- 21202, Life Technologies 
Table 5 - Table showing the secondary antibody used, dilution and catalogue numbers. 
 
 Image analysis 
2.2.2.1 Quantifying cellular markers 
All immunostainings were quantified through the semi-automated CellInsight NXT High 
Content Screening (HCS) platform (ThermoScientific). The Studio software enables users to 
set threshold parameters to allow unbiased comparisons throughout treatments and 
plates. Parameters were kept constant within studies but varied throughout different 
experimental set ups. On rare occasions parameters were varied within studies to account 
for changes in the brightness of the stains (See section  08.1.1 for parameters used). 
 
Protocols and scripts were developed using Studio’s Cell Health Profiling BioApplication 
which relies on the nuclear stain (386 wavelength) to identify cells and set a search area for 
identifying other stains in the 488 and 555 wavelengths. The user first instructs the 
software to “autofocus” on the nuclear stain then sets an exposure time for image 
acquisition for each of the 3 channels and acquires several representative images. It is 
important the stain is visible but not oversaturated due to background noise. These images 
are then used to validate the selected nuclear stain, where one can discard stains too small 
to count as nuclei and set segmentation parameters to distinguish cell borders. The 
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representative images are then divided into positive images and negative control images 
(wells stained with DAPI and secondary antibodies alone) and average intensity thresholds 
are set to distinguish specific fluorescent signal from unspecific binding and background 
noise. The threshold must be higher than highest intensity signal seen in the negative 
control images (see Figure 7).  Once positive (cells with intensity higher than the set 
threshold) and negative cells (cells with a lower intensity than the set threshold) are 
identified on sample images, the software will capture 15 fields per selected well and 
compute the percentage of all cells (identified via the nuclear stain) are positive for each 
marker. The software can also calculate other information such as nuclear area and number 
of cells per field. Both the calculations and the images can then be exported.   
 
 
Figure 7 - Screenshot of the CellInsight Platfrom (Thermofisher) software being used to set an average 
intensity threshold. Positive cells are on the left and negative controls (secondary antibody alone) on the 
right. Below the representative images there is a scatter plot showing the average intensity for a specific 
channel (Ch2: channel 2) of each cell within that image. This stage of the protocol involves setting an average 
intensity threshold (horizontal line) above background noise and unspecific binding, we therefore set the 
threshold to be above the signal emitted by negative control wells. Cells surrounded by a red mask are the 
cells selected as having a positive stain if this threshold was to be applied 
 




Figure 8 -  Panel of representative images of immunostaining following the proliferation assay. Each square represents a field as analysed by the CellInsight software.In 
each row, the nuclear marker DAPI is in the image followed by Ki67 and CC3 (row 1), H2AX, NRF3 (row 2) or NESTIN and SOX2 (row 3). The final image in each row is the 
merged image showing all three stains combined. Scale bar representing 100µM is reported in the bottom left corner of each image. 




Figure 9 - Panel of representative images of immunostaining following the proliferation assay.. Each square represents a field as analysed by the CellInsight software. In 
each row, the nuclear marker DAPI is in the image followed by Ki67 and CC3 (row 1), H2AX, NRF3 (row 2) or NESTIN and SOX2 (row 3). The final image in each row is the 
merged image showing all three stains combined. Scale bar representing 100µM is reported in the bottom left corner of each image.
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2.3 Molecular analysis 
 Quantitative Polymerase Chain Reaction  
Quantitative Polymerase Chain Reaction (qPCR) was carried out to investigate gene 
expression throughout this project. Primer design methods and primer sequences are 
reported in section 3.2.4. 
 
2.3.1.1 RNA extraction and DNase treatment 
Cells were grown in 6-well plates underwent the proliferation or differentiation protocol 
explained in section 2.1.4 and 2.1.5. Each well was lysed mechanically and resuspended in 
1ml TRIreagent (T9424, Sigma). Trizoled sample was transferred to phase lock tubes 
(Invitrogen™ ) and chloroform (1 chloroform : 5 trizol ratio) was added to each sample and 
RNA was separated by vigorous shaking and centrifuging at 10000 RPM for 5 minutes. The 
aqueous layer containing RNA was then transferred to a new tube, treated with 500µl of 
isopropanol and centrifuged. The resulting pellet containing the nucleic acids was then 
washed with 80% ethanol and air dried. The pellet was resuspended in 100µl H20 and 
incubated on ice for 15 minutes before the addition of 10µl Sodium Acetate followed by 
300µl of 100% ethanol and overnight incubation at -80˚C. Though optional, the sodium 
acetate was carried out on all samples to ensure the highest possible purity. The next 
morning samples were spun at 13000 RPM for 15 minutes, the supernatant was discarded 
and the wash in 80% ethanol was repeated. Samples were left to air dry and then 
resuspended in H2O and assessed for purity and RNA concentration using the NanoDropTM 
1000 spectrophotometer (Thermo Scientific). If the purity indicated by the 260/280 ratio 
was not satisfactory, the sodium acetate step was repeated.  A minimum of 1.4µg of RNA 
was subsequently treated with 1µl of TURBO DNA-free (AM1907, Life Technologies) to 
remove any remaining DNA, and finally with DNase Inactivation Reagent (AM1907, Life 
technologies), as per supplier instructions. 
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2.3.1.2 Reverse Transcription 
0.7µg of extracted RNA was combined with 250ng of random hexamers (N8080127, nLife 
Technologies) and 1mM dNTP mix (RO191, Thermo Scientific) and made up to 13µl with 
nuclease free water (Sigma-Aldrich).  The mix was heated at 65˚C for 5 minutes and then 
placed on ice for 1 minute before being made up to 20µl with the reagents shown in Table 
6 and nuclease free water. 
   
Reagent Concentration Catalog # / supplier 
First Strand buffer 1 unit Invitrogen 
Dithithretiol 5mM 18080-044, life Technologies 
RNaseOUT 40 units 10777, Life Technologies 
SuperScript III Reverse Transcriptase 200 units Invitrogen 
Table 6 - Table showing components for reverse transcription 
Samples were then incubated at 25˚C for 5 minutes (primer annealing), 50˚C for 1 hour 
(optimal temperature for reverse transcriptase function), 55˚C for 30 minutes (to remove 
secondary structures) and 70˚C for 15 minutes (to inactivate the reverse transcriptase) 
before being diluted in nuclease free water. Dilutions were carried out aiming for maximal 
use of samples while ensuring a cycle threshold (CT) value lower than 30 to ensure efficient 
qPCR readouts. Dilutions varied from 1:25 to 1:35. 
 
2.3.1.3 Thermocycler protocol 
10µl of diluted cDNA was combined with 4µl 5X EvaGreen (08-24-00008, Solis BioDyne, 
Estonia), 2µl of 2µM primer mix and 4µl of nuclease-free water. qPCRs were carried out 
with the Chromo4 Real-Time PCR detector (Bio-Rad), following the protocol outlined in 
Figure 10. Following the protocol outlined in Figure 10, a melt curve was carried out from 
60 ˚C to 90 ˚C by carrying out a plate read at each 1˚C increment. UV zapped white 96-
welled qPCR plates (AB-0900/W, ThermoFisher) were used for all qPCRs. All reactions were 
carried out in triplicates accompanied by negative controls where cDNA was replaced by 
H2O. 
 





2.3.1.4 qPCR analysis 
Using the Opticon MonitorTM (Bio-Rad) software, the melting curve profile for each sample 
was assessed and if satisfactory, the CT value and efficiency were exported. When carrying 
out cross-plate comparisons, the same fluorescence threshold was used across all plates to 
extract the  corresponding CT values. The Pfaffl method was used to quantify the relative 
levels of the qPCR transcript. The formula is reported below:  
 
 
Where target is the target gene being analysed, ref is the average of the housekeeping 
genes and E = PCR efficiency. Therefore, ΔCTtarget = difference in CT values of the target gene 
between sample and control conditions, ΔCTref  = difference in CT values of housekeeping 
genes between sample and control conditions. Media only conditions and/ or low passage 
number cells were used as control conditions. Technical triplicates were averaged and used 
to generate the final CT value and efficiency used per sample.  When standard deviation 














Figure 10 -Schematic representing the qPCR protocol. Samples were heated to 95˚C for 15 minutes to 
denature the cDNA and ensure all cDNA is single stranded.  This is followed by 45 cycles involving 30 seconds 
at 95˚C for denaturation of any double strands formed by the extension step, 30 seconds at 60˚C for primer 
annealing and 30 seconds at 72˚C for strand extension by polymerase. Fluorescence was recorded after each 
cycle. 
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3 The Systemic Milieu:  A Putative Model to Induce Neural Stem Cell 
Ageing 
3.1 Introduction 
 Cognition as an ageing biomarker 
Currently, there is a lack of effective biomarkers for healthy human ageing (Lara et al., 
2015). This causes difficulties in identifying healthy from pathological ageing and hinders 
research due to the inability to compare results across various animal models and human 
populations.  Efforts are therefore being made to firstly define different ageing domains, 
and secondly to define biomarkers within these. An important domain in assessing healthy 
ageing is cognitive function, which can be subdivided in executive function, processing 
speed and episodic memory (Lara et al., 2015). Cognitive performance reliant on these 
three subcategories is known to decline with age. Therefore, cognitive tests assessing these 
functions are being proposed as useful human biomarkers of cognitive ageing (Hedden and 
Gabrieli, 2004). Focussing on episodic memory specifically, tests assessing pattern 
separation, the process responsible for distinguishing similar new patterns from known old 
patterns, have been widely used in both animal models (Sahay et al., 2011; Wilson et al., 
2004, 2005) and human populations for this purpose (Stark et al., 2010, 2013; Yassa and 
Stark, 2011). In addition, tasks requiring spatial awareness such as object-location tasks are 
also heavily reliant on episodic memory and therefore affected by age. Object-location 
tasks such as paired associates learning (PAL) in fact, have also been employed in both 
animals and humans and show great potential for assessing age-related cognitive decline 
(Cès et al., 2018; Mirescu et al., 2006; Mitchell et al., 2000; Wimmer et al., 2012). 
 
Episodic memory is defined as the recollection of events which are unique in terms of 
spatial and temporal context. It differs from semantic memory, which usually refers to 
knowledge about facts, objects or concepts (Hayes et al., 2004). Interestingly, groups have 
also highlighted performance on other memory tasks, such as traditional recognition reliant 
on semantic memory,  does not decline in healthy ageing but does decline in participants 
with mild cognitive impairment (Stark et al., 2013). These findings suggest a battery of 
cognitive tasks can be employed to distinguish healthy from pathological cognitive-decline.  




 Neurogenesis and neural stem cells as ageing biomarkers 
Both animal and human studies have identified the dentate gyrus of the hippocampus as 
having an important role in episodic memory (Berron et al., 2016; Hayes et al., 2004; Sahay 
et al., 2011). In particular, hippocampal neurogenesis and NSCs have repeatedly been 
implicated in episodic memory in animal models (Clelland et al., 2009; McAvoy et al., 2015; 
Sahay et al., 2011). The presence of adult neurogenesis in humans has been debated for 
decades and has recently been the focus of discussions as prominent journals have 
published opposing studies about its presence and the decline rate (Boldrini et al., 2018; 
Sorrells et al., 2018). Regardless, authors on both sides agree that better techniques are 
necessary to study neurogenesis in humans as current ones are hindered by a number of 
pitfalls (Boldrini et al., 2018; Kempermann et al., 2018; Lee and Thuret, 2018; Sierra et al., 
2011; Sorrells et al., 2018). Currently available techniques in fact, rely mainly on post-
mortem immunohistochemical analysis which prevents longitudinal studies and is impaired 
by marker degradation and post-mortem interval effects (Sierra et al., 2011). Rodent 
studies have in fact shown markers of neurogenesis such as DCX are particularly affected 
by post-mortem interval with as little as 8 hour-delays inducing drastic changes in the 
resulting DCX stain (Boekhoorn et al., 2006). Though, varying post-mortem intervals are 
likely to confound results, standardising these in human studies is obviously problematic.  
 
As described in Chapter 1, the current gold standard for detecting adult hippocampal 
neurogenesis involves the incorporation of thymidine analogues or 14C into DNA as 
employed by Erkisson and Spalding respectively (Eriksson et al., 1998; Spalding et al., 2013). 
These methods are a more direct measure of neurogenesis compared to staining methods 
but it has been suggested this incorporation may be the result of DNA repair rather than 
replication. Though this is unlikely as even extensive repair following injuries such as stroke 
remains undetectable by 14C, it has highlighted the need for additional and differing 
methodologies to assess this phenomenon (Huttner et al., 2014). In line with this, the 
occurance of adult hippocampal neurogenesis is also supported by the ex-vivo isolation of 
adult human progenitor cells (Palmer et al., 2001) and extensive immunohistochemical 
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analysis that successfully identified cell proliferation and neuroblast markers in human 
post-mortem tissues  (Boekhoorn et al., 2006; Curtis et al., 2003; Dennis et al., 2016b; Liu 
et al., 2008; Mathews et al., 2017). Despite these developments, no technique currently 
enables researchers to assess neurogenesis in vivo resulting in existing findings being 
confounded by aspects such as the lack of experimental control, perimortem physiological 
state as well as the previously discussed post-mortem interval. 
 
Other techniques such as imaging, have been suggested but the slow rate at which 
neurogenesis occurs in the adult human brain suggests neurogenesis alone is unlikely to 
cause measurable volumetric changes (Spalding et al., 2013). Though a decline in 
neurogenesis may contribute to the marked decrease in human hippocampal subfield 
volumes seen with age. (Daugherty et al., 2016; Peters, 2006; Shing et al., 2011; Warner-
Schmidt and Duman, 2006). 
 
 The systemic environment as an ageing biomarker 
In addition to cognitive tasks, peripheral biofluids are a new promising avenue and source 
of ageing biomarkers. This is already being explored in age-related diseases such as 
Alzheimer’s where blood-derived fluids such as plasma or serum are being evaluated 
(Geekiyanage et al., 2012; Hye et al., 2014; Song et al., 2009). The large body of evidence 
implicating the systemic environment in ageing and cognition discussed in the general 
introduction, supports the notion that blood-based analysis could provide fast, minimally 
invasive and cost-effective biomarkers for both healthy and pathological ageing (Maruszak 
et al., 2017; O’Bryant et al., 2011; Villeda et al., 2011, 2014). The effect of the systemic 
environment on the brain has often been ignored owing to concepts such as the blood-
brain barrier suggesting the brain is a separate and isolated entity from the rest of the body. 
However, findings showing that especially during ageing and inflammation, the blood-brain 
barrier is more permeable than initially predicted, combined with parabiosis studies have 
proven the systemic environment is capable of affecting the brain (van der Flier and 
Scheltens, 2005; Villeda et al., 2014). Though there are some discrepancies between 
analytes identified by studies using serum or plasma, these are mainly attributed to the 
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differing ways of processing of the samples and the two can often be used interchangeably 
(Galasko and Golde, 2013). Interestingly, as discussed in section 1.3, the systemic 
environment has also been implicated in nutrition and neurogenesis. Understanding how 
the systemic environment impacts the ageing brain could thus provide a basis for useful 
new biomarkers in ageing research. In summary, systemic environment composition and 
performance on cognitive tasks are promising biomarkers for cognitive-ageing. In addition, 
both have strong evidence from animal models suggesting a link to adult hippocampal 
neurogenesis. The lack of techniques to robustly assess human adult neurogenesis 
however, has prevented studies from confirming this in human populations. Therefore, 
further research focused on developing new methodologies and translating these findings 
to humans is necessary. 
 
 Ageing research and model organisms 
A variety of animal models have been employed in ageing research. As discussed in the 
chapter 1, studies using model organisms have identified important conserved molecular 
pathways and highlighted mechanisms behind ageing phenotypes. A decrease in adult 
neurogenesis for example, has been linked to age-related cognitive deficits thanks to 
rodent studies and the importance of nutrient-sensing pathways in longevity was first 
identified in C. elegans and yeast models  (Conrad et al., 2014; Lees et al., 2016; Villeda et 
al., 2011; Walker et al., 2005). Furthermore, the importance of the systemic milieu was 
identified due to mouse-based parabiosis studies (Villeda et al., 2011, 2014). However, 
many are reporting issues in translating animal findings to humans. With meta-analyses 
showing that over 90% of behavioural neuroscience results fail to replicate in humans 
(Garner, 2014). Besides the obvious differences in lifespan across different models, this 
translational gap is often attributable to problems in identifying animal behaviours that 
resemble human cognition as well as the need to consider aspects such as emotion, social 
status and education which proves difficult in non-human models (Lees et al., 2016).  In 
addition, and as discussed in the section 1.2.1 when investigating aspects such as 
neurogenesis, considerable differences in neuronal turnover, rate of decline and 
neurogenic niches have been identified (Bergmann et al., 2015; Imayoshi et al., 2008; 
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Spalding et al., 2013). Though some authors suggest animal models are simply in need of 
stricter methodology and more honest reporting of negative findings, others suggest the 
field ought to move towards human based studies (Garner, 2014). Nevertheless, the field 
is in need of projects aimed at bridging this gap (Butler, 2008; Check, 2003). 
 
Human studies however, are accompanied by several ethical and practical restrictions 
which often make elucidating molecular mechanisms behind phenotypes difficult. In an 
attempt to bridge some of the translational gap, but preserve the advantages of easily 
modifiable systems, human-based in vitro models are often employed. Advances in 
laboratory techniques such as iPSCs and human immortalised cell-lines have allowed 
several groups to start validating animal model findings in human-based models (Anacker 
et al., 2011; Deng, 2017; Jiménez-Moreno et al., 2017; Zhang et al., 2013). Unpublished 
research by the Thuret laboratory has focused on validating the mouse-based parabiosis 
studies in a human-based cellular model. Murphy and colleagues showed treatment with 
serum from older participants caused increased cell death in human hippocampal 
progenitor cells when compared to treatment with serum from young participants (Murphy 
et al., 2018). In addition, Maruszak and colleagues showed cellular readouts from the same 
in vitro parabiosis assay were able to predict mild cognitive impairment conversion to 
Alzheimer’s with over 90% sensitivity and specificity (Maruszak et al., 2017). Models such 
as these not only provide possible new biomarkers for early detection of pathology but also 
a new platform with which to study the molecular mechanisms behind cognitive ageing.  
 
 Nutrient-sensing pathways 
To better understand and target cognitive health, we must identify the driving molecular 
mechanisms. As discussed in the general introduction, three nutrient-sensing pathways 
have been highlighted by existing literature as having important roles in neural stem cells 
and longevity. Overall dysregulation of these pathways has been identified as a key driver 
of ageing, but the roles of specific pathway components within this relationship are yet to 
be clarified. Elucidating the interaction between pathway components is a necessary first 
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step in understanding the role of these pathways in health and disease. Here we briefly 
introduce the key components of these pathways. 
 
3.1.5.1 mTOR pathway 
The mTOR pathway is a highly conserved molecular pathway responsible for cell growth, 
metabolism and cytoskeleton organisation (Costa-Mattioli and Monteggia, 2013).  In 
neurons, it responds to changes in insulin, neurotransmitter, neurotrophins and cyclic 
AMP. These alterations signal through the phosphatidylinositol 3-kinase (PI3K)-AKT 
pathway to mTOR, serine/threonine kinase. The PI3K-AKT pathway is described in further 
detail below (see 3.1.5.2). mTOR is a central component of this pathway and forms either 
the mTORC1 or mTORC2 complex (see section 1.4.1). mTORC1, which has been linked to 
longevity in various studies (Blagosklonny, 2008; Fok et al., 2014; Harrison et al., 2009; 
Wanke et al., 2008), has 4 principal substrates; S6K1, 4EBP1, SREBP and GRB10.  These 
substrates have important functions in transcriptional and translational control (Malley and 








Figure 11 - mTOR pathway. Diagram showing the key players of the mTOR pathway. The extracellular space 
is shown in blue and the cell is shown in yellow.  Ligands (in green) such as insulin bind to the insulin receptor 
(InsR) or the insulin-like growth factor receptor 1 (IGF1R) (in orange). This activates the insulin substrate 2 
(IRS2) which initiates the phosphatidylinositol 3-kinase (PI3K) - AKT kinase cascade which culminates in the 
regulation of the mTORC1 complex. mTORC1 (in brown) is made up several proteins including Raptor, MLST8, 
PRAS40, deptor and mTOR, a serine/threonine kinase. mTOR is responsible for the phosphorylation of several 
downstream targets including GRB10, SREBP, 4EB-P1 and S6K. 4EB-P1 is responsible for regulating translation 
by interacting with eukaryotic translation initiation factor 4E (eIF4E).  Finally, phosphatase and tensin 
homolog (PTEN) regulates this pathway by controlling the PI3K-AKT signalling cascade. Selected candidate 
genes in this project are shown in blue. Candidates present in multiple pathways are highlighted by a red 
outline. 
S6K1 is a ribosomal protein kinase responsible for the phosphorylation of the S6 ribosomal 
protein, which induces ribosomal protein synthesis.  S6K1 activation by mTOR has been 
linked to autophagy regulation (Chung et al., 1992; Datan et al., 2014) and negative 
feedback (Malley and Pidgeon, 2016). Eukaryotic translation initiation factor 4E-binding 
protein (4EBP1) interacts with eukaryotic translation initiation factor 4E (eIF4E). This 
interaction prevents the assembly of the complex responsible for recruiting 40S ribosomal 
subunits to the 5I end of mRNAs and thereby represses translation. mTORC1 
phosphorylation of 4EBP1 prevents this interaction which frees eIF4E and allows complex 
assembly and translation initiation (Gingras et al., 2001). Sterol responsive element binding 
proteins (SREBP) are basic helix-loop-helix-leucine zippers transcription factor which are 
responsible for regulating fatty-acid and cholesterol synthesis (Porstmann et al., 2008). 
Finally, growth factor receptor-bound protein 10 (GRB10) is an adaptor protein with 
important functions in negative feedback and mTOR pathway regulation. It has also been 
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suggested to have tumour suppressor functions (Liu and Liu, 2014; Malley and Pidgeon, 
2016; Yu et al., 2011).  
 
As well as the studies mentioned in the section 1.4.1, several recent publications have 
further implicated the mTOR pathway in neurons and NSCs. mTORC1 was found to promote 
neuronal differentiation in both rodents and humans and its hyperactivity was linked to 
increased proliferation and abnormal differentiation in human iPSCs. In addition, 
decreased mTORC1 activity was linked to ageing rodent NCSs and mTORC1 activation was 
able to restore NSC function and neurogenesis in aged mice (Lee et al., 2016; Li et al., 2017; 
Meng et al., 2018; Romine et al., 2015; Skalecka et al., 2016). These findings, combined 
with the importance of mTOR in nutrient-sensing, warrant further studies to elucidate this 
pathway’s function in the interplay between ageing, nutrition and cognition. 
 
3.1.5.2 Insulin and insulin-like growth factor signalling pathway 
The IIS pathway is activated by carbohydrates or proteins binding to the insulin (InsR) or 
insulin-like growth factor (IGF1R) receptors. Upon ligand binding, intracellular Insulin-
receptor substrates 1-4 (IRS 1-4) are phosphorylated. These in turn, activate either PI3K-
AKT signalling or RAS-ERK signalling.  
 
In the PI3K-AKT branch, PI3K converts phosphatidylinositol 4,5-bisphosphate (PIP2) into the 
second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3). Increased levels of PIP3 
signal for the activation of AKT, a serine/threonine kinases that phosphorylates and 
inactivates FOXO transcription factors. This inactivation leads to the suppression of gene 
transcription.  Interestingly, the conversion of PIP2 to PIP3 can be inhibited by phosphatase 
and tensin homolog (PTEN) a protein shared by both the mTOR and the IIS pathway (van 
Heemst, 2010).  The RAS-ERK branch instead, relies on the kinase cascade initiated by RAF 
kinase which culminates in the inhibition of the translocation-Ets-leukemia virus (ETV6), a 
repressor of gene transcription.  Genes targeted by both FOXO and ETV6 generally regulate 
cell growth and differentiation and have been identified as key players in longevity 
(Sizemore et al., 2017; White, 2015). See Figure 12 for a diagram of the IIS pathway. 
 




Figure 12 - Insulin and insulin-like sensing pathway. Diagram showing the key players of the insulin and 
insulin-like sensing pathway. The extracellular space is shown in blue and the cell is shown in yellow.  Ligands 
(in green) such as insulin bind to the insulin receptor (InsR) and insulin-like growth factor receptor 1 (IGF1R) 
(in orange). Alternatively, ligands bind to the scavenger receptor insulin-like growth factor receptor 2 (IGF2R) 
(in blue). Upon ligand binding, InsR and IGF1R phosphorylate the insulin receptor substrate 2 (IRS2). IRS2 can 
activate both the phosphatidylinositol 3-kinase (PI3K) - AKT kinase cascade or RAF/ERK signalling. The 
RAF/ERK branch consist of a kinase cascade that culminates in the inhibition of the translocation-Ets-leukemia 
virus (ETV6). In the PI3K-AKT branch, PI3K (in dark green) converts phosphatidylinositol 4,5-bisphosphate 
(PIP2) (in grey) into the second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3) (in grey). Increased 
levels of PIP3 signal for the activation of AKT (in pink), a serine/threonine kinases that phosphorylates and 
inactivates FOXO transcription factors (in blue). Selected candidate genes in this project are shown in blue. 
Candidates present in multiple pathways are highlighted by a red outline. 
 
3.1.5.3 Sirtuin pathway 
Mitochondrial dysfunction and deregulated nutrient-sensing pathways are key hallmarks 
of an ageing organism (López-Otín et al., 2013).  Hence, pathways responsible for regulating 
energy availability are key targets in ageing research.  Sirtuin deacetylases regulate 
mitochondrial function and are therefore ideal mediators for the interplay between 
nutrition, energy balance and ageing. As discussed in section 1.4.2, several studies have 
already implicated sirtuins in both ageing and nutrient-sensing but the exact proteins 
responsible for this association remain unknown.  
 
Sirtuins are nicotinamide adenine dinucleotide (NAD+) dependent deacetylases. Following 
deacetylation, nicotinamide (NAM) and 2-O-Acetyl ADP ribose are created as by-products. 
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In the presence of the rate-limiting enzyme Nicotinamide phosphoribosyltransferase 
(NAMPT), NAM is recycled back to NAD+ by the salvage pathway. Through the process of 
deacetylation, sirtuins control the expression of several genes involved in neuronal 
protection, inflammation, stress resistance, fatty acid oxidation, fatty acid mobilization, 
insulin secretion, glucose production and lipid homeostasis (Donmez and Outeiro; 
Guarente, 2014; Oellerich and Potente, 2012; Renault et al., 2009).  SIRT1, the most 
thoroughly studied sirtuin in mammals, has also been linked to several longevity-related 
processes (Cantó and Auwerx, 2009; Guarente, 2014; Satoh et al., 2013). For example, 
SIRT1 has been associated to mitochondrial biogenesis via the inhibition of human nuclear 
receptor interaction protein (NRIP) and to the IIS and mTOR pathways due to inhibitory 
effects on FOXO3A (Cohen et al., 2004; Smith et al., 2009).  Interestingly, sirt1 was also 
implicated in insulin secretion in pancreatic beta cells via its repression of the uncoupling 
protein 2 (UCP2) (Bordone et al., 2005).  UCP2’s important function in energy metabolism 
of proliferating NSCs suggests this interaction may occur in other cell types as well 
(Rupprecht et al., 2014). Importantly, SIRT1 has also been linked to lineage decisions owing 
to its inhibitory effect on MASH-1 activity; MASH-1 is a basic helix-loop-helix transcription 
factor that is central for neuroblast differentiation (Prozorovski et al., 2008). Despite these 
findings, many downstream targets and physiological functions of SIRT1 remain unknown 
highlighting the need for further research. See Figure 13 for a diagram of the key molecules 
involved in the Sirtuin pathway. 
 




Figure 13 - Sirtuin pathway.  Diagram showing some of the key molecules involved in the Sirtuin pathway.  
SIRT1 deacetylation causes the conversion of nicotinamide adenine dinucleotide (NAD+) to nicotinamide 
(NAM) and 21-O-acetyl ADP-ribose. This is recycled back to NAD+ via nicotinamide phosphoribosyltransferase  
(NAMPT). SIRT1-dependent deacetylation inhibits several downstream targets including nuclear receptor 
interaction protein 1 (NRIP1) and the transcription factors MASH and FOXO3A, linking the deacetylase to the 
regulation of several other pathways. In addition, SIRT1 also represses uncoupling protein 2 (UCP2) via 
deacetylation-independent mechanisms. Selected candidate genes in this project are shown in blue. 
Candidates present in multiple pathways are highlighted by a red outline. 
 
 ABTB1: candidate from exploratory analysis 
Recent work by Murphy et al, showed expression alterations of several known and novel 
ageing genes following treatment of HPCs with serum from young or old donors (Murphy 
et al., 2018). This work highlighted the Ankyrin repeat and BTB/POZ domain-containing 
protein 1 (ABTB1) as one of the 10 most differentially expressed proteins in response to 
aged serum. In addition, this protein was also shown to undergo methylation changes in 
relation to age by Horvath’s clock (Horvath, 2013). Though the protein’s exact function 
remains unknown, studies have suggested a role in protein-protein interactions due to the 
presence of the BTB/POZ domain (Albagli et al., 1995; Geyer et al., 2003). Interestingly, a 
study has shown an interaction between ABTB1 and PTEN suggesting a role for ABTB1 in 
nutrient-sensing pathways (Unoki and Nakamura, 2001). These findings, combined with 
ABTB1’s high expression in the dentate gyrus of the hippocampus in both mice and humans 
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(Allen Human Brain Atlas (2010)), warrant further research into the function of this gene in 
cognitive ageing. 
 Aims of this chapter 
In summary, research has a highlighted the need for developing better human biomarkers 
of ageing in general and of cognitive-ageing specifically. In addition, there is a need to focus 
on translating animal models to humans and to further understand the molecular pathways 
responsible for the link between nutrition and longevity. 
 
In this chapter, we focus on the effects of the systemic environment to determine its impact 
on human HPCs. We aim to 1) assess whether there are changes in NSC function in response 
to treatment with ageing serum and to relate these to human 2) imaging and 3) cognitive 
data belonging to the serum donors. In addition, we aim to 4) assess whether ageing serum 
causes gene expression alterations in candidate nutrient sensing-pathway components and 
5) if these are associated to cellular changes in the NSCs. Hereby we aim to evaluate the 
potential use of the systemic environment as an ageing biomarker, determine the 
translational potential of our in vitro parabiosis model and assess the function of nutrient-
sensing genes in human NSC maintenance. 
 
To investigate the effects of the systemic environment, we employ an in vitro parabiosis 
model. This consists in the treatment of hippocampal progenitor cells with serum from 
patients of different ages to ascertain the effects of an ageing systemic environment on 
NSC regulation. For aims 1, 2 and 3 a cohort comprised of middle-aged to old participants 
is used. For aims 4 and 5 instead, we use a cohort comprised of young and old individuals 
to maximise the age difference between participants. See diagram below for 
representation of the aims and hypotheses for this chapter. 
 





Figure 14 - Chapter 3 hypothesis.  We hypothesise that ageing and diet (e.g. calorie restriction (CR)) affect 
the systemic environment and that in turn, this causes alterations in the mTOR, Sirtuin, and insulin and 
insulin-like sensing (IIS) nutrient-sensing pathways. We then hypothesise that these alterations affect the 
neural stem cell (NSC) regulation which leads to cognitive decline and increased risk of disease. To test these 
hypotheses, we aim to determine whether (1) ageing serum can cause NSC alterations in vitro and whether 
these alterations are associated to (2) imaging and (3) cognitive data of the serum donors. We also aim to 
determine (4) whether ageing serum treatment can affect the expression of nutrient-sensing pathway 
components and (5) whether these are associated to cellular alterations in the NSCs.  
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3.2 Materials and methods 
 Serum sample processing 
All participants were required to fast for two hours prior to blood sample collection, which 
occurred in the morning. During these fasting periods, only fluids with no sugar or milk 
were allowed. Blood samples were collected and stored in serum separator tubes, these 
were inverted 5 times and allowed to rest for 30 minutes at room temperature. Tubes were 
then spun at 1500g for 15 minutes at 4 degrees. The serum, which was now present in the 
top layer of the tube was collected and stored at -80˚C. The samples were then thawed, 
aliquoted in working volumes into Matrix 2D storage tubes (3711, Thermo Fisher) and 
stored at -80˚C until use to standardise the freeze-thaw cycles. At the point of use samples 
were thawed at 37˚C and swirled periodically to preserve serum viability by preventing the 
formation of crystalline precipitates. Once thawed serum was added at a 1% concentration 
to cell culture media and incubated with human hippocampal progenitor cells as explained 
in section 2.1 
 Middle aged to old cohort (MATOC) 
This cohort was used for aims 1,2 and 3 of this chapter, as outlined in section 3.1.7. Cell 
work using samples from middle-aged to old cohort (MATOC) was carried out in equal 
proportions by Dr. Tytus Murphy and myself. Recruitment, imaging and cognitive 
assessment were carried out by Dr. Paul Wright and other members of the O’Sullivan 
group. Analysis was carried out by myself and Dr. Paul Wright. 
3.2.2.1 Recruitment and descriptive statistics 
The middle-aged to old cohort (MATOC) from which serum samples were derived was 
recruited by the O’Sullivan group.  
 
Participants used in this study were cognitively healthy control individuals recruited as part 
of the larger STRATEGIC study investigating memory performance in stroke patients 
headed by Prof. O’Sullivan and funded by the Medical Research Council. The exclusion 
criteria included moderate to severe head injury, diagnosis of a cognitive, neurological or 
major psychiatric disorders, self-referral for cognitive symptoms and a mother tongue 
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other than English. As Magnetic Resonance Imaging (MRI) was used, all its pertaining 
exclusion criteria, such as presence of pacemakers and penetrating eye injury, were applied 
as well. All participants gave informed, written consent and were recruited in accordance 
with the London-Bromley Research Ethics Committee. Serum samples of 25 individuals 
were available, of these 19 participants also had available cognitive score data (see table 








Imaging and Cellular 25 5:20 52.6 - 89.4 (73.2 ± 9.5) 
Cognition and Cellular 19 4:15 55.6 - 89.4 (74.5 ±8.9) 
Table 7 - Participants in the middle aged to old cohort. Table showing the number of participants, female to 
male ratio and age distribution of the middle-aged to old cohort (MATOC)  
Education was scored following the coding in Table 8. The maximum time difference 
between imaging and blood sample was 2 years. 
Code Qualification 
1 No qualification 
2 NVQ1/SVQ1 
3 O-Level/GCSE/NVQ2/SVQ2/Scottish Intermediate 
4 Scottish higher, NVQ3, city and qulds, Pitman 
5 A Level, Scottish Advanced Higher 
6 Higher Vocational training (e.g. Diploma, NVQ4, SVQ4) 
7 University degree 
8 Postgraduate degree (e.g. Masters or PhD), NVQ5, SVQ5 
Table 8 - Education questionnaire. Table reporting the method used to code education data within the 
middle aged to old cohort The first column shows the numerical value given to the participant’s answer 
(second column). 
3.2.2.2 Imaging 
MRI were carried out using a 3T General Electric MR750 scanner at the Clinical Research 
Facility at King’s College Hospital.T1-weighted images were acquired to obtain 192 sagittal 
slices each with a thickness of 1.2mm, a field of view of 270mm, a 1mm in-plane resolution 
and an acquisition matrix of 256X256. FreeSurfer(Version 6.0) (Iglesias et al., 2015; Pereira 
et al., 2014)  was used to analyse volumetric T1-weigthed images. This software uses labels 
derived from an ex-vivo atlas of hippocampal subfields to segment the hippocampus in the 
acquired images. It implements an algorithm that uses a generative model and Bayesian 
inference. The ex-vivo atlas was derived from post-mortem images which were labelled 
manually.  
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In this study, the resulting hippocampal segmentations were checked visually for 
concordance with hippocampal boundaries by a single rater. According to these 
segmentations, volumes for each subfield were measured and normalised to intracranial 
volume extracted from FreeSurfer. This created a set of normalised subfield volumes per 
hemisphere per person, the volumes of each hemisphere were summed to obtain the 
values used in the analysis. Of the resulting subfields the CA1, CA3, CA4, dentate gyrus (DG) 
and the subiculum were used in the analysis as well as whole hippocampal volume. 
3.2.2.3 Paired Associate Learning task 
To assess associative memory, the O’Sullivan developed a version of the PAL. The task 
consisted in associating an object to a location. Objects were coloured and shaded line 
drawings known as Snodgrass and Vanderwart “like” objects (obtained from 
http://wiki.cnbc.cmu.edu/Objects (date accessed: 02/09/18)) and included objects like a 
drawing of an apple, a whistle or a coloured ball. The spatial locations were provided by a 
10-box grid comprised of 4 columns with 2,3,3 and 2 boxes each. As shown in 
Figure 15. 
 
Figure 15 - Paired associate learning task - Diagram showing the recognition phase of the task 
designed by the o'Sullivan group. An object is show in two locations on the 10-box grid and the participant is 
asked to identify which on is the correct location. The objects displayed were taken from 
http://wiki.cnbc.cmu.edu/Objects. The task consisted of two phases. During the learning phase, participants 
were shown the same object in two locations on the grid (a correct and an incorrect one) they were then 
asked to select the correct location using a touch pad. Once one of the two locations was selected, feedback 
was given with a 2s delay: a green smiley face and a pleasant sound for a correct response and a red unhappy 
face and an unpleasant sound for an incorrect response. This was done for all 10 objects.   
During the initial part of the learning phase, the choice of “correct” location on behalf of 
the participant was a guess. Following this however, the 10 object-location pairs were 
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presented another 3 times to help the participant learn the objects’ locations. There was 
no indication of set completion and randomisation was applied within each repeat so that 
each 10 objects appeared in different orders but always appeared once before the next 
repetition. Following these 4 feedback sets, the task moved onto the recall phase. During 
this phase, 1 of the 10 boxes in the grid was highlighted at random and the participant was 
asked to recall the object belonging to that location by giving a verbal response.  There was 
no time limit in this phase. Performance was assessed by two outcome measures:  the 
recognition score, which consisted in the sum of all correct responses in the final 3 sets of 
the learning phase, and the recall score based on the number of correct recalls in the recall 
phase. The recognition phase has a maximum score of 30 whilst the recall phase has a 
maximum achievable score of 10.Statistics 
Pearson correlations were carried out using SPSS and GraphPad Prism software. If a 
significant correlation was found linear regressions were also carried out. Age regressed 
values were used for regressions on cell readouts and hippocampal volumes while 
regressions involving PAL scores were controlled for education as well as age. When 
applicable Bonferroni correction was applied to correct for multiple testing.  
 Young-Old cohort 
This cohort was used for aims 4 and 5 of this chapter as detailed in section 3.1.7. Dr. Tytus 
Murphy carried out the recruitment of young participants and tissue culture using the 
young-old cohort (YOC) samples.  I carried out all molecular work and all analyses  described 
here. 
3.2.3.1 Recruitment and descriptive statistics 
Samples from old participants were derived from cognitively healthy control subjects taking 
part in two ongoing disease biomarker discovery programmes: AddNeuroMed, a 
multicentre European study (Lovestone et al., 2009) and the Maudsley Biomedical 
Research Centre for Dementia Case Registry at King’s Health Partners. To ensure cognitive 
health across participants, inclusion criteria stated participant must score more than 27/30 
on the Mini Mental State Examination (MMSE) which indicates a normal cognitive level. In 
both programmes informed consent was obtained per the Declaration of Helsinki (1991). 
Furthermore, all participants with other neurological or psychiatric disease, significant 
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unstable illness or organ failure and alcohol or substance abuse were excluded. Samples 
from 22 old control subjects were obtained for this study with a mean age of 77.6 years 
(SD±6.43) comprised of 13 females and 9 males. Old participants’ age ranged from 53-89. 
Young participants were recruited through internal advertising within the Institute of 
Psychiatry, Psychology and Neuroscience between November 2012 and June 2014. Consent 
and good health were confirmed via a questionnaire as part of the Alzheimer’s disease 
biomarker programmes stated above. Serum was collected at one timepoint for each 
participant. 15 young control subjects were recruited with a mean age of 27.1 years 
(SD±5.03) comprising of 8 females and 7 males. Young participants’ age ranged from 20-
32. Protocols and procedures were approved by the appropriate Institutional Ethics Review 
Board at King’s College London. Serum was extracted, as explained in section 3.2.1, and 
used on the cellular assay to create the in vitro parabiosis assay used in this chapter. 
 Primer design and gene selection 
Candidate genes involved in nutrient-sensing pathways, ageing and stem cell function were 
selected by literature searches. The selected genes were then assessed for expression 
within our cell line using a microarray carried out by previous lab members. Primers for the 
candidate genes were designed using Primer3Plus (www.primer3plus.com). Single 
nucleotide polymorphisms (SNPs) were avoided and primers were designed to cross exon 
boundaries wherever possible. Primer sequences were also checked for single-peaked melt 
curves on the uMelt software (https://www.dna.utah.edu/umelt/umelt.html). Selected 
primer sequences (reported in Table 9) were sent to integrated DNA technology for 
oligomer synthesis. The lyophilized primers were resupsended to obtain a 100µM stock 
concentration and stored at -20˚C.  Forward and reverse primers for each gene were also 
mixed and diluted in water to obtain a 2µM primer mix working solution. 
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Table 9 - Primer sequences for target and housekeeping genes. Primer pairs and respective amplicon lengths 
for each gene used in quantitative polymerase chain reaction experiments. Genes are subdivided according 
to pathway. 
 
Based on the microarray previously carried out by our group, the following housekeepers 
were selected; Vimentin, Ribosomal Protein Large P2 (RPLP2) and Gamma Actin1 (ACTG1). 
These genes were selected as the genes undergoing the least variability following both 
media-only and treatment conditions across 5 different time-points in the genome-wide 
array. Variability was assessed by measuring the coefficient of variation - dividing the 
standard deviation of expression by the mean expression.  A low coefficient of variation is 
regarded as the gold-standard in housekeeper selection (Hill et al., 2014). Negligible 
variability between conditions was also seen across qPCR results in the present study. 
Primers for these are reported in Table 9. The primers were also checked for specificity by 




mTOR TCTTCCATCAGACCCAGTGA GCTGCCAGCGATCTGAATAA 90 
GRB10 CACCTGCCTGGCTTCTATTA TGACTGAGGAGCAGAGAAATG 102 
4E-Bp1 CGGAAATTCCTGATGGAGTG CCGCTTATCTTCTGGGCTATT 153 
s6K CATGAGGCGACGAAGGAG GGTCCAGGTCTATGTCAAACA 101 
eIF4e GAAAAACAAACGGGGAGGAC TCTCCAATAAGGCACAGAAGTG 105 
Insulin and insulin like growth factor 
IGF2r GAAACAGAGTGGCTGATGGA CTGAGGGCTTTCACTGACTT 104 





ETV6 AGGCACCATAATCCCTCCCT GGGGTCTGCAGCTGTTTAGT 90 
FoxO3a GGAGAGCTGAGACCAGGGTA AGATTCTCGGCTGACCCTCT 84 
Sirtuin and Nampt pathway 
Sirt1 AGAACCCATGGAGGATGAAAG TCATCTCCATCAGTCCCAAATC 111 
MASH1 GCAGCACACGCGTTATAGTA ACTCGTTTCTAGAGGGCTAAGA 122 





NAMPT CCAGGAAGCCAAAGATGTCTAC GAAGATGCCCATCATACTTCTCA 98 
Other 
ABTB1 ACCATGAACCCGTCCTGA AAGCAGGCATAGTACCTCCA 89 
 Housekeepers  
VIM CTTTGCCGTTGAAGCTGCTA GAAGGTGACGAGCCATTTCC 92 
RPLP2 CAGAGGAGAAGAAAGATGAGAAGAA CTTTATTTGCAGGGGAGCAG 101 
ACTG1L GGCTGAGTGTTCTGGGATTT GGCCAAAGACATCAGCTAAGA 125 
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agarose gel electrophoresis. Briefly, agarose gels were made with 1x tris-acetate-EDTA 
(TAE) buffer and agarose (A9539, Sigma-Aldrich) at a concentration of 1.5%. After melting 
the agarose in TAE, ethidium bromide (1% solution in water, 111615, MerckMillipore) was 
added at 1µl/100ml TAE and the solution was poured into moulds containing well combs. 
Samples were mixed with 1x DNA Loading Dye (R0611, Thermo Fisher Scientific) and loaded 
into the wells of the solidified gel alongside a 100 base-pair DNA ladder (07-11-00050, Solis 
Biodyne). The gel was run with 1% TAE at 4V/cm for approximately 30 minutes and 
analysed using the BioSpectrumAC Imaging System (UVP) and the Vision Works LS software 
(UVP).Statistics 
Statistical analysis for qPCR data was carried out using the GraphPad Prism software. The 
Shapiro-Wilkin test was used to test for normality. Accordingly, parametric t-tests or the 
non-parametric Mann-Whitney tests were carried out to compare the relative expression 
between the young and old subgroups for each gene. Relative expression and cellular 
readouts were tested for associations with correlations. If a significant correlation was 
found, linear regressions were carried out to investigate this association. The significance 
threshold was then adjusted according to the number of multiple comparisons as per the 
Bonferroni method. 
  




In this chapter, the MATOC cohort was used to test whether serum can alter cellular 
readouts according to age of the donor in an in vitro NSC parabiosis model. We also aimed 
to correlate the cellular readouts to hippocampal volumes and cognition. Finally, using the 
Young-Old cohort we aimed to identify molecular effectors behind these associations by 
testing the expression levels of candidate nutrient-sensing genes within this in vitro assay.  
 
 Cellular readouts following in vitro parabiosis assay are not associated with age 
but to hippocampal subfield volumes in MATOC cohort. 
To test whether serum donor’s age impacted the cellular readouts following the 
differentiation assay of the parabiosis model were first tested for correlation to serum 
donor’s age.  Immunocytochemical analysis followed by Pearson’s correlations revealed no 
association between the expression of CC3 (apoptosis marker), H2AX (DNA damage 
marker), MAP2 (immature neuron marker), DCX (neuroblast marker), Ki67 (proliferation 
marker) or the number of cells following the assay and participant’s age (see Figure 16). 
The p and R values of each correlation are reported in Table 10.  
  
 3. The Systemic Milieu:  A Putative Model to Induce Neural Stem Cell Ageing 
82 
 
Figure 16 -  Effect of serum donor’s age on cellular markers. Scatterplots showing the percentage of positive 
HPC0A07/03A cells for each cellular marker following serum treatment and the corresponding participant’s 
age. Markers for apoptosis (CC3), DNA damage (H2AX), immature neurons (MAP2), neuroblasts (DCX) and 
proliferation (Ki67) are reported. Also reported is the number of cells per field as a measure of cell density 
based on the nuclear marker DAPI.  Each dot represents a participant.  
   Cellular readouts r p value 
Age and CC3% -0.05 0.82 
Age and H2AX% -0.26 0.20 
Age and MAP2% 0.31 0.12 
Age and DCX% -0.18 0.36 
Age and KI67% 0.28 0.16 
Age and Cells per Field -0.36 0.06 
Table 10 - Correlation results of the effect of serum donor’s age on cellular markers. Table showing the r 
value and p value of each Pearson’s correlation assessing the association between each cellular marker and 
serum donor’s age.  
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To assess if the cellular readouts of the in vitro parabiosis assay were related to 
hippocampal volumes, subfield volumes were investigated. First, each relevant subfield 
was tested for association to participant’s age. This revealed strong associations between 
each subfield and participant’s age. Following linear regressions, increased age was found 
to be predictive of decreased subiculum, dentate gyrus, CA1, CA3, CA4 and whole 
hippocampus volumes. Graphs for these associations are in Figure 17. p values and r and r2 
for each correlation and linear regression are reported in Table 11. 
 
Figure 17 - Effect of age on hippocampal subfield volume  - Scatterplots showing linear regressions assessing 
the relationship between hippocampal volumes and participant’s age in years. Liner regression line is shown 
on each graph. DG - Dentate Gyrus 
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   Age and Subfields Volumes r r2 p value 
Age and Subiculum -0.59 0.36 0.002* 
Age and Dentate Gyrus (DG) -0.57 0.35 0.003* 
Age and CA1 -0.78 0.43 <0.0001* 
Age and CA3 -0.70 0.43 <0.0001* 
Age and CA4 -0.72 0.47 <0.0001* 
Age and Whole Hippocampus -0.74 0.54 <0.0001* 
Table 11 - Correlation and linear regression results of the effect of age on hippocampal subfield volumes - 
Table showing the results of correlations and linear regressions testing the association between age and 
hippocampal volumes. r value following Pearson’s correlation and the r2 and p values following linear 
regressions are reported. Following Bonferroni correction to account for the 6 multiple comparisons, the 
significance threshold for this analysis was set to 0.0083. Significant results before correction are in bold. * 
denotes results surviving multiple testing correction.  
 
Once the association of subfields and hippocampus volume with age was confirmed, 
cellular markers were tested for association to each subfield’s volume and to whole 
hippocampus volume. To do this, the percentage positive cells for each marker following 
incubation with serum was tested for association to the serum donor’s subfield and whole 
hippocampus volumes. Values were age-regressed to account for the strong effect of age 
on hippocampal volumes. No association was found between volumes and CC3, MAP2, Ki67 
expression or cell density (See section 8.2.1 in appendix for correlation matrix ). However, 
the level of DNA damage, shown by H2AX expression in the HPCs, correlated with 
Subiculum, CA3, CA4 and Whole hippocampus volumes. In addition, the number of 
neuroblasts, as shown by DCX expression in the HPCs, correlated with dentate gyrus, CA3, 
CA4 and whole hippocampus volume.  Due to the large number of multiple comparisons 
(36) needed to test each marker against each subfield, these associations did not survive 
multiple testing. Correlation and linear regression results for H2AX and DCX are reported 
in Table 12 and Table 13 respectively. Figure 18 and Figure 19 shows the scatterplots 
illustrating these associations. 
 




Figure 18 - Associations of DNA damage marker to hippocampal subfield volumes Scatterplots showing the 
association between DNA damage (H2AX expression) following serum incubation and serum donor’s 
hippocampal volumes. In each graph, the x-axis shows the age-regressed percentage of HPC0A07/03A cells 
positive for H2AX expression and the y-axis shows the age-regressed volume of the specific hippocampal 
subfield. Linear regression line shown in black, graphs with no line indicate non-significant correlation results. 
Values are age-regressed. DG- Dentate gyrus. 
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   H2AX and Subfield Volumes r r2 p value 
H2AX and Subiculum 0.43 0.20 0.025 
H2AX and Dentate Gyrus (DG) 0.38 0.14 0.061 
H2AX and CA1 0.41 0.15 0.053 
H2AX and CA3 0.39 0.17 0.039 
H2AX and CA4 0.49 0.19 0.029 
H2AX and Whole Hippocampus 0.45 0.19 0.028 
Table 12 - Correlation and linear regression results for the association of DNA damage marker to 
hippocampal subfield volumes Table showing the results of correlations and linear regressions testing the 
association between H2Ax expression following the parabiosis assay and serum donor’s hippocampal 
volumes.  r value following Pearson’s correlation and the r2 and p values following linear regressions are 
reported. Bonferroni correction was used to account for 36 multiple comparisons (6 subfields and 6 markers), 
the significance threshold for this analysis was set to 0.0014. Significant results before correction are in bold. 
No association survived multiple testing correction. 




Figure 19 - Associations of neuroblast marker to hippocampal subfield volumes - Scatterplots showing the 
association between number of neuroblasts (DCX expression) following serum incubation and hippocampal 
volumes. In each graph, the x-axis shows the age-regressed percentage of HPC0A07/03A cells positive for 
H2AX expression and the y-axis shows the age-regressed volume of the specific hippocampal subfield. Linear 
regression line shown in black, graphs with no line indicate non-significant correlation results. Values are age-
regressed. DG- Dentate gyrus. 
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   DCX and Subfield Volumes r r2 p value 
DCX and Subiculum 0.28 0.14 0.065 
DCX and Dentate Gyrus (DG) 0.45 0.23 0.016 
DCX and CA1 0.10 0.06 0.258 
DCX and CA3 0.50 0.30 0.005 
DCX and CA4 0.47 0.28 0.007 
DCX and Whole Hippocampus 0.32 0.18 0.035 
Table 13 - Correlation and linear regression results for the association of neuroblast marker to hippocampal 
subfield volumes - Table showing the results of correlations and linear regressions testing the association 
between DCX expression following the parabiosis assay and serum donor’s hippocampal volumes. r value 
following Pearson’s correlation and the r2 and p values following linear regressions are reported. Bonferroni 
correction was used to account for 36 multiple comparisons (6 subfields and 6 markers), the significance 
threshold for this analysis was set to 0.0014. Significant results before correction are in bold. No association 
survived multiple testing correction. 
 
 Cellular readouts following in vitro parabiosis assay are associated to 
performance on PAL task in MATOC. 
Next, to assess the relationship between cellular readouts resulting from the parabiosis 
assay and cognition, we investigated PAL performance.  Firstly, PAL was tested for 
correlation with age and education to assess whether these affected PAL score.  
Performance on the recall phase, but not the recognition phase, of the PAL task showed a 
negative association with participant’s age. In contrast scores from the recognition phase, 
but not the recall phase, of the PAL task were positively correlated with the participant’s 
level of education. These results suggest participants with lower education levels and 
increased age are more likely to perform badly on the PAL task. Results from the Pearson’s 
correlations and subsequent linear regressions are reported in Table 14. These associations 
however, did not survive Bonferroni correction. Scatterplots of the 4 correlations are 
reported in Figure 20. 




Figure 20 - Effect of age and education on paired associates learning task -  Scatterplots showing the 
association of recall and recognition on paired associates learning (PAL) scores to age and education. In each 
graph, age is reported on the x-axis and PAL recall or PAL recognition is on the y-axis. Linear regression line 
shown in black, graphs with no line indicate non-significant correlation results.   
 
  PAL and Covariates r r2 p value 
PAL Recognition and Age -0.30 0.09 0.198 
PAL Recall and Age -0.49 0.24 0.028 
PAL Recognition and Education 0.53 0.28 0.029 
PAL Recall and Education -0.07 0.03 0.536 
Table 14 - Correlation and linear regression results for the effect of age and education on paired associated 
learning task -  Table showing the results of correlations and linear regressions testing the association 
between paired associated learning (PAL) score and age or education level. r value following Pearson’s 
correlation and the r2 and p values following linear regressions are reported. Following Bonferroni correction 
to account for 4 multiple comparisons, the significance threshold for this analysis was set to 0.0125. 
Significant results before correction are in bold. No association survived multiple testing correction. 
 
Next, to address the 3rd aim of this chapter (outlined in section 3.1.7), we assessed the 
relationship between cellular readouts resulting from the parabiosis assay and PAL 
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performance. Given the above results showing a possible association of PAL performance 
to age and education, age and education regressed PAL values were used. in Pearson’s 
correlations showed no association to PAL performance for cell death (CC3), DNA damage 
(H2AX), neuroblast number (DCX) or proliferation (KI67). The number of immature 
neurons, as evidenced by the percentage of cells positive for MAP2, showed significant 
association to PAL recognition scores. This result indicates serum from participants with 
worse PAL recognition scores induced an increase in immature neurons. Furthermore, cell 
density, as evidence by cells per field, showed significant association to PAL recall scores. 
This indicates serum from participants who performed better on the recall phase of the 
cognitive task induced an increase in cell number. Importantly, these associations did not 
survive multiple testing correction. Table 15 and Table 16 show the Pearson’s correlation 
and linear regression results assessing the association between cellular readouts and PAL 
performance. Figure 21 shows scatterplots of the association between MAP2 and cells per 
field to PAL performance. 
 
Figure 21 - Association between cellular markers and paired associates learning task -  Scatterplots showing 
RIGHT the association of performance on the recognition phase of the paired associates learning (PAL 
recognition) (y-axis) to MAP2 expression in the in vitro model following treatment with corresponding serum 
(x-axis) and LEFT the association of performance on the recall phase of the paired associates learning (PAL 
recall) (y-axis) to cell density (cells per field) in the in vitro model following treatment with corresponding 
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PAL Recognition and Cellular r r2 p value 
PAL and CC3% 0.39 - NS (>0.05) 
PAL and H2AX% -0.34 - NS (>0.05) 
PAL and MAP2% -0.51 0.25 0.029 
PAL and DCX% -0.26 - NS (>0.05) 
PAL and KI67% -0.15 - NS (>0.05) 
PAL and Cells per Field 0.18 - NS (>0.05) 
Table 15 - Correlation and linear regression results for the association of performance on paired associates 
learning recognition and cellular markers - Table showing the results of correlations and linear regressions 
testing the association between paired associates learning (PAL) recognition score and cellular marker 
expression following the parabiosis assay. r value following Pearson’s correlation and the r2 and p values 
following linear regressions are reported. Following Bonferroni correction to account for 4 multiple 
comparisons, the significance threshold for this analysis was set to 0.0125. Significant results before 
correction are in bold. No association survived multiple testing correction. 
 
  PAL Recall and Cellular r r2 p value 
PAL and CC3% 0.38 - NS (>0.05) 
PAL and H2AX% 0.08 - NS (>0.05) 
PAL and MAP2% -0.31 - NS (>0.05) 
PAL and DCX% -0.03 - NS (>0.05) 
PAL and KI67% -0.29 - NS (>0.05) 
PAL and Cells per Field 0.54 0.27 0.022 
Table 16 - Correlation and linear regression results for the association of performance on paired associates 
learning recall and cellular markersTable showing the results of correlations and linear regressions testing 
the association between paired associates learning (PAL) recall score and cellular marker expression following 
the parabiosis assay. r value following Pearson’s correlation and the r2 and p values following linear 
regressions are reported. Following Bonferroni correction to account for 4 multiple comparisons, the 
significance threshold for this analysis was set to 0.0125. Significant results before correction are in bold. No 
association survived multiple testing correction. 
 
 Molecular pathways mediating the impact of the systemic milieu on 
hippocampal NSCs 
To address the final two aims of this chapter, we performed a literature-based candidate 
gene selection. Following this, the expression levels of the selected genes were tested using 
serum from the YOC cohort. As opposed to the MATOC cohort used thus far, this cohort 
allowed for the direct comparison of the effects of young donor serum to those of old donor 
serum. Given the heterogeneity seen following the work with the MATOC cohort, we 
believed this experimental setup was better suited to identify molecular alterations. 
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3.3.3.1 Candidate gene selection 
After encouraging results suggesting a relationship between the assay’s cellular readouts 
and human cognitive and imaging data, we aimed to investigate the molecular pathways 
driving these associations.  
As detailed in the chapter 1, literature search revealed the mTOR, IIS and Sirtuin pathways 
to be key mediators in the interplay between nutrition, ageing and stem cell function.  
Furthermore, ABTB1 was highlighted as differentially expressed (14% decrease, p value 
0.001, Murphy et al. in prep.) in a microarray carried out by previous lab members.  As well 
as ABTB1, 5 genes in each pathway were selected as candidate genes within this chapter. 
The 5 genes were selected to span various levels of the signalling cascade, therefore key 
receptors, second messengers and effector molecules were selected.  
3.3.3.2  Expression of candidate genes is unaltered in Young to Old cohort 
To assess the role of the candidate genes in the parabiosis assay, a case-control cohort was 
used. The YOC cohort was comprised of young or old participants allowing the comparison 
of gene expression between the two groups following the differentiation assay. Shapiro-
Wilk normality test was used to determine which comparison test to use. For normally-
distributed data the Welch’s t-tests were used to compare the expression levels of each 
gene in the young and old groups. Due to different sample sizes (15 young and 22 old) and 
different variances between subgroups, Welch’s t-test was selected over Student t-test. 
Degrees of freedom and p values for each test are reported in Table 17 For data without 
normal distribution, Mann-Whitney U tests were used to compare the two groups. U 
statistic and p values are reported in Table 18. Following Bonferroni correction, no gene 
showed significant differences in expression levels between cells treated with serum from 
young and old participants. Graphs for the 16 tests are shown in Figure 22. 
 




Figure 22 - Candidate gene expression following in vitro parabiosis - Gene expression levels of the 16 candidate genes by the HPC0A07/03A cells following treatment with 
serum from the young (green) and old (red) subgroups of the young to old cohort. In all graphs, relative expression is on the y-axis . Error bars represent standard deviation. 
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   Gene Test df p value 
FOXO3A Welch's t-test 0.190 0.851 
MASH1 Welch's t-test 0.780 0.443 
UCP2 Welch's t-test 1.396 0.172 
GRB10 Welch's t-test 0.540 0.593 
ABTB1 Welch's t-test 0.498 0.623 
S6K Welch's t-test 2.319 0.027 
EIF4E Welch's t-test 0.234 0.817 
4EBP1 Welch's t-test 0.454 0.654 
NRIP Welch's t-test 0.437 0.666 
Table 17 - Welch’s t-test results comparing gene expression following treatment with young or old serum  
- Table showing the results of the t-tests carried out to compare the expression levels of candidate genes in 
the HPC0A07/03A following treatment with serum from either the young or old subgroups. Gene expression 
was measured as relative expression following the serum assay.  df - Degrees of freedom. Following 
Bonferroni correction to account for 16 multiple comparisons, the significance threshold for this analysis was 
set to 0.0031. Significant results before correction are in bold. No result survived multiple testing correction 
 
    Gene Test df p value 
MTOR Mann-Whitney U test 136.5 0.387 
SIRT1 Mann-Whitney U test 129.5 0.566 
IGF2R Mann-Whitney U test 124.5 0.459 
PTEN Mann-Whitney U test 117 0.571 
NAMPT Mann-Whitney U test 118.5 0.609 
ETV6 Mann-Whitney U test 124.5 0.767 
IRS2 Mann-Whitney U test 131 0.950 
 Table 18 -  Mann-Whitney U tests results comparing gene expression following treatment with young or 
old serum  - Table showing the results of the Mann-Whitney U tests carried out to compare the expression 
levels of candidate genes in the HPC0A07/03A cells following treatment with serum from either the young or 
old subgroups. Gene expression was measured as relative expression following the serum assay. df – Degrees 
of freedom. Following Bonferroni correction to account for 16 multiple comparisons, the significance 
threshold for this analysis was set to 0.0031.. 
 
3.3.3.3 Associations between candidate gene expression levels and cellular 
readouts 
Due to the lack of significant differences in gene expression between young and old 
subgroups, we investigated whether gene expression related to cellular readouts (i.e. KI67, 
CC3, MAP2 and DCX expression or cell density) irrespective of participant age. 
Following Shapiro-Wilk normality test, all variables showed a normal distribution except for 
Ki67 values.  Ki67 data was therefore log-transformed and retested for normality. 
Log(%Ki67) showed a normal distribution and was therefore used in this section. Pearson’s 
correlations were used to assess potential associations between molecular and cellular 
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readouts following the in vitro parabiosis assay.  Expression levels of MASH, ETV6, S6K, 
EIF4E, 4EBP1, IRS2, NRIP showed no correlation to cellular readouts. See appendix section 
8.2.2 for p and r values of these correlations. The remaining genes showed interesting 
correlations to cellular readouts and are reported below.  
 
3.3.3.3.1 Significant correlations with genes in the mTOR pathway 
mTOR expression showed a positive correlation with cell number. There was no correlation 
with other cellular markers. Figure 23 shows the graph representing the association 
between cell number and mTOR expression. Correlation results for both significant and 
non-significant associations between mTOR expression and cellular markers are reported 
in Table 19 GRB10, another molecule involved in mTOR signalling showed a similar 
association to cell density: increase GRB10 expression was correlated to increased cell 
number. Again, this was not reflected in correlations with other cellular markers.  See Table 
20 for r and p values of the correlations testing GRB10 expression and cellular markers for 




Figure 23 - Association between genes in the mTOR pathway and cellular markers - Scatterplots showing 
the significant correlation between (Left) mTOR and cell density (cells per field) and (Right) GRB10 and cell 
density (cells per field) following the in vitro parabiosis assay. Each dot represents a participant. Line of best 
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   mTOR r p value 
mTOR and Ki67 0.02 NS (0.917) 
mTOR and CC3% -0.20 NS (0.292) 
mTOR and MAP2% 0.18 NS (0.479) 
mTOR and DCX% -0.22 NS (0.251) 
mTOR and cells/field 0.42 0.016 
Table 19 - Correlations results for the association of cellular markers and mTOR gene expression - Table 
reporting the Pearson’s correlation results of mTOR expression and cellular markers. Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field). All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold 
   GRB10 r p value 
GRB10 and Ki67 -0.32 NS (0.088) 
GRB10 and CC3% -0.19 NS (0.335) 
GRB10 and MAP2% 0.26 NS (0.192) 
GRB10 and DCX% 0.11 NS (0.586) 
GRB10 and cells/field 0.45 0.012 
Table 20 - Correlations results for the association of cellular markers and GRB10 gene expression Table 
reporting the Pearson’s correlation results of GRB10 expression and cellular markers.  Cellular markers 
include proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density 
(cells /field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis. Significant results in bold.  
 
3.3.3.3.2 Significant correlations with Insulin and insulin-like pathway genes 
Expression levels of FOXO3A, a key molecule in the IIS pathway, correlated with the 
apoptosis marker (CC3), the number of immature neurons (MAP2) and cell density. These 
results show increased FOXO3A expression was associated to increased numbers of cells in 
general and immature neurons in particular. In addition, FOXO3A expression levels were 
associated with decreasing apoptosis. See Figure 24 and Table 21 for graphs and results of 
these correlations respectively. Expression of PTEN, a negative regulator of the IIS pathway, 
was negatively correlated with cell density but not to other markers. Figure 24 shows the 
graphical representation of this association and Table 22 reports the correlation results of 
all correlations testing PTEN expression level for association. Expression of IGF2R, the 
scavenger receptor of the IIS pathway, showed a significant and negative association to cell 
density and no association to any of the other markers. See Figure 24 and Table 23 for 
graphs and results of the correlation pertaining to IGF2R expression levels and cellular 
markers. 





Figure 24 - Association between genes in the Insulin and Insulin-like pathway and cellular markers 
(FOXO3A) Scatterplots showing the significant correlation between FOXO3A expression, apoptosis (CC3), 
immature neurons (MAP2%) and cell density (cells per field) following the parabiosis assay. (PTEN) Scatterplot 
showing the significant correlation between PTEN and cell density (cells per field) following the parabiosis 
assay. (IGF2R) Scatterplots showing the significant correlation between IGF2R expression and cell density 
(cells per field) following the in vitro parabiosis assay. Each dot represents a participant. Line of best fit is 
shown on each graph. 
 
    FOXO3 r p value 
FOxO3a and Ki67% -0.18 NS (0.335) 
FOXO3A and CC3% -0.42 0.022 
FOXO3A and MAP2% 0.48 0.009 
FOXO3A and DCX% -0.13 NS (0.503) 
FOXO3a and cells/field 0.76 <0.0001* 
Table 21 -  Correlations results for the association of cellular markers and FOXO3A gene expressionTable 
reporting the Pearson’s correlation results of FOXO3A expression and cellular markers.  Cellular markers 
include proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density 
(cells /field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold.  
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   PTEN r p value 
PTEN and Ki67 -0.04 NS (0.843) 
PTEN and CC3% 0.05 NS (0.824) 
PTEN and MAP2% -0.04 NS (0.843) 
PTEN and DCX% 0.02 NS (0.918) 
PTEN and cells/field -0.41 0.031 
Table 22 - Correlations results for the association of cellular markers and PTEN gene expression Table 
reporting the Pearson’s correlation results of PTEN expression and cellular markers.  Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold.  
 
   IGF2R r p value 
IGF2r and Ki67 0.26 NS (0.166) 
IGF2r and CC3% 0.40 NS (0.037) 
IGF2r and MAP2% -0.32 NS (0.101) 
IGF2r and DCX% 0.38 NS (0.046) 
IGF2r and cells/field -0.53 0.003 
Table 23 - Correlations results for the association of cellular markers and IGF2R gene expression Table 
reporting the Pearson’s correlation results of IGF2R expression and cellular markers.  Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold.  
 
3.3.3.3.3 Significant correlations with genes in the Sirtuin pathway 
Expression levels of NAMPT, the rate limiting enzyme in NAD+ biosynthesis, showed a 
significant association with increased proliferating cells (KI67). As shown by the results in 
Table 24, this increase was not accompanied by changes in other cellular markers. Figure 
25 shows the association between increasing number of KI67 positive cells and increasing 
NAMPT expression. UCP2, another protein in the sirtuin pathway, showed a similar 
association to proliferating cells. As for NAMPT, this was accompanied by a lack of further 
association to cellular markers changes Figure 25 displays this association. 
As shown in Table 26, there were no significant associations between cellular readouts and 
SIRT1 expression. 




Figure 25 - Association between genes in the sirtuin pathway and cellular markers -  Scatterplot showing 
the significant correlation between NAMPT expression and proliferation  in the HPC0A07/03A  cells following 
the parabiosis assay. Each dot represents a participant. Line of best fit is shown. Y axis shows the Log 
transformed percentage of cells positive for KI67, y axis reports the relative expression of NAMPT 
 
   NAMPT r p value 
NAMPT and Ki67% 0.47 0.012 
NAMPT and CC3% 0.08 NS (0.700) 
NAMPT and MAP2% -0.20 NS (0.340) 
NAMPT and DCX% -0.13 NS (0.530) 
NAMPT and cells/ field 0.08 NS (0.700) 
Table 24 - Correlations results for the association of cellular markers and NAMPT gene expression Table 
reporting the Pearson’s correlation results of NAMPT expression and cellular markers.  Cellular markers 
include proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density 
(cells /field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold. 
 
   UCP2 r p value 
UCP2 and Ki67% 0.48 0.008 
UCP2 and CC3% 0.07 NS (0.720) 
UCP2 and MAP2% -0.34 NS (0.086) 
UCP2 and DCX% -0.03 NS (0.894) 
UCP2 and cells/ field -0.24 NS (0.212) 
Table 25 - Correlations results for the association of cellular markers and UCP2 gene expressionTable 
reporting the Pearson’s correlation results of UCP2 expression and cellular markers.  Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the in vitro parabiosis assay. Significant results in bold.  
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   SIRT r p value 
SIRT and Ki67 0.31 NS (0.092) 
SIRT and CC3% 0.20 NS (0.319) 
SIRT and MAP2% 0.01 NS (0.951) 
SIRT and DCX% 0.20 NS (0.314) 
SIRT and cells/field -0.19 NS (0.316) 
Table 26 - Correlations results for the association of cellular markers and SIRT1 gene expressionTable 
reporting the Pearson’s correlation results of ABTB1 expression and cellular markers.  Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field).  All markers except for cell density are defined as the percentage of HPC0A07/03A cells positive for 
that marker relative to the total number of cells following the serum assay. Expression levels are the resulting 
gene expression levels following the in vitro parabiosis assay. 
 
3.3.3.3.4 Significant correlations with ABTB1 
Finally, correlations testing the association of ABTB1 to cellular markers results showed a 
number of interesting associations. As shown in Table 27, increased expression of ABTB1 
correlated with an increase in cell number (cells per field), as well as an increase in 
immature neurons (MAP2) and a decrease in apoptotic cell death (CC3). Increased ABTB1 
also correlated with decreased proliferation. Figure 26 depicts the significant correlations 
between ABTB1 expression and KI67, CC3, MAP2 and cell density. 
 




Figure 26 - Association of ABTB1 to cellular markers - Scatterplots showing the significant correlations 
between ABTB1 expression (x-axis) and proliferation (KI67), apoptosis (CC3), immature neurons (MAP2) and 
cell density (cells per field) (y-axis) in the HPC0A07/03A cells following the in vitro parabiosis assay.  Each dot 
represents a participant. Line of best fit is shown. Log transformed percentage of cells positive for KI67 is 
reported in the first graph. 
 
Table 27 - Correlations results for the association of cellular markers and ABTB1 gene expression Table 
reporting the Pearson’s correlation results of ABTB1 expression and cellular markers.  Cellular markers include 
proliferation (KI67), apoptosis (CC3), immature neurons (MAP2), neuroblasts (DCX) and cell density (cells 
/field).  All markers except for cell density are defined as the percentage of cells positive for that marker 
relative to the total number of cells following the serum assay. Expression levels are the resulting gene 
expression levels following the serum assay. Significant results in bold  
   ABTB1 r p value 
ABTB1 and Ki67% -0.43 0.024 
ABTB1 and CC3% -0.69 <0.0001 
ABTB1 and MAP2% 0.70 <0.0001 
ABTB1 and DCX% -0.01 NS (0.959) 
ABTB1 and cells/ field 0.58 0.001 




In this chapter, we aimed to assess whether serum affected cellular readouts of NSC 
function, whether this was related to human cognitive and imaging data and finally, 
whether alterations in nutrient-sensing pathways accompanied these changes. We report 
no effects of serum age on cellular readouts but show interesting associations between 
cellular readouts and both PAL performance and hippocampal subfield volumes. Finally, we 
report correlations between cellular readout and the expression levels of several nutrient-
sensing genes following the serum assay that are irrespective of serum donor’s age.  
 
 Translational potential of the in vitro parabiosis assay 
To address the first aim of this chapter, we tested cellular readouts for association with 
serum donor’s age. We tested cellular markers for apoptotic cell death, DNA damage, 
immature neurons, neuroblasts, proliferation and cell density. No marker showed 
association to donor age in the middle to old-age MATO cohort. This was surprising given 
the rodent literature suggesting an ageing systemic environment causes alterations in 
hippocampal NSCs (Katsimpardi et al., 2014; Villeda et al., 2011, 2014). Given previous 
research in this in vitro model showing increased apoptosis following treatment with aged 
serum when compared to treatment with young serum, the lack of association may be 
explained by the age-range of the serum donors. In this study, the participants ranged from 
52 to 89 which is nearly identical to the age range of the old subgroup used by Murphy et 
al. (53-89) (Murphy et al., 2018). This suggests that either the effects of an ageing systemic 
environment plateaus off past middle-age and therefore the effects of a middle-aged 
serum are not significantly different to those of older serum, or that a wider age gap is 
necessary to detect these effects. Besides the difference in age, the experimental design 
used by Murphy, consisted in distinct young and old subgroups with a 20-year age 
difference between the two groups. These differences may have allowed for more easily 
detectible differences than the design used here. The wider experimental age-range used 
by Murphy et al for example, may have made the results less susceptible to interindividual 
differences, a known issue in human research (Mori et al., 2009; Van Rooij et al., 1994). 
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Next, to gain insight into the translatability of this in vitro model, we assessed whether 
cellular readouts following the exposure of our hippocampal progenitors to donor serum 
related to the donor’s own hippocampal volume. To do this, we first we assessed the effect 
of age on hippocampal volumes corrected for whole-brain volume. We report a predictive 
effect of age on volume for all hippocampal subfields as well as whole hippocampus. Our 
results are in line with several studies reporting a reduction in hippocampal subfield 
volumes (Peters, 2006; Shing et al., 2011; Warner-Schmidt and Duman, 2006). This 
reduction is often attributed to neuronal and dendritic loss but the exact mechanisms 
behind this phenomenon remain unclear (Daugherty et al., 2016). Authors have however 
highlighted contradicting results when investigating age-related changes in hippocampal 
subfield volumes, with some reporting no associations and others reporting associations of 
certain subfields alone. (Daugherty et al., 2016; Mueller et al., 2011; Raz and Rodrigue, 
2006; Van Petten, 2004). Mueller and colleagues for example, initially reported a 
correlation between age and CA1 volume but a lack of association between age and 
subiculum, CA2 or CA3/4 (Mueller et al., 2007) and only later found an association with 
CA3/DG as well (Mueller and Weiner, 2009). Shing and colleagues suggest these 
contradictions may depend on other age associated-factors such as vascular risk 
confounding the results (Shing et al., 2011). Others suggest the ambiguous findings are a 
result of the cytoarchitectonic heterogeneity of the hippocampal formation which presents 
with distinct subfields and requires high spatial resolution to be analysed. Until recently, 
inadequacies in imaging resolution and available techniques have prevented accurate 
segmentation of the subfields and have contributed to discrepancies between studies 
(Iglesias et al., 2015). Results in the present study were obtained using the latest FreeSurfer 
algorithm which ensures accurate segmentation and allows for the novel separation of the 
CA3, CA4 and DG subfields providing stronger support for the existing evidence of an age-
related decline in hippocampal volume (Iglesias et al., 2015, 2016). 
 
Upon assessing the substantial effect of age on hippocampal volumes, subfield volumes 
were age-regressed for subsequent analysis. Partial correlations evaluating the association 
between participant hippocampal subfield volumes and cellular readouts showed 
interesting results. Increased DNA damage in the HPCs following incubation with serum, 
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was predictive of larger subiculum, CA3, CA4 and whole hippocampus volumes.  Similarly, 
increased number of neuroblasts following the in vitro assay was predictive of increased 
DG, CA3, CA4 and whole hippocampus volumes. These associations however, did not 
survive correction for multiple testing, further research and larger samples are needed to 
confirm these associations. Nevertheless, the high proportion of subfields correlating to 
both cellular markers suggests these associations are not by chance. Were these 
associations to be confirmed, they would support the translatability of this cellular assay 
demonstrating how the systemic milieu is biologically relevant and a reflection of 
hippocampal volumes. The associations between neuroblast number and hippocampal 
volumes are of particular interest given recent results by Powell et and colleagues. Using 
the same hippocampal progenitor line used here, Powell and colleagues showed that 
differentiation caused the upregulation of a gene set that was significantly enriched for 
genes predictive of hippocampal volume (Powell et al., 2017). These results suggest similar 
mechanisms are involved in both the regulation of the differentiation process and in the 
determination of hippocampal volumes. This is in line with our data showing a positive 
association between neuroblast number and DG, CA3, CA4 and whole hippocampal 
volume. It is also interesting to note that an increase in neuroblasts being associated to 
larger subfield volumes is supportive of the possible effect of neurogenesis on brain volume 
(Daugherty et al., 2016). Further studies assessing the maturation and integration potential 
of the neuroblasts and resulting neurons however, would be needed to support this claim.  
 
In addition to these findings, we also report the resulting number of cells and immature 
neurons following the in vitro assay are predictive of performance on PAL, validating 
further the translatability of the assay. Incubation with serum from individuals with better 
performance on PAL, led to fewer immature neurons in culture but higher overall cell 
density.  While the higher cell density is also supportive of a role of neurogenesis in PAL 
performance, the lower number of immature neurons is surprising especially given the lack 
of association with apoptosis or cell proliferation. The higher number of immature neurons 
upon treatment with serum from participants with poorer PAL performances, suggests 
either a negative role for new neurons in the formation of new memories or a 
compensatory mechanism attempting to create new neurons to counteract cognitive 
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decline. There is indeed evidence from existing literature for both  a role for neurogenesis 
as a destabilizing mechanism that may lead to memory loss and as a compensatory 
mechanism for neuronal damage (Epp et al., 2016; Kuhn et al., 2001). Interesting research 
by the Frankland group has in fact highlighted that an increase in neurogenesis can weaken 
existing memories while facilitating the encoding of new conflicting information. 
Importantly, the group has also shown that the timing of training in relation to the increase 
neurogenesis plays a key role in neurogenesis-mediated forgetting (Epp et al., 2016; Gao 
et al., 2018). As the temporal dynamics of neurogenesis are key for both a destabilising and 
a compensatory function, further research is needed to discern which is occurring here.   
 
It is important to note that the number of immature neurons was associated to the score 
obtained in the recognition phase of the cognitive task while the association to cell density 
was linked to performance in the recall phase. Different cognitive processes are responsible 
for performance in each phase of the task; the recognition phase has been associated to 
memory encoding while the recall phase has been associated to both encoding and 
retrieving (Lowndes et al., 2008). The finding that immature neuron number decreases with 
improved performance in the PAL recognition phase, may thus be in line with findings from 
the Frankland group suggesting increased neurogenesis selectively destabilises recently 
encoded memories (Gao et al., 2018). It is therefore possible that performance in each 
phase is differentially affected by the composition of systemic environment and that this is 
reflected in our cellular model readouts. However, it is also possible that differences seen 
here between the two PAL phases are due to the limited number of participants available. 
The direction of the association between immature neurons and PAL was the same for both 
PAL phases but the correlation between PAL recall and immature neurons did not achieve 
significance. The same goes for cell density: the association between cell density and PAL 
recognition was similar to that between cell density and recall but escaped significance, 
possibly due to low power. This suggests similar cellular readouts are associated to 
performance in both phases but by chance only satisfy the significance threshold in one of 
the phases. Similarly, we report a negative association between age and PAL recall but not 
age and PAL recognition and between level of education and PAL recognition but not PAL 
recall. These results are in line with existing literature showing a strong and detrimental 
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effect of age on PAL performance and support the notion that education is an important 
factor to consider when assessing cognitive performance (Barnett et al., 2015; Bento-
Torres et al., 2017; Blackwell et al., 2010; Lee et al., 2013). As was the case for the cellular 
readouts, age showed a similar trend in terms of direction of association to both PAL recall 
and PAL recognition suggesting that the low number of participants is a limiting factor 
within this study. In line with this, no association survived multiple testing suggesting 
further research, with larger cohort sizes,is needed to confirm these findings and assess 
the translational potential of this assay. Interestingly, unpublished research by the 
O’Sullivan group explored the association between PAL performance and hippocampal 
subfields in the MATO cohort used in the present study and found a positive association 
between CA1 and PAL recall (Hartopp et al., 2018). This association is supportive of a role 
for the hippocampus in object-location tasks such as PAL. Furthermore, the possible 
association between our cellular readouts and PAL performance is suggestive of the 
involvement of adult hippocampal neurogenesis. Though a direct association between 
object-location tasks and neurogenesis has not been shown, the spatial element and the, 
only subtle, differences between correct and incorrect answers in PAL suggests such tasks 
may entail aspects of pattern separation and therefore be reliant on neurogenesis.  
 
 Nutrient-sensing pathway alterations are associated to cellular readouts 
We aimed to identify whether treatment with young or aged serum triggered gene 
expression alterations in nutrient-sensing pathways and whether these were related to 
cellular readout variations. We report no significant alterations according to age group in 
any of the 16 genes examined following serum treatment. As previous research in this 
cohort by Murphy et al showed expression alterations in other genes such as MAP3K7, 
ENDOG and RFN126, this data suggests nutrient-sensing genes are more susceptible to 
interindividual variation than those tested by Murphy and colleagues (Murphy et al., 2018). 
Nutrient-sensing pathways are closely linked to lifestyle factors such as diet and exercise 
(Kapahi et al., 2010; Walker et al., 2005). Therefore, while these pathways are also likely to 
be affected by age, not accounting for aspects such as diet may mask this association. This 
is particularly important in our assay owing to the use of the systemic environment whose 
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composition is known to be greatly affected by nutritional intake. To assess the effect of 
serum on these molecular pathways, we adopted an endophenotype approach based on 
stem cell maintenance; we evaluated the association between gene expression and cellular 
readout irrespective of age. Hereby, 8 genes were highlighted as being associated to 
cellular markers following serum treatment. Notably, this approach highlighted interesting 
genes across all 3 nutrient-sensing pathways: mTOR, IIS and sirtuin as well as ABTB1.  
Table 28 summarises these associations. 
 
Gene Ki67 CC3 MAP2 DCX Cell density 
mTOR - - - -  
GRB10 - - - -  
FOXO3A -   -  
PTEN - - - -  
IGF2R - - - -  
NAMPT  - - - - 
UCP2  - - - - 
ABTB1    -  
 
Table 28 - Summary of the significant associations between cellular and molecular readouts following the 
in vitro parabiosis assay.  Table showing positive (in green) and negative (in red) correlations between gene 
expression and cellular readout. “-“ denotes results with no significant association. All genes that showed 
significant associations to at least one cellular readout are reported in the first column. Gene expression was 
compared to cellular readouts of proliferation (Ki67), apoptosis (CC3), immature neurons (MAP2), 
neuroblasts (DCX) and cell density.  
Firstly, our data supports a role for the mTOR pathway in stem cell maintenance. We report 
positive associations to cell density for both mTOR and GRB10 expression levels. This 
relationship is supported by studies showing mTOR positively regulates cell proliferation 
(Sarbassov et al., 2005). The inhibition of mTOR has been associated to decreased 
proliferation and selective induction of apoptosis in several cell lines, but to our knowledge 
this has not yet been explored in human NSCs. Interestingly, GRB10 which is positively 
regulated by mTOR showed a similar association (Laplante and Sabatini, 2012; Thoreen et 
al., 2009; Yu et al., 2009). Surprisingly, both GRB10 and mTOR expression levels showed no 
correlation with apoptosis or proliferation. Suggesting other mechanisms are responsible 
for the higher cell number or that a combination of both is involved making the changes in 
each undetectable. The positive association between mTOR and GRB10 expression was also 
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confirmed by our own experiments as was a negative association between PTEN and GRB10 
(see appendix section 8.2.3). 
 
In addition, our data supports a role for the IIS, and particularly for FOXO3A, in NSC 
function. Increased levels of FOXO3A were accompanied by an increase in cell number, our 
data suggests this increase can be explained by a decrease in apoptotic cell death as 
evidenced by the negative association between FOXO3A levels and CC3 positive cells. The 
higher number of immature neurons (MAP2 positive cells) associated with increasing 
FOXO3A expression is suggestive of a push towards neuronal differentiation. Surprisingly 
however, there was no association to neuroblast number (DCX positive cells) suggesting 
the higher proportion of immature neurons may be due to the selective apoptosis of other 
cell types. PTEN and IGF2R, two other components of the IIS pathway, also showed 
associations to cell number; both showed opposite associations to that seen between 
FOXO3A and cell number. Interestingly, both PTEN and IGF2R are responsible for the 
negative regulation of the IIS pathway by inhibiting the conversion of PIP2 to PIP3 and 
acting as a scavenger receptor respectively. Surprisingly, given the important function for 
IIS in regulating proliferation and cell growth, FOXO3a, PTEN and IGF2R all showed no 
association to the expression of the proliferation marker KI67. This may be attributable to 
a slowing of the cell cycle which would ultimately result in lower proliferation levels but 
would not be reflected in a decrease in KI67 positive cells. Despite this, our results are in 
line with those from rodent studies showing the involvement of the IIS in NSC maintenance 
and differentiation regulation (Åberg et al., 2000, 2003; Chaker et al., 2016).  
 
Genes involved in the sirtuin pathway, a pathway responsible for regulating mitochondrial 
function and energy availability, also showed interesting associations to in vitro cellular 
markers. This is of particular interest given the mounting evidence linking energy 
metabolism alterations to ageing (López-Otín et al., 2013). NAMPT, the enzyme responsible 
for the conversion of NAM back to NAD+ and therefore the rate limiting enzyme for SIRT1-
dependent deacetylation, showed a positive correlation with the proportion of 
proliferating cells (Guarente, 2007). As did UCP2, a protein downstream of SIRT1 but 
unrelated to its deacetylation activity. Our results aligned with rodent studies showing 
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NAMPT ablation led to decreased NSC proliferation and UCP2 deficiency led to decreased 
proliferation of liver cells (Elorza et al., 2008; Stein and Imai, 2014). Surprisingly however, 
we saw no significant associations between cellular readouts and SIRT1 expression despite 
the key function of SIRT1 in the sirtuin pathway. Further studies assessing pathway 
regulation at other levels, such as through post-translation modifications, are necessary to 
elucidate the exact mechanism through which ageing impacts this pathway. 
 
Finally, we report higher ABTB1 levels being associated to higher cell density, higher 
proportion of immature neurons, lower cell death and lower proportion of proliferating 
cells. Besides a role in basic cellular functions involving protein-protein interactions, the 
exact role of ABTB1 remains unknown. Its importance in ageing however, was highlighted 
by both Horvath’s clock and by previous work by Murphy et al (Horvath, 2013; Murphy et 
al., 2018). The results presented here suggest for the first time that ABTB1 expression is 
involved in NSC regulation and in particular, is associated to a shift towards neuronal 
differentiation and away from proliferation. To our knowledge, this is the first study linking 
ABTB1 to NSCs yet this association is supported by studies showing an interaction between 
ABTB1 and PTEN a key regulatory molecule of the mTOR and IIS pathway (Unoki and 
Nakamura, 2001). These findings therefore, provide insight into a potential new role for 
ABTB1. Additionally, given the interaction of ABTB1 with PTEN, a known regulator of 
nutrient-sensing pathways, these findings highlight ABTB1 as a novel candidate in the 
search of mediators responsible for the interplay between ageing, nutrition and NSC 
regulation. 
 Summary and future directions 
In summary, we report associations between cellular readouts of the human in vitro NSC 
model and hippocampal subfield volumes, between cellular readouts and cognitive 
performance and between cellular readouts and gene expression levels of nutrient-sensing 
pathway components. Despite the lack of association between cellular readouts and 
chronological age itself, the links established in this study with these three age-related 
phenotypes, are suggestive of an important role of NSCs in ageing and for the neuro-
translatability of the systemic environment, and of this in vitro model specifically, in ageing 
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research. Our findings support the notion of a discrepancy between chronological and 
biological ageing, and the use of endophenotype approaches to study human ageing. 
Finally, our data also supports an important role for ABTB1 and the mTOR, IIS and sirtuin 
pathways in human NSC maintenance and finds several rodent findings relevant to human 
cellular biology. It also shows potential differences and highlights the need for further 
studies, with more controlled human interventions, to fully elucidate whether the NSC 
changes precede the expression level alterations or vice versa. Finally, given the 
importance of post-translational modifications in nutrient-sensing pathways other 
techniques such as western-blots to gain information on protein expression and protein 
modifications such as phosphorylation, may provide additional information on the 
involvement of these candidate genes in NSC maintenance.  
 Limitations 
Despite exciting results, this study was subject to a number of limitations. Firstly, though 
the in vitro model used here enabled the study of molecular mechanisms associated to 
specific in vivo phenotypes in a human context, it was not free of limitations. Firstly, cell-
models are somewhat removed from an in vivo system making it challenging to account for 
any organism-wide compensatory mechanisms that maybe occurring. Further to this, our 
model specifically, is hindered by the lack of microglia which are known to have key effects 
in both ageing and NSC regulation (De Lucia et al., 2016; Norden and Godbout, 2013; Perry 
et al., 2002) and by the use of ‘young’ foetal neural stem cells to study ageing. Were a cell 
line derived from adult hippocampi available, it would be interesting to repeat this study 
using adult NSCs to test whether intrinsic changes as well as extrinsic ones drive NSC 
alterations in ageing. In addition, as studying the effects of an ageing systemic environment 
is a key area in biogerontology, future studies must take into account lifestyle factors such 
as nutrition when employing this as an experimental variable. Finally, larger participant 
numbers would benefit studies such as the present one by providing stronger statistical 
power to detect associations
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4 Oxidative stress, DNA damage and passaging: An Alternative 
Multimodal Model to Induce Neural Stem Cell Ageing 
In chapter 3, we investigated the use of serum from participants of varying ages to create 
an in vitro parabiosis assay to model ageing. Whilst this proved a useful model to study 
human variability, a more controlled ageing model is required to assess gene expression in 
response to ageing. To this end, we set up an alternative ageing model that replicates 
several aspects of ageing to test the expression levels of the candidate genes highlighted 
in the previous chapter. 
4.1  Introduction 
 Oxidative stress in ageing and neural stem cells. 
Oxidative stress (OS) is a known hallmark of ageing (López-Otín et al., 2013). To understand 
how this contributes to the ageing phenotype, it is important to first describe the different 
agents involved in this biological response.  
 
Oxidants and oxidative agents are key players in oxidative stress, they are chemical species 
that either remove electrons from other species or transfer electronegative atoms. 
Accordingly, reducing agents donate electrons to other chemical species, as part of a 
reduction-oxidation (redox) reaction, thereby becoming oxidised. Importantly, free radicals 
are oxidants that have unpaired electrons in their outer orbital which allows them to 
interact with non-radical species and start free radical chain reactions. In biological species, 
an important type of free radicals are reactive oxygen species (ROS). ROS are highly 
unstable ions that react with other molecules to gain stability, these can be either oxygen 
radicals or non-radicals that are oxidising agents. To compensate for the damage caused 
by ROS, biological systems employ antioxidants as part of oxidative defence (Halliwell, 
2006). Antioxidants are able to either delay or prevent substrate oxidation and are usually 
controlled by master regulators. One such regulator is nuclear factor erythroid 2–related 
factor 2 (Nrf2) a major antioxidant transcription factor and master regulator of the cellular 
defence pathway (Vomund et al., 2017). It is responsible for controlling genes involved in 
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DNA damage recognition as well as the repair removal and degradation of damaged 
proteins (Bakunina et al., 2015).  
 
OS occurs when there is an imbalance between oxidants and antioxidants in favour of 
oxidants. This imbalance can be caused either by excessive ROS or by a decrease in 
antioxidative response and can lead to redox disruption, signalling-pathway alterations, 
lipid peroxidation and DNA and protein damage (Bakunina et al., 2015).  Low levels of OS 
however, are also a side product of several routine processes such as cell differentiation, 
making OS consequences largely dependent on tissue and cell types. ROS levels are even 
thought to be responsible for regulating the proliferation-differentiation balance in stem 
cells (Bigarella et al., 2014; Chiu and Dawes, 2012; Hochmuth et al., 2011; Myant et al., 
2013). Adequate regulation of ROS and prevention of oxidative damage in stem cells is 
therefore essential to maintain functional stem cells (Wallace, 2005). 
 
Due to its high metabolic rate and only modest antioxidant levels, the brain is particularly 
susceptible to OS and oxidative damage. It follows that OS plays an important role in NSC 
maintenance (Bakunina et al., 2015). Supporting this, studies investigating the production 
of H202 showed it is generated by hippocampal stem and progenitor cells to regulate 
intracellular pathway and thereby regulate their proliferation (Dickinson et al., 2011). In 
addition, experiments showing H202 supplementation causing an overall increase in NSC 
proliferation and lower endogenous ROS levels being associated to a decline in NSC self-
renewal showed the importance of endogenous and exogenous ROS in NSCs (Le Belle et 
al., 2011). In line with this, adult neurogenesis was shown to transiently generate OS both 
in vivo and in vitro; Walton and colleagues showed the highest concentrations of oxidised 
DNA and lipid markers, two OS hallmarks, were found in the dentate gyrus of the 
hippocampus and that isolated mouse NSCs undergoing the highest levels of proliferation 
also showed the highest levels of OS load (Walton et al., 2012).  
 
In addition to its role in stem cell maintenance, OS also plays a key role in ageing.  Ageing 
is in fact sometimes regarded as the accumulation of damage caused by ROS over an 
extended period of time. This notion was initially proposed by Harman’s “free radical 
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theory of ageing” which suggested lifespan could be extended by augmenting antioxidant 
defences (Harman, 1956). In line with this, there is overwhelming evidence showing 
increased oxidative damage with age in general and in the brain specifically (Dröge and 
Schipper, 2007; López-Otín et al., 2013; Wallace, 2005). Notably, human studies by Rinaldi 
and colleagues also showed a correlation between age-related memory impairments and 
both brain and plasma antioxidant levels (Rinaldi et al., 2003). 
 
Initially Harman’s theory appears to diverge from the one tested throughout this thesis 
suggesting specific genes within nutrient-sensing pathways are responsible in part for 
animal and human longevity. However, advances in our understanding of the causes and 
consequences of ROS, OS and oxidative damage have highlighted the two theories may 
complement one another (Dröge and Schipper, 2007). Several components of nutrient-
sensing pathways have in fact been highlighted as key players in oxidative responses. The 
FOXO transcription factors for example, regulate cell metabolism and oxidative response, 
in part, by promoting the expression of antioxidants (Signer and Morrison, 2013). In 
addition, the insulin and mTOR signalling pathways were shown to be involved in the 
cellular response to OS following H202 treatment of chinese hamster ovary cells (Schmitt et 
al., 2005). Finally, sirtuins have been repeatedly shown to have important functions in 
regulating ROS levels owing to both their deacetylation activity and their role in 
mitochondrial regulation, this, combined with their susceptibility to food-derived 
polyphenols such as resveratrol, makes them exciting candidates to mediate the link 
between nutrition, ageing and OS (Howitz et al., 2003; Lombard et al., 2011; Merksamer et 
al., 2013). Given these links, studies elucidating the relationship between ageing, nutrient-
sensing pathways and OS in human models are an important next step in ageing research. 
 Senescence in ageing neural stem cells. 
Cellular senescence is another known hallmark of ageing. It is defined as an irreversible 
cellular response to exogenous or endogenous sources that causes otherwise proliferative 
cells to cease proliferating in response to growth factors (Campisi and d’Adda di Fagagna, 
2007). However, along with cell-cycle arrest, senescent cells also undergo morphological 
epigenetic, mitochondrial, metabolic and protein expression changes (Tan et al., 2014).  




Senescence was initially thought to be a direct consequence of telomere shortening; a 
phenomenon that occurs with each replication due to the inability of DNA polymerase to 
elongate single stranded 3’ ends. Telomere-shortening gave rise to the concept that a 
mammalian cell population may only replicate a finite number of times before cell division 
stops, which is usually referred to as the Hayflick limit (Watts, 2011).  
 
The Hayflick limit has long been considered the number one driver of senescence, however, 
studies have now begun identifying other inducers of senescence. These are usually 
classified in two main groups: replicative senescence and stress-induced senescence. 
Replicative senescence encompasses telomere-shortening as suggested by Hayflick, it 
activates DNA damage responses that trigger cell-cycle arrest by regulating tumour 
suppressor genes and cell-cycle kinases (Di Micco et al., 2008). Stress-induced senescence 
instead, is independent of telomere shortening and can be induced by DNA damage, sub-
cytotoxic doses of oxidative stress, calcium dysregulation and protein misfolding. Like 
replicative senescence, this type of senescence also typically up-regulates tumour 
suppressor genes like p53, p21 and p16 but importantly, it is not dependent on continuous 
proliferation. A third classification, oncogene induced senescence, is also proposed which 
is a specific type of stress-induced senescence caused by the activation of an oncogene 
(Larsson, 2011). While some downstream targets and consequences of senescence are 
specific the type of senescence, others are shared regardless of the inducer. Most types of 
senescence for example, will cause p16 upregulation (Tan et al., 2014). 
 
In mammalian organisms, cells expressing senescence markers accumulate with age 
specifically at sites of age-related pathology; this suggests senescence may play a 
contributing role to organismal ageing (Campisi and d’Adda di Fagagna, 2007). Given the 
strong association between proliferation and senescence, research aimed at elucidating 
senescence’s contribution to ageing has focused on stem and progenitor cells and resulted 
in studies showing age-dependent rises in senescence markers such as p16-expressing 
stem and progenitor cells (Campisi and d’Adda di Fagagna, 2007; Janzen et al., 2006; 
Molofsky et al., 2006). p16 expressing progenitor cells were also associated to brain-ageing 
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related phenotypes such as a decline in neurogenesis and forebrain progenitors in mice 
(Molofsky et al., 2006).  In addition, NSC senescence was implicated in neurogenesis by 
studies showing telomere shortening in aged mouse hippocampal NSC related to decreased 
neuritogenesis and neuronal differentiation (Ferrón et al., 2009). In line with this, a recent 
study showed short treatments with hydroxyurea (HU), an anti-neoplastic drug that 
represses ribonucleotide reductase and thereby incurs double strand breaks in DNA, 
caused senescence-like changes in human NSC proliferation and DNA damage (Daniele et 
al., 2016).  
 
Senescence in neuronal cells remains a relatively unexplored field possibly due to their low 
proliferation rates and the, only recently disproven, notion that senescence only occurs in 
highly proliferative cells. The discovery that senescence occurs through mechanisms other 
than Hayflick’s limit in fact, has expanded senescence research into post-mitotic cells such 
as neurons. Indeed, Panossian and colleagues showed senescence phenotypes in wake 
neurons and notably linked them to SIRT1 levels (Panossian et al., 2011) while Jurk and 
colleagues showed increased senescence-associated -galactosidase (SA gal) following 
DNA damage in mouse post-mitotic purkinje cells in vivo  (Jurk et al., 2012).  SA gal is a 
lysosomal enzyme that catalyses the hydrolysis of galactosides at pH6 in senescent but not 
in young cells and is therefore widely employed in ageing research (Hall et al., 2016). SA 
gal was also used to show prolonged culture of rat hippocampal neurons caused 
senescence-like phenotypes as did rat cerebral granule neuron culture (Dong et al., 2011; 
Uday Bhanu et al., 2010). 
 
 These studies prove the presence of senescence in NSCs as well as in post-mitotic cells like 
neurons and highlight the importance of DNA damage as well as that of increased 
proliferation in causing senescent phenotypes. They also support the need for future 
studies to study the contribution of senescent neuronal cells in ageing. Identifying 
senescence however, remains challenging as there is no single gold-standard marker of a 
senescent state. Studies have instead focused on identifying several phenotypes which, in 
aggregate, can mark as cell as senescent. The two most obvious senescence phenotypes 
are the permanent cell cycle arrest and the acquisition of a senescent morphology. Besides 
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the decrease in proliferation, senescent cells in fact, show considerable morphological 
alterations usually consisting in flattened enlarged and irregular cell bodies. These 
alterations are usually accompanied by DNA damage, increased expression of SA-gal and 
the upregulation of cell cycle regulators such as p16. When several of these alterations are 
detected a cell is said to be senescent (Hernandez-Segura et al., 2018; Rodier and Campisi, 
2011). 
 Aims of this chapter 
Research has shown stem cell ageing and NSC ageing in particular, are accompanied by a 
number of exogenous and endogenous alterations such as increases in ROS resulting OS, 
DNA damage accumulation and signalling pathway alterations. Though studies have 
focused on identifying the contribution for each of these aspects to the overall ageing 
phenotype of NSCs, they have also highlighted the multifaceted nature of ageing. A more 
holistic approach to modelling ageing may therefore be more realistic than only modelling 
some of its characteristics. In addition, there is only a limited number of studies assessing 
these in human models of NSCs. Therefore, in this chapter we set the following aims. 1) Set 
up a human NSC ageing model that encompasses OS, DNA damage and prolonged 
proliferation to model several aspects of ageing and to elucidate their individual and 
combined effects. To this end, tert-Butyl hydroperoxide (tBHP) is employed as a H202 
analogue, to mimic oxidative stress within the neurogenic niches, hydroxyurea is employed 
to induce DNA damage and stress-induced senescence and prolonged passaging is 
employed to mimic aged NSCs which would accrue damage as would happen in vivo over 
time. 2) Assess whether this multimodal NSC ageing model can induce cellular changes 
indicative of neurogenic or NSC maintenance alterations. 3) Assess whether this novel 
multimodal NSC ageing model induces molecular alterations in the candidate nutrient-
sensing genes selected in the previous chapter.  
Figure 27 shows the rationale behind the aims and hypotheses of this project. 
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Figure 27 - Chapter 4 hypothesis. We hypothesise that increased levels of reactive oxygen species (ROS) and 
oxidative stress (OS), DNA damage and replicative senescence contribute to neural stem cell (NSC) ageing. 
Therefore, we aim to set up an in vitro ageing model which encompasses these three aspects by establishing 
viable doses of tert-Butyl hydroperoxide (tBHP) and hydroxyurea (HU) as well as determining passage 
numbers that might replicate ageing phenotypes (1). Next, we aim to establish whether this ageing model 
leads to cellular modifications by quantifying cellular markers of neurogenesis and NSC maintenance (2).  
Finally, we aim to assess whether the ageing model causes alterations in the TOR, sirtuin or insulin and insulin-
like signalling (IIS) pathways (3).   
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4.2 Materials and methods 
 Ageing cell bank 
To mimic aged NSCs and to replicate the accumulation of damage increased, high passage 
cells were compared to low passage cells. To do this, a cell bank of high and low passages 
was created. This enabled us to have a stock of low passage number vials (p16) and of high 
passage number vials (p22) all with the same number of freeze-thaw cycles to minimise 
any interexperimental variability. This was achieved by using 2 vials with an intermediate 
passage (p11) from the original cell bank and passaging them exponentially until passage 
14. 14 passage 14 vials (each containing 2 million cells) were frozen and stored while 
remaining cells were passaged further and exponentially until passage 22 when another 14 
vials were frozen and stored (see Figure 28). These cells were used in all experiments 
comparing young and old passage numbers. 
 
 
Figure 28 - Schematic of ageing cell bank methods  - Passage 11 HPC0A07/03A cells were passaged 
exponentially for 3 passages; 28 million passage-14 cells were frozen in whilst a subset was carried on for an 
additional 7 passages obtaining a further 28 million cells at passage 22. Both sets of cells (passage 14 and 
passage 22) underwent two freeze-thaw cycles prior to use and were cultured in identical conditions.  
Throughout the experiments outlined in this chapter, HPCs were treated with varying 
concentrations of tBHP (Fisher Scientific,10703571) and HU (Sigma, H8627) to establish a 
new senescence model. t-BHP was stored at 4˚C for a maximum of 2 weeks since opening, 
HU was dissolved in ddH2O aliquoted and stored at -20˚C until use. Both t-BHP and HU were 
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diluted to target concentrations in culture media prior to incubation with HPCs. 
Concentration and assay durations match those explained in section 2.1.6 unless otherwise 
stated.  When setting up the model, 3 different incubation times were tested for HU; the 
standard incubation of 48 hours, an 8-hour incubation and a 3-hour incubation. Cells 
undergoing the shorter incubation times of 8 and 3 hours underwent media changes at the 
usual ‘treatment’ timepoints. As shown in Figure 29, all other assay parameters and timings 
were kept the same. Importantly, as the aim was to analyse short term effects, cells 
undergoing the differentiation assay that were destined for 8- and 3-hour incubations were 
not treated during the proliferation portion of the assay. Control wells for each incubation 
period received a media-only wash at the treatment timepoint. 
 
 
Figure 29 - Schematic of proliferation and differentiation assays including shorter incubations for 
hydroxyurea (HU).  Timescale of the experiments showing the treatment timepoints and growth factors used. 
Cells are cultured in media containing growth factors (EGF, bFGF and 4-OHT) for the duration of the 
proliferation assay (first 72 hours) at which point the plates can be fixed to complete the proliferation assay. 
Alternatively, to begin the differentiation assay, plates undergo 2 full media changes with differentiation 
media (lacking EGF, bFGF and 4-OHT) and are cultured for a further 7 days in differentiation media containing 
treatment.  Standard treatment timepoints shown in black and used in previous chapters were at the 24-hour 
and 48-hour timepoint. Shorter incubations periods tested in this chapter are shown in green. For both the 
8-hour and 3-hour treatment, overall assay parameters are kept the same. Cells are washed with control 
media at the 24-hour and 48-hour timepoints and then treated later in the assay, 8 or 3 hours prior to fixing. 
Cells undergoing the differentiation assay and destined for 8- or 3-hour incubation were not treated during 
the proliferation portion of the assay. 
 
 Morphological analysis 
In a subset of experiments involving DCX and Map2 staining (see section 2.2)  for staining 
methods), morphological analysis was carried out using the Columbus TM Image Data 
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Storage and Analysis System version 2.5.0 (Perkin Elmer). Images were acquired on the 
CellInsight as described in see section 2.2)  and exported onto the Columbus platform. 
Similarly to the CellInsight analysis, the DAPI stain was used to identify the nuclei. Map2 or 
DCX stain was then used to identify the cytoplasm and again positive stains were 
distinguished from non-specific signal using thresholding methods. Once the population of 
either Map2 or DCX positive cells was selected, machine learning was carried out to class 
the cells into either a ‘stunted’ or an ‘elongated’ morphology in an unbiased manner. The 
machine learning protocol involves a training phase in which a subset of images is used to 
train the machine to recognise the different morphological properties characterising each 
subclass. The software was always trained on a minimum of 5 fields. This is followed by a 
checking phase in which the user can see whether the correct cells are being selected for 
each class (See Figure 30). Once the parameters are set, the software can calculate the 
percentage of cells belonging to each class across the entire plate as well as identify which 
morphological properties were used to create the classes and specifically how these 
properties differ. Details on the parameters used for the machine learning protocol and the 
pertinent scripts can be found in appendix section 8.3.1.1 . 
 
Figure 30  - Morphological analysis on Columbus software.   On the left is a representative image of the 
training phase of the Machine Learning protocol showing how the user selects sample cells for each of the 
classes (here identified as “stunted” in red and “elongated” in green. On the right is a representative image 
of the “checking phase” in which the software assigned a class to the remaining cells and highlighted them in 
either red or green if identified as belonging to the “stunted” or “elongated” class respectively. 
 
Stunted
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 Statistical analyses 
GraphPad Prism was used for all analysis in this chapter. For all analyses Bonferroni 
correction was applied to correct for multiple testing. 
4.2.3.1 Immunocytochemistry  
Cells were stained and analysed as explained see section 2.2 . The percentage of positive 
cells for three biological replicates was averaged per condition. Conditions were then 
compared with one-way ANOVAs or two-way ANOVAs. One-way ANOVAs were used when 
comparing the different treatments or passage numbers and two-way ANOVAs were used 
to compare conditions in which both treatment and passage number varied. Following 
significant one-way ANOVAs the Bonferroni post-hoc test was carried out in GraphPad 
Prism. When two-way ANOVAs identified significant variance between groups, Fisher least 
significant difference (LSD) was carried out on GraphPad Prism to calculate degrees of 
freedom, t and p values. To apply multiple testing corrections, the Bonferroni method was 
applied and the significance threshold was lowered, according to the number of multiple 
comparisons, to adjust for the increased probability of false discovery. The relevant 
significance threshold for each set of results is reported in the results section. This was 
done to ensure the correct number of multiple comparisons was corrected for rather than 
the default number set by GraphPad Prism. 
4.2.3.2 Morphological analysis 
The percentage of cells with stunted morphology for three biological replicates was 
averaged per condition. Conditions were then compared with either one-way or two-way 
ANOVAs as explained above.  
4.2.3.3 qPCR analysis 
qPCR analysis was carried out as explained in section 2.3 and section 3.2.4 The relative 
expression was calculated using the Pfaffl method within each biological replicate. The 
three biological replicates were then averaged per condition and the conditions compared 
with one-way or two-way ANOVAs as explained above.  




In this chapter, we set up an in vitro ageing model that encompasses several aspects of 
ageing NSCs. We aimed to establish whether this novel multimodal model induced changes 
in the HPCs and to investigate the expression levels of the 9 candidate genes selected in 
Chapter 3. 
 Establishing a multimodal ageing model 
4.3.1.1 Selecting treatment concentrations and timings 
Firstly, we aimed to select viable concentrations for the two treatments involved in the 
ageing model. Three different tBHP concentrations were tested as well as six HU 
concentrations across three different timepoints. For this preliminary work cells were 
treated either during proliferation or during differentiation. In addition to the standard 
incubation times of 48 hours for the proliferation assay and 7 days for the differentiation 
assay, experiments assessing HU also tested two new incubation periods of 8 and 3 hours 
prior to fixing. Both tBHP and HU caused considerable reductions in cell number at higher 
concentrations following the standard proliferation (Figure 31) and differentiation (Figure 
32) assays. Shorter incubation periods with higher concentrations of HU however, did not 
show this toxicity see Figure 31 and Figure 32. Representative images for these results are 
shown in Figure 33. 
 




Figure 31 - Proliferation assay: Selecting tert-Butyl hydroperoxide (tBHP) and hydroxyurea (HU) 
concentrations.  Graphs showing the resulting HPC0A07/03A cell density (cells per field) following  
treatments during the human progenitor cell proliferation assay. HPC0A07/03A passage 17 cells were used 
for all conditions.  The top row shows standard incubation periods of 48 hours. The left graph shows cell 
density decreasing with increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls 
treated with media only.  The graph on the right shows decreasing cell density with increasing HU 
concentrations (10µM, 50 µM, 100µM). The bottom row shows the resulting cells per field following shorter 
incubation periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, 
cells were fixed 72 hours after seeding. Standard deviation is reported as error bars. Each dot represents a 




















































































































































































Figure 32 - Differentiation assay: Selecting tert-Butyl hydroperoxide (tBHP) and hydroxyurea (HU) 
concentrations.  Graphs showing the resulting cell density (cells per field) following various treatments during 
the human progenitor cell differentiation assay. HPC0A07/03A passage 17 cells were used for all conditions. 
The top row shows standard incubation periods of 48 hours. The left graph shows cell density decreasing with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows decreasing cell density with increasing HU concentrations (10µM, 50 µM, 100µM). 
The bottom row shows the resulting cells per field following shorter incubation periods with HU; 8-hour 
incubation on the left and 3-hour incubation on the right. In all cases, cells were not treated during the 
proliferation assay (72 hours). They were then either washed and treated at the 72 hour timepoint and left 
to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to differentiate in media 
only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 days after seeding. 
Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 technical replicates 











































































































































































Figure 33 - Representative images of DAPI stain following the differentiation assay with tert-Butyl 
hydroperoxide (tBHP) or hydroxyurea (HU) treatments. Each square represents a field as analysed by the 
CellInsight software.  HPC0A07/03A passage 17 cells were used for all conditions. DAPI (in blue) stains the cell 
nucleus by binding to DNA. DAPI stain was quantified using the CellInsight software to quantify cell density. 
Treatment concentration is reported in the top left corner of each image. Treatment duration is reported in 
the top left corner of each row.  First row shows the DAPI stain of cells following tBHP treatment of 7 days at 
each concentration tested: 10µM and 20µM show a considerable reduction in cell number. The second row 
shows DAPI stain of following HU treatment of 7 days, as for tBHP higher concentrations appear to cause 
reductions in cell number. The third row shows the resulting DAPI following an 8-hour incubation with HU 
and the bottom row shows the DAPI stain of cells following a 3-hour incubation with HU.  Both shorter 
incubations do not show an obvious change in cell number.  
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These changes were accompanied by promising alterations in cellular markers suggesting 
tBHP treatment during the proliferation assay caused dose-dependent changes in stemness 
(SOX2), apoptosis (CC3), proliferation (Ki67) while tBHP treatment during the 
differentiation assay caused changes in apoptosis rate, proliferation rate, neuroblasts 
numbers (DCX) and immature neurons numbers (MAP2). Preliminary results also suggested 
treatment with HU during the proliferation assay caused changes in apoptosis and DNA 
damage (H2AX) while HU treatment during the differentiation assay caused possible 
increases in apoptosis, proliferation, DNA damage and immature neurons (see appendix 
section 8.3.2.1 for graphs).  As these experiments were carried out as a single biological 
replicate and 3 technical replicates to assess treatment viability, statistical analysis of these 
results was not possible. Rather, these results were used to confirm treatment did cause 
unexpected changes in cell markers and to inform concentration choice. Given most 
cellular marker alterations seemed to already be present at the lower concentrations, 
which were not accompanied by extensive cell loss, these were selected for further 
experiments. A tBHP concentration of 1µM and HU concentrations of 10µM and 50µM at 
standard treatment timepoints were selected. 
 
Cell density was assessed at these concentrations following individual and combination 
(tBHP + HU) treatment at both proliferation and differentiation timepoints. One-way 
ANOVAs on 3 biological replicates showed a statistically significant change in cell density 
between treatment groups following the proliferation assay (F(5,12) = 7.12, p = 0.0026). 
Post-hoc analysis using the Bonferroni method revealed a significant reduction in cells per 
field in the 50µM HU group relative to control (t(12)=3.52, p = 0.02) and in the 1µM tBHP + 
50µM HU treatment group relative to control (t(12)=4.69, p = 0.003). Other treatment 
groups did not show cell density differences relative to controls.  
 
In addition, one-way ANOVAs on 3 biological replicates also showed a statistically 
significant change in cell density between treatment groups following the differentiation 
assay F(5,12) = 9.64, p = 0.0007. Bonferroni post-hoc analysis revealed, similarly to the 
proliferation assay results, that there was a significant decrease in cell number in both the 
50µM HU treatment group (t(12)=4.37, p = 0.0046) and the 1µM tBHP + 50µM HU 
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treatment group (t(12)=3.52, p = 0.02)  relative to control. No other treatment groups 
showed changes in cell density. See Figure 34 for graphs of the proliferation and 
differentiation assay results and Figure 35 for representative images of these results. 
 
 
Figure 34 -  Cell number (cells per field) following individual and combination treatments with tert-Butyl 
hydroperoxide (tBHP) and hydroxyurea (HU).  Left graph: Proliferation assay results, HPC0A07/03A passage 
17 cells were seeded and treated after 24 hours with either 1µM tBHP, 10µM HU, 50µM HU, 1µM tBHP + 
10µM HU or 1µM tBHP + 50µM HU. Cells were incubated with the corresponding treatment for 48 hours and 
then stained with DAPI and analysed with the CellInsight software. The 50µM HU treatment group showed a 
52.9% reduction in cell number relative to the media-only control while the 1µM tBHP + 50µM HU showed a 
70.6% reduction in cell number relative to media-only control. Other treatments showed no significant effects 
on cell number. Right graph: Differentiation assay results, cells were seeded and treated after 24 hours with 
either 1µM tBHP, 10µM HU, 50µM HU, 1µM tBHP + 10µM HU or 1µM tBHP + 50µM HU. Cells were incubated 
with the corresponding treatment for 48 hours, cells were then allowed to differentiate and were incubated 
with the corresponding treatment for 7 further days before being stained with DAPI and analysed with the 
CellInsight software. The 50µM HU treatment group showed a 71.1% reduction in cell number relative to the 
media-only control while the 1µM tBHP + 50µM HU showed a 57.3% reduction in cell number relative to 
media-only control. Other treatments showed no significant effects on cell number. Error bars represent 
standard deviation. One-way ANOVAs followed by Bonferroni post-hoc analysis. 3 biological replicates and 3 
technical replicates. Significance displayed as * p < 0.05, ** p <0.01. 





Figure 35 - Representative images of DAPI stain following the proliferation and differentiation assay with 
tert-Butyl hydroperoxide (tBHP) or hydroxyurea (HU) treatments. Each square represents a field as analysed 
by the CellInsight software.  DAPI (in blue) stains the cell nucleus by binding to DNA. DAPI stain was quantified 
using the CellInsight software to quantify HPC0A07/03A cell density. Treatment concentration is reported in 
the top left corner of each image. Top Panel: DAPI stain following the proliferation assay; 48-hour incubation 
with treatment. Bottom Panel: DAPI stain following the differentiation assay; this included a 48-hour 
incubation during proliferation and a 7-day incubation during differentiation 
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4.3.1.2 Selecting passage number 
Next, we aimed to assess the effects of increasing passage number. Preliminary work was 
therefore carried out to determine whether cells were able to grow until high passages and 
whether they retained their stemness and proliferative abilities during the proliferation 
assay and their differentiation abilities during the differentiation assay.  Therefore, cells per 
field and percentage positive cells for Ki67 (proliferation), nestin (stemness) and SOX2 
(stemness) were quantified following the proliferation assay. Similarly, following the 
differentiation assay, cells per field and the percentage positive cells for Ki67 
(differentiation), DCX (neuroblasts) and MAP2 (immature neurons) were quantified. The 
effect of combination treatment (1µM tBHP + 10µM HU) at different passage numbers was 
also assessed. As this work was carried out as pilot work (2 biological replicates, 3 technical 
replicates), no statistical analysis was carried out. Following both the proliferation and the 
differentiation assay, cell number appeared stable throughout passages and only slightly 
affected by treatment. In addition, all stemness, proliferation and differentiation markers 
continued to be expressed regardless of passage number. These results showed that higher 
passage numbers are indeed a viable experimental condition. Though there were some 
fluctuations in cell marker expression, most higher passages showed comparable 
expression across markers, therefore passage 26 was selected for future experiments as a 
high, yet easily obtainable, passage given the passage 22 cell bank. These preliminary 
results are reported in Figure 36 and Figure 37.  
 




Figure 36 - Proliferation markers are expressed at different passage number. Proliferation assay results, 
HPC0A07/03A cells at different passage numbers were seeded and incubated with media-only or treated 
after 24 hours and incubated with 1µM tert-Butyl hydroperoxide (tBHP) + 10µM hydroxyurea (HU) for 48 
hours. Passage numbers included 17 (p17) as a control and several higher passages ranging from passage 25 
(p25) to passage 30 (p30). DAPI: DAPI was used to quantify the number of cells per field (y-axis); treatment 
(light grey) appeared to cause slight reductions in cell number at most passage numbers. Besides some 
fluctuations passage number did not seem to affect cell number. Ki67: Ki67 was used to assess proliferation, 
the percentage of cells positive for this marker is displayed on the y-axis. Ki67 was expressed at all passage 
numbers and did not seem affected by treatment (light grey). Nestin and SOX2 graphs show the percentage 
positive cells (y-axis) for these stemness markers. Cells at all passage numbers retained their stemness as 
evidenced by largely unchanged SOX2 and nestin expression. Dark grey: media-only controls. Light grey: with 
1µM tBHP + 10µM HU. Two biological replicates, 3 technical replicates. Error bars display standard deviation. 
 




Figure 37 - Differentiation markers are expressed at different passage number. Differentiation assay results, 
HPC0A07/03A cells at different passage numbers were incubated in either media only conditions or with 1µM 
tert-Butyl hydroperoxide (tBHP) + 10µM hydroxyurea (HU) for 48 hours during the proliferation stage and for 
7 days during the differentiation stage. Passage numbers included 17 (p17) as a control and several higher 
passages ranging from passage 25 (p25) to passage 30 (p30). DAPI: DAPI was used to quantify the number of 
cells per field (y-axis); treatment (light grey) appeared to cause slight reductions in cell number at most 
passage numbers. Besides some fluctuations passage number did not seem to affect cell number. Ki67: Ki67 
was used to assess any remaining proliferation during the differentiation assay, the percentage of cells 
positive for this marker is displayed on the y-axis. Low levels of Ki67 was expressed at all passage numbers 
with a possible increase at higher passages. It did not seem affected by treatment (light grey). DCX and MAP2 
graphs show the percentage positive cells (y-axis) for the neuroblast maker (DCX) and immature neuron 
(MAP2). Cells retained their ability to differentiate towards a neuronal lineage at high passage numbers and 
did not appear affected by treatment (light grey). Two biological replicates (p27 and p30 only have 1 biological 
replicate), 3 technical replicates. Error bars display standard deviation. 
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 Validation of the ageing model 
4.3.2.1 Cellular readouts remain unaltered following ageing model 
The preliminary work described in section 4.3.1 highlighted tBHP concentration of 1µM and 
HU concentrations of 10µM and 50µM as possible treatment concentrations and passage 
26 as a practical passage number to use as part of the ageing model. 
 
To validate the ageing model, we investigated its effect on cellular readouts for NSC 
maintenance. Firstly, we focused on the effects of individual and combination treatments 
and assessed proliferation, differentiation, apoptosis, stemness, oxidative-stress response 
(NRF2) and DNA damage (H2AX) in proliferating and in differentiating cells.  Following the 
proliferation assay, one-way ANOVAs showed no significant variation between treatment 
groups for the percentage of CC3 positive cells (F(5,11) = 0.86 p = 0.53), SOX2 positive cells 
(F(5,11) = 1.17 p = 0.38), nestin positive cells (F(5,11) = 0.50 p = 0.77),  NRF2 positive cells 
(F(5,11) = 0.26 p = 0.92) or H2AX positive cells (F(5,11) = 0.88 p = 0.52). Significant variation 
between treatment groups however, was identified in the percentage of Ki67 positive cells 
(F(5,11) = 4.49 p = 0.02). Bonferroni post-hoc analysis revealed this was due to a decrease 
in the percentage of Ki67 positive cells in the 50µM HU treatment group relative to control 
(t(11)=3.43, p = 0.03). There was no difference in Ki67% in any other treatment groups 
including the combination treatment of 1µM tBHP + 50µM HU. See Figure 38 for graphs 
reporting the effect of treatments on cellular markers following the proliferation assay. 
 




Figure 38- Proliferation markers following individual or combination treatment of tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU).  Proliferation assay results; passage 17 HPC0A07/03A cells were seeded and 
after 24hrs incubated with either 1µM tBHP,  10µM HU, 50µM HU, 1µM tBHP + 10µM HU or 1µM tBHP + 
50µM HU for 48 hours. Cells were then fixed and stained for cellular markers. In each graph the percentage 
of positive cells for each marker is displayed on the y-axis. Ki67: Ki67 was used to assess proliferation. There 
was a significant reduction in Ki67% positive cells in the 50µM HU treatment group. CC3 Graph showing the 
percentage positive cells for CC3, an apoptosis marker, remained unchanged between treatment groups. 
SOX2 and nestin Graphs showing the percentage positive cells for SOX2 and nestin, stemness markers, 
remained unchanged between treatment groups. NRF2 Graph showing the percentage of cells positive for 
NRF2, an oxidative stress response marker, remained unchanged between treatment groups. H2AX Graph 
showing the percentage of cells positive for H2AX, a marker for DNA damage, remained unchanged between 
treatment groups. One-way ANOVAs followed by Bonferroni post-hoc. 3 biological replicates, 3 technical 
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 Following the differentiation assay, one-way ANOVAs showed no significant variation 
between treatment groups for the percentage of Ki67 positive cells (F(5,12) = 0.23 p = 0.94), 
 CC3 positive cells (F(5,12) = 1.98 p = 0.15), DCX positive cells (F(5,12) = 0.02 p = 0.99), MAP2 
positive cells (F(5,12) = 1.60 p = 0.23) or NRF2 positive cells (F(5,11) = 0.49 p = 0.78). 
Significant variation between treatment groups however, was found in the percentage of 
H2AX positive cells (F(5,11) = 3.49 p = 0.039). Bonferroni post-hoc analysis revealed this 
was due to an increase in the percentage of H2AX positive cells in the 50µM HU treatment 
group relative to control (t(11)=3.51, p = 0.03). There was no difference in H2AX% in any 
other treatment groups including the combination treatment of 1µM tBHP + 50µM HU. 
 
Importantly however, during both assays, the cell number was greatly affected by the 
higher concentration of HU (see section 4.3.1.1) explaining the large standard deviation in 
the cellular marker results for the treatment groups involving 50µM HU and suggesting the 
changes in Ki67 and H2AX may be artefacts. See Figure 39 for graphs reporting the effect 
of treatments on cellular markers following the differentiation assay. 
 




Figure 39 - Differentiation markers following individual or combination treatment of tert-Butyl 
hydroperoxide (tBHP) and hydroxyurea (HU).  Differentiation assay results; passage 17 HPC0A07/03A cells 
were incubated in either media only conditions or with either 1µM tert-Butyl hydroperoxide (tBHP), 10µM 
hydroxyurea (HU), 50µM HU, 1µM tBHP + 10µM HU or 1µM tBHP + 50µM HU during the proliferation stage 
and for 7 days during the differentiation stage. In each graph the percentage of positive cells for each marker 
is displayed on the y-axis. Ki67: Ki67 was used to assess proliferation. There was no significant change in the 
percentage of Ki67 positive cells between treatment groups. CC3 Graph showing the percentage positive cells 
for CC3, an apoptosis marker, remained unchanged between treatment groups. DCX Graph showing the 
percentage of cells positive for DCX, a neuroblast marker, remained unchanged between treatment groups. 
MAP2 Graph showing the percentage of cells positive for MAP2, a marker for immature neurons, remained 
unchanged between treatment groups. NRF2 Graph showing the percentage of cells positive for NRF2, an 
oxidative stress response marker, remained unchanged between treatment groups. H2AX Graph showing the 
percentage of cells positive for H2AX, a marker for DNA damage, throughout treatment groups. H2AX% 
positive cells remained largely unchanged besides a significant increase in the 50µM HU treatment group. 
One-way ANOVAs followed by Bonferroni post-hoc. 3 biological replicates, 3 technical replicates. Error bars 
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Next, we assessed the variation in these 6 cellular markers in treated and untreated 
passage 17 and passage 26 cells with the aim to validate the tri-modal in vitro model. For 
these experiments, the most promising treatment was selected, i.e.1µM tBHP + 10µM HU. 
The percentage of positive cells was assessed following both the proliferation and the 
differentiation assays. Following the proliferation assay, two-way ANOVAs revealed there 
was no significant variation between groups in any of the cellular markers. Effect of 
passage:  Ki67 F (1, 8) = 1.19  p=0.31, CC3 F (1, 8) = 1.30 p=0.29, SOX2 F (1, 8) = 0.89 p=0.37, 
nestin F (1, 8) = 0.06  p=0.81, NRF2 F (1, 8) = 3.28 p=0.11, H2AX  F (1, 8) = 0.010 p=0.92. 
Effect of treatment: Ki67 F (1, 8) = 0.02 p=0.90, CC3 F (1, 8) = 0.10 p=0.76, SOX2 F (1, 8) = 
0.02p=0.88, Nestin F (1, 8) = 0.36 p=0.56, NRF2 F (1, 8) = 0.19 p=0.68, H2AX F (1, 8) = 0.032 
p=0.86. Interaction: Ki67 F (1, 8) = 0.004 p=0.95, CC3 F (1, 8) = 0.70 p =0.43, SOX2 F (1, 8) = 
0.008 p=0.93, nestin F (1, 8) = 0.28 p =0.61, NRF2 F (1, 8) = 0.22 p =0.65, H2AX F (1, 8) = 
0.006 p=0.94. See Figure 40 for graphs reporting the effect of treatments and passage 
number on cellular markers following the proliferation assay. 




Figure 40 - Proliferation markers following increase passage and treatment.  Proliferation assay results; 
HPC0A07/03A cells were incubated in either media only conditions or with 1µM tBHP + 10µM HU during the 
proliferation assay. In each graph, the percentage of positive cells for each marker is displayed on the y-axis. 
Ki67: Ki67 was used to assess proliferation. There was no significant change in the percentage of Ki67 positive 
cells between experimental conditions. CC3 Graph showing the percentage positive cells for CC3, an 
apoptosis marker, remained unchanged between experimental conditions. DCX Graph showing the 
percentage of cells positive for DCX, a neuroblast marker, remained unchanged between experimental 
conditions. MAP2 Graph showing the percentage of cells positive for MAP2, a marker for immature neurons, 
remained unchanged between experimental conditions. NRF2 Graph showing the percentage of cells positive 
for NRF2, an oxidative stress response marker, remained unchanged between experimental conditions. H2AX 
Graph showing the percentage of cells positive for H2AX, a marker for DNA damage, between experimental 
conditions. H2AX% positive cells remained unchanged. One-way ANOVAs followed by Bonferroni post-hoc. 3 
biological replicates, 3 technical replicates. Error bars display standard deviation.  
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Similarly, following the differentiation assay, two-way ANOVAs revealed there was no 
significant variation between groups in any of the markers. Effect of passage:  Ki67 F (1, 8) 
= 0.09 p=0.77, CC3 F (1, 8) = 0.02 p=0.89, DCX F (1, 8) = 0.95 p=0.36, MAP2 F (1, 8) = 0.18 
p=0.68, NRF2 F (1, 8) = 0.36 p=0.57, H2AX F (1, 8) = 0.11 p=0.75 Effect of treatment: Ki67 F 
(1, 8) = 0.87 p=0.38, CC3 F (1, 8) = 1.16p=0.31, DCX F (1, 8) = 0.67 p=0.44, MAP2 F (1, 8) = 
0.002 p=0.96, NRF2 F (1, 8) = 0.11p=0.74, H2AX F (1, 8) = 0.05 p=0.83 Interaction: Ki67 F (1, 
8) = 0.30p=0.60, CC3 F (1, 8) = 0.78p=0.40, DCX F (1, 8) = 0.07 p=0.80, MAP2 F (1, 8) = 0.08 
p=0.78, NRF2 F (1, 8) = 0.29 p=0.60, H2AX F (1, 8) = 0.03 p=0.87. See Figure 41 for graphs 
reporting the effect of treatments and passage number on cellular markers following the 
differentiation assay. 
 




Figure 41 - Differentiation markers following increase passage and treatment.  Differentiation assay results; 
HPC0A07/03A cells were incubated in either media only conditions or with, 1µM tBHP + 10µM HU during the 
proliferation stage and for 7 days during the differentiation stage. In each graph, the percentage of positive 
cells for each marker is displayed on the y-axis. Ki67: Ki67 was used to assess proliferation. There was no 
significant change in the percentage of Ki67 positive cells between experimental conditions. CC3 Graph 
showing the percentage positive cells for CC3, an apoptosis marker, remained unchanged between 
experimental conditions. DCX Graph showing the percentage of cells positive for DCX, a neuroblast marker, 
remained unchanged between experimental conditions. MAP2 Graph showing the percentage of cells 
positive for MAP2, a marker for immature neurons, remained unchanged between experimental conditions. 
NRF2 Graph showing the percentage of cells positive for NRF2, an oxidative stress response marker, remained 
unchanged between experimental conditions. H2AX Graph showing the percentage of cells positive for H2AX, 
a marker for DNA damage, between experimental conditions. H2AX% positive cells remained unchanged. 
One-way ANOVAs followed by Bonferroni post-hoc. 3 biological replicates, 3 technical replicates. Error bars 
display standard deviation. 
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4.3.2.2 Morphological alterations as a result of passaging 
Despite there being no change in the number of neuroblasts or immature neurons, there 
were noticeable morphological differences in these cell types with passage number. In 
cultures with higher passage numbers, both DCX and MAP stained cells appeared more 
round in than in their lower passage counter parts. To investigate this phenotype, machine 
learning was carried out to quantify the proportion of cells with this stunted morphology 
as compared to those with the usual more elongated morphology typically seen in lower 
passage numbers. Two-way ANOVAs on the results of machine learning carried out on 
MAP2 stains, showed there was significant variation in between groups and that 83% of 
the variation was due to passage number (F (1, 8) = 41.39 p=0.0002).  There was no effect 
of treatment (F (1, 8) = 3e-007 p=0.99) or interaction effect (F (1, 8) = 0.60 p=0.46). Fisher’s 
LSD post-hoc analysis revealed this variation was due to an increase in the proportion of 
MAP2 positive cells with stunted morphology in the untreated passage 26 group when 
compared to their proportion in the untreated passage 17 group (t (8) = 5.096 p=0.0009). 
Similarly, treated passage 26 cells showed a significantly different proportion of stunted 
MAP2 positive cells when compared to treated passage 17 cells (t (8) = 4.55p=0.004).  
 
Bonferroni correction was applied manually, and the significance threshold was set to 
0.017 to correct for 3 multiple comparisons. Similarly, two-way ANOVAs on the machine 
learning results carried out on DCX stains, showed there was significant variation in 
between groups and that 81% of the variation was due to passage number (F (1, 8) = 35.28 
p=0.0003).  There was no effect of treatment (F (1, 8) = 0.3273 p=0.5830) or interaction 
effect F (1, 8) = 0.1832 p=0.6799). Fisher’s LSD post-hoc analysis revealed this variation was 
due to an increase in the proportion of DCX positive cells with stunted morphology in the 
untreated passage 26 group when compared to their proportion in the untreated passage 
17 group (t (8) = 4.503 p=0.002). Similarly, treated passage 26 cells showed a significantly 
different proportion of stunted DCX positive cells when compared to treated passage 17 
cells (t (8) = 3.90 p=0.005). Bonferroni correction was applied manually, and the significance 
threshold was set to 0.017 to correct for 3 multiple comparisons (passage 17 control vs 
passage 26 control, passage 17 control vs passage 17 control and passage 26 treated vs 
passage 26 treated). 




Furthermore, machine learning results showed that similar factors were used to determine 
whether each cell belonged to the stunted or the elongated morphology subgroup for both 
MAP2 and DCX positive cells. For MAP2 positive cells, cytoplasm width to length ratio, 
cytoplasm width, nucleus area and nucleus roundness were used, and all were higher in 
stunted cells compared to elongated ones. Similarly, for DCX positive cells, cytoplasm width 
to length ratio, cytoplasm roundness, nucleus area and nucleus roundness were used to 
determine the subgroup each cell belonged to (see annex section 8.3.2.3). See Figure 42 
for graphical representations of the morphological change in DCX and MAP2 positive cells 
and for representative images of this change.




Figure 42 - Map2 and DCX positive cell morphology following increased passage number and treatment.  Differentiation assay results; passage 17 (p17) and passage 26 
(p26) HPC0A07/03A cells were incubated in either media only conditions (control) or with 1µM tert-Butyl hydroperoxide (tBHP) + 10µM hydroxyurea (HU) (treated) during 
the proliferation stage and again for 7 days during the differentiation stage. Machine learning was used to quantify the proportion of rounded (stunted morphology) and the 
proportion of elongated cells in MAP2 positive cells (A) and DCX positive cells (B). According to results from both markers, there was a significantly higher proportion of cells 
with stunted morphology in p26 cells compared to p17 cells in both treated and untreated groups.  (C) and (D) show representative images of MAP2 and DCX positive 
untreated cells at passage 17 and at passage 26. Cells with typical elongated or stunted morphology are indicated by white arrows and reported at a higher magnification on 
the right with the pertinent label. Two-way ANOVAs. 3 biological replicates, 3 technical replicates. Error bars display standard deviation. Manual Bonferroni correction set 
the significance threshold to p < 0.017 therefore * symbolises p value <0.0017, ** p < 0.003.
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Importantly, this morphological change was also reflected in the preliminary data looking 
at passage number 25-30 (see appendix 8.3.2.2) suggesting this phenotype may become 
increasingly apparent as passage number increases. Furthermore, as suggested by the 
combination-treatment data shown above, treatment had no effect on morphology (see 
Figure 43). One-way ANOVAs showed this was the case for all combinations tested as well 
as for individual treatments in both DCX positive cells (F (5, 12) = 0.33 p=0.88) and MAP2 
positive cells (F (5, 11) = 0.33 p=0.89). 
 
Figure 43 - Map2 and DCX positive cell morphology following treatment. Differentiation assay results; 
HPC0A07/03A cells were incubated in either media only conditions (control) or with either 1µM tert-Butyl 
hydroperoxide (tBHP), 10µM hydroxyurea (HU), 50µM HU, 1µM tBHP + 10µM HU or 1µM tBHP + 50µM HU 
during the proliferation stage and for 7 days during the differentiation stage. Machine learning was used to 
quantify the proportion of rounded (stunted morphology) and the proportion of elongated cells in MAP2 
positive cells (left) and DCX positive cells (right). According to results from both markers, there was no 
significant variation across groups. One-way ANOVAs. 3 biological replicates, 3 technical replicates. Error bars 
display standard deviation.  
 
 Ageing model alters expression of genes of interest 
After assessing interesting morphological alterations in higher passages which were 
presumably related to ageing phenotypes, we aimed to evaluate whether treatment and 
passage number affected the expression levels of the 9 candidate genes highlighted in the 
previous chapter. Therefore, we quantified expression of FOXO3A, SIRT1, IGF2R, ABTB1, 
NAMPT, PTEN, UCP2, GRB10 and mTOR in passage 17 and passage 26 cells in treated and 
untreated conditions via qPCR. mRNA levels were assessed after both the proliferation and 
the differentiation assays. 
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Firstly, the candidate genes’ expression levels were compared between control, tBHP only, 
HU only and combination treatment (tBHP + HU). The previously selected concentrations 
of 1M tBHP and 10M HU were used in this experiment.  One-way ANOVAs showed there 
was no variation between the 4 treatment groups for any of the genes that were tested.  
See Figure 44 for the graphs relating to the proliferation assay and Figure 45 for the graphs 
relating to the differentiation assay.  Proliferation assay results: FOXO3A F (3, 8) =0.81, 
p=0.52, SIRT1 F (3, 8) = 0.61 p=0.62, IGF2R F (3, 8) = 1.42 p=0.31, ABTB1 F (3, 8) = 1.61 
p=0.26, NAMPT F (3, 8) = 0.13 p=0.94, PTEN F (3, 8) = 0.23 p=0.87, UCP2 F (3, 8) = 0.24 
p=0.87, GRB10 F (3, 8) = 0.07 p=0.97, mTOR F (3, 8) = 0.14 p=0.93. Differentiation assay 
results: FOXO3A F (3, 8) = 0.03 p=0.99, SIRT1 F (3, 8) = 0.21 p=0.89, IGF2R F (3, 8) = 0.81 
p=0.52, ABTB1 F (3, 8) = 0.68 p=0.59, NAMPT F (3, 8) = 0.17 p=0.91, PTEN F (3, 8) = 0.04 
p=0.99, UCP2 F (3, 8) = 0.08 p=0.97, GRB10 F (3, 8) = 0.04 p=0.99, mTOR F (3, 8) = 0.17 
p=0.92.  




Figure 44 - Candidate gene expression levels following individual and combination treatment: Proliferation 
assay.  HPC0A07/03A cells were incubated in either media only conditions (control) or with 1µM tert-Butyl 
hydroperoxide (tBHP), 10µM hydroxyurea (HU) or 1µM tBHP + 10µM HU (Combination) during the 
proliferation assay. Quantitative polymerase chain reaction (qPCR) was used to measure gene expression. Y-
axis show the expression of each gene relative to control as calculated by the Pfaffl method. FOXO3A, SIRT1, 
IGF2R, ABTB1, NAMPT, PTEN, UCP2, GRB10 and mTOR expression were not found to be altered following 
treatment. One-way ANOVAs 3 biological replicates, 3 technical replicates. Error bars represent standard 













































































































































































































































































































































































Figure 45 - Candidate gene expression levels following individual and combination treatment: 
Differentiation assay.  HPC0A07/03A cells were incubated in either media only conditions (control) or with 
1µM tert-Butyl hydroperoxide (tBHP), 10µM hydroxyurea (HU) or 1µM tBHP + 10µM HU (Combination) during 
the proliferation stage and for 7 days during the differentiation stage. Quantitative polymerase chain reaction 
(qPCR) was used to measure gene expression. Y-axis show the expression of each gene relative to control as 
calculated by the Pfaffl method. FOXO3A, SIRT1, IGF2R, ABTB1, NAMPT, PTEN, UCP2, GRB10 and mTOR 
expression were not found to be altered following treatment. One-way ANOVAs 3 biological replicates, 3 
technical replicates. Error bars represent standard deviation. Y-axis is a log scale. 
 
Next, the effect of passage number on expression levels was investigated as well as the 
effect of combining treatment and passage number. For this, we compared treated and 
untreated passage 17 cells, untreated passage 17 cells and untreated passage 26 cells and 
treated passage 17 and treated passage 26 cells. Graphs for these experiments are 
reported in Figure 46. Following the proliferation assay, two-way ANOVAs highlighted 
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FOXO3A analysis showed 70% of the variation was due to passage number (F (1, 8) = 20.15 
p=0.002) whilst there was no effect of treatment (F (1, 8) = 0.45 p=0.52) or interaction (F 
(1, 8) = 0.006 p=0.94). Accordingly, Fisher’s LSD post-hoc analysis revealed FOXO3A 
messenger RNA (mRNA) levels in the passage 17 untreated and passage 26 untreated 
groups was significantly different (t(8) 3.23 p= 0.012) as well as the difference in expression 
between passage 17 treated and passage 26 treated subgroups (t(8)= 3.12 p= 0.014). These 
results show that in both treated and untreated cells, higher passage number causes 
decreased FOXO3A expression.  
 
NAMPT mRNA levels showed 82% of the variation between groups was due to passage (F 
(1, 8) = 120.2 p<0.0001), 6% treatment (F (1, 8) = 8.73 p=0.018) and 7% due to interaction 
effects (F (1, 8) = 10.1 p=0.013). Post-hoc analysis showed untreated passage 17 and 
passage 26 were significantly different (t(8) 5.50 p= 0.0006) as well as treated passage 17 
and passage 26 cells (t(8) 9.998 p= <0.0001) and treated and untreated passage 26 cells 
(t(8) 4.34 p=0.0025). These results show that passage number alone causes increased 
NAMPT levels in culture and that there is a summative effect of passage number and 
treatment but that treatment alone is not able to elicit expression changes. 
 
GRB10 also showed 85% of variation was due to passage (F (1, 8) = 63.25 p<0.0001).  
number following the proliferation assay. Treatment (F (1, 8) = 1.80 p=0.22) and interaction 
between treatment and passage number had no effect (F (1, 8) = 0.99 p=0.35). Post-hoc 
analysis showed untreated passage 17 and untreated passage 26 cells displayed 
significantly different expression levels of GRB10 (t(8) 6.33 p= 0.0002) as did treated 
passage 17 and passage 26 cells t(8)= 4.92 p= 0.0012.  
 
All other genes showed no mRNA level changes between groups following the proliferation 
assay. Passage number effect: SIRT1 F (1, 8) = 4.13 p=0.08, IGF2R F (1, 8) = 0.07 p=0.80, 
ABTB1 F (1, 8) = 2.87 p=0.13, PTEN F (1, 8) = 0.50 p=0.50, UCP2 F (1, 8) = 2.63 p=0.14, mTOR 
F (1, 8) = 1.06 p=0.33. Treatment effect: SIRT1 F (1, 8) = 1.14 p=0.32, IGF2R F (1, 8) = 1.2 
p=0.30, ABTB1 F (1, 8) = 1.00 p=0.35, PTEN F (1, 8) = 0.27 p=0.62, UCP2 F (1, 8) = 0.10 
p=0.76, mTOR F (1, 8) = 0.23 p=0.65. Interaction effect: SIRT1 F (1, 8) = 0.24 p=0.64, IGF2R 
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F (1, 8) = 0.96 p=0.36, ABTB1 F (1, 8) = 0.02 p=0.89, PTEN F (1, 8) = 0.03 p=0.87, UCP2 F (1, 
8) = 0.01 p=0.92, mTOR F (1, 8) = 0.31 p=0.59. 
 
 
Figure 46 - Candidate gene expression levels in passage 17 (p17) and passage 26 (p26) cells following 
combination treatment: Proliferation assay. HPC0A07/03A cells were incubated in either media only 
conditions (control) or with 1µM tBHP + 10µM HU (Treated) during the proliferation assay. Quantitative 
polymerase chain reaction (qPCR) was used to measure gene expression. Y-axis show the expression of each 
gene relative to control as calculated by the Pfaffl method. FOXO3A expression levels decreased as a result 
of passage number. While NAMPT expression levels showed an increase due to passage number and a 
significant interaction between passage number and treatment caused a further increase in NAMPT 
expression as a result of treatment on higher passage cells. GRB10 expression levels also decreased as a result 
of passage number both in control and treated conditions. Significant results highlighted by green squares, 
all other genes (SIRT1, IGF2R, ABTB1, PTEN, UCP2 and mTOR ) showed no significant alterations in gene 
expression following treatment or passage number increase. Two-way ANOVAs, 3 biological replicates, 3 
technical replicates. Error bars represent standard deviation. Y-axis is a log scale. Bonferroni correction to 
control for 3 multiple comparisons set significance threshold to p<0.017. Therefore, * symbolises p<0.017 
and ** symbolises p<0.003. 
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mRNA levels of the 9 candidate genes were also assessed following the differentiation 
assay (see Figure 47). Two-way ANOVAs showed significant variation across groups in the 
gene expression of FOXO3A, PTEN, GRB10 and mTOR. The source of variation for FOXO3A 
was due to passage number 75% (F (1, 8) = 26.3 p=0.0009). Treatment (F (1, 8) = 0.59 
p=0.46) and interaction (F (1, 8) = 0.10 p=0.75) showed no significant effects. Fisher’s LSD 
post-hoc analysis revealed untreated passage 17 and passage 26 groups displayed 
significant variation (t (8) = 3.35 p= 0.0095) as did treated passage 17 and passage 26 groups 
(t (8) = 3.84 p= 0.005). As for proliferation, increased passage number appeared to cause a 
decrease in FOXO3A expression. 
 
Similarly, PTEN mRNA levels showed 50% of the variation due to passage number (F (1, 8) 
= 11.37 p=0.0098) while treatment (F (1, 8) = 1.11 p=0.32) and interaction (F (1, 8) = 2.12 
p=0.18) showed no effect on variance. Fisher’s LSD showed treated passage 17 and passage 
26 displayed significantly different PTEN levels (t (8) = 3.415 p= 0.0092). This was not the 
case for untreated cells which showed no difference in PTEN expression at passage 17 
compared to passage 26 (t(8)=1.354 p=0.21). These results suggest that treatment of higher 
passage number cells, but not of cells with lower passage numbers, causes a decrease in 
PTEN levels. 
 
GRB10 analysis showed 84% of the variance between groups was caused by passage 
number (F (1, 8) = 47.84 p=0.0001). Again, treatment (F (1, 8) = 0.009 p=0.93) and 
interaction (F (1, 8) = 0.14 p=0.72) showed no significant effects. Unlike for PTEN, GRB10 
expression was significantly different between both untreated passage 17 and passage 26 
cells (t (8) = 4.63 p=0.0017) and between treated passage 17 and passage 26 cells (t (8) = 
5.152 p= 0.0009). These results are similar to those of the proliferation assay suggesting 
GRB10 levels are consistently lowered during both proliferation and differentiation as a 
result of increased passage numbers. 
 
Finally, analysis of mTOR levels following the differentiation assay showed significant 
variation between groups with 48% of the total variation attributable to passage number 
(F (1, 8) = 8.30 p=0.02) and no significant effect on variation of treatment (F (1, 8) = 0.77 
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p=0.40) and interaction effects (F (1, 8) = 0.50 p=0.50). Similarly to PTEN, there was 
significant variance in mTOR expression levels between treated passage 17 and passage 26 
cells (t (8) = 2.54 p= 0.035) but not between untreated passage 17 and passage 26 cells (t 
(8) = 1.539 p= 0.16). This suggests mTOR levels are lowered in cells with higher passage 
numbers. 
 
All other genes showed no significant variance between groups following the 
differentiation assay. Passage number effect: SIRT1 F (1, 8) = 2.35 p=0.16, IGF2R F (1, 8) = 
0.32 p=0.59, ABTB1 F (1, 8) = 0.98 p=0.35, NAMPT F (1, 8) = 0.14 p=0.71, UCP2 F (1, 8) = 
0.72 p=0.42. Treatment effect: SIRT1 F (1, 8) = 0.27 p=0.62, IGF2R F (1, 8) = 0.31 p=0.59, 
ABTB1 F (1, 8) = 0.49 p=0.50, NAMPT F (1, 8) = 0.08 p=0.78, UCP2 F (1, 8) = 0.04 p=0.84. 
Interaction effect: SIRT1 F (1, 8) = 0.08 p=0.79, IGF2R F (1, 8) = 0.0006 p=0.98, ABTB1 F (1, 
8) = 0.03 p=0.88, NAMPT F (1, 8) = 0.77 p=0.40, UCP2 F (1, 8) = 0.02 p=0.89 
 
For all analyses involving two-way ANOVAs comparing passage number and treatment 
effects, manual Bonferroni correction was applied to account for 3 comparisons. The 
significance threshold was therefore set to 0.017. All results reported as significant, except 
the difference in mTOR mRNA levels between treated passage 17 and passage 26 cells, 
survived this threshold. 




Figure 47 - Candidate gene expression levels in passage 17 (p17) and passage 26 (p26) cells following 
combination treatment: Differentiation assay. HPC0A07/03A  cells were incubated in either media only 
conditions (control) or with 1µM tBHP + 10µM HU (Treated) during the proliferation stage and for 7 days 
during the differentiation stage. Quantitative polymerase chain reaction (qPCR) was used to measure gene 
expression. Y-axis show the expression of each gene relative to control as calculated by the Pfaffl method. 
FOXO3A expression levels decreased as a result of passage number irrespective of treatment. PTEN 
expression levels showed decrease due to passage number only in treated cells. While GRB10 expression 
levels decreased as a result of passage number both in control and treated conditions. mTOR showed 
significant variance as a result of passage number likely due to a decrease in expression levels in treated p26 
when compared to treated p17 (p= 0.035) this variance however did not satisfy the significance threshold of 
0.017. Significant results highlighted by green squares, all other genes (SIRT1, IGF2R, ABTB1, NAMPT and 
UCP2) showed no significant alterations in gene expression following treatment or passage number increase. 
Two-way ANOVAs, 3 biological replicates, 3 technical replicates. Error bars represent standard deviation. Y-
axis is a log scale. Bonferroni correction to control for 3 multiple comparisons set significance threshold to 
p<0.017. Therefore, * symbolises p<0.017 and ** symbolises p<0.003. 
 
Following the results above suggesting alterations in age-related nutrient sensing pathways 
due to passage number and treatment, mRNA levels of the known senescence markers 
NRF2 and p16 were tested by qPCR. Two-way ANOVAs revealed no significant changes in 
NRF2 expression following the proliferation or differentiation assay. NRF2 mRNA levels 
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following proliferation assay; Passage effect: F (1, 8) = 0.02 p=0.90, Treatment effect: F (1, 
8) = 0.31 p=0.60, Interaction effect: F (1, 8) = 5e-005 p=0.99. NRF2 mRNA levels following 
differentiation assay: Passage effect: F (1, 8) = 0.31 p=0.59, Treatment effect: F (1, 8) = 0.59 
p=0.46, Interaction effect: F (1, 8) = 0.070 p=080. 
 
Similarly, p16 mRNA levels following both assays showed no significant alterations. p16 
mRNA levels following the proliferation assay: Passage effect: F (1, 8) = 0.94 p=0.36, 
Treatment effect: F (1, 8) = 4.93 p=0.057. Interaction effect: F (1, 8) = 0.22 p=0.65. 
Importantly however, the effect of treatment on p16 mRNA levels only marginally escaped 
significance. The two-way ANOVA results suggest it may indeed be responsible for 35% of 
the variance. Investigative post-hoc analysis was carried out which showed the 
comparisons of groups testing the effect of treatment, (i.e. comparing treated and 
untreated p17 cells (t (8) = 1.24 p= 0.25) and comparing treated and untreated p26 cells (t 
(8) = 1.90 p= 0.09)) also escaped significance. p16 mRNA levels following the differentiation 
however showed no variance between groups: Passage effect: F (1, 8) = 0.01 p=0.92, 
Treatment effect: F (1, 8) = 0.11 p=0.75, Interaction effect: F (1, 8) = 0.57 p=0.47. 
See Figure 48 for graphs showing the relative expression levels of NRF2 and p16 following 
the proliferation and the differentiation assays. 




Figure 48 - Expression levels of senescence markers following proliferation and differentiation assays. 
HPC0A07/03A cells were incubated in either media only conditions (control) or with 1µM tBHP + 10µM HU 
(Treated) during the proliferation stage and for 7 days during the differentiation stage. Cells that provided 
the proliferation assay results (left column) only underwent the proliferation stage whilst cells that provided 
the differentiation assay results (right column) underwent both the proliferation and the differentiation 
stages. Quantitative polymerase chain reaction (qPCR) was used to measure gene expression. Y-axis show the 
expression of each gene relative to control as calculated by the Pfaffl method. NRF2 and p16 did not show 
significant gene expression alterations due to passage number or treatment. Two-way ANOVAs, 3 biological 
replicates, 3 technical replicates. Error bars represent standard deviation. Y-axis is a log scale. 
  




In this chapter, we assessed a novel multimodal ageing model of human NSC by identifying 
viable passage numbers and non-toxic concentrations of tBHP and HU. We also showed 
that while there were no alterations in the number of cells expressing each cellular marker, 
there were distinct morphological changes as a consequence of increased passage number. 
Finally, we showed that increased passage number and treatment induced gene-expression 
alterations of key molecules within the mTOR, IIS and sirtuin sensing pathways  
 Ageing model: chronic stressors on older cells 
To establish the ageing model, appropriate components had to be selected. We aimed to 
model the OS, DNA damage and replicative senescence that usually accompany NSC ageing; 
we therefore selected treatment with tBHP, treatment with HU and increased passaging 
respectively. 
 
Though H2O2 is more physiologically relevant, tBHP was chosen to induce OS due to its 
higher stability. H2O2 in fact, was shown to be unstable and affected by several factors such 
as the presence of solids, pH and temperature changes. In particular, the susceptibility to 
temperature increase causing a temperature-dependent decrease in concentration made 
H2O2 particularly unsuitable for culturing given the high temperatures needed to culture 
the cell line (Yazici and Deveci, 2010). tBHP instead, only begins undergoing thermolysis at 
69.5°C, a temperature which is outside of the range used in cell culture (Liu et al., 2012). 
tBHP is a membrane permeable oxidant that has been previously used in in vitro models 
and shown to generate oxidative damage. It can be easily metabolised and, like  H2O2, it 
causes ROS generation, lipid peroxidation, ATP synthesis impairments and DNA damage 
(Chen and Chen, 2011). Cells of diverse origins have been treated for varying treatment-
periods at numerous peroxide concentration ranging from nanomolar to millimolar. This is 
not surprising as the effects of OS are dependent on cell type, experimental conditions and 
peroxide type (Bae et al., 2010; Harvey et al., 2012; Saffari and Sadrzadeh, 2004; Sée and 
Loeffler, 2001; Sun et al., 2010). In this chapter, we tested concentrations of 1µM, 10 µM 
and 100 µM and, to mimic chronic rather than acute OS, we opted for treatment duration 
similar to that used in the previous chapters of 48 hours during proliferation and 7 days 
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during differentiation. To our knowledge, such an extended treatment duration has not 
been tested on NSCs.  We report tBHP to have considerable effects on cell number at higher 
concentrations but to only cause a modest decrease at the lowest concentration tested; 
1µM was therefore selected for inducing OS in our model. 
 
To induce DNA damage, another key feature of ageing NSCs, HU was used. This anti-
neoplastic drug has been used by several groups to model ageing in vitro. By repressing 
ribonucleotide reductase, HU causes the accumulation of double stand breaks in both 
mitochondrial and nuclear DNA leading to cellular and mitochondrial stress and 
dysfunction (Dong et al., 2014). As for tBHP, several concentrations were tested to assess 
the most suitable one for the HPC model. Unlike tBHP however, varying treatment 
durations were also assessed, this was done both to replicate previous studies and to assess 
whether the anti-proliferative characteristics of HU meant longer treatments were not 
sustainable. So far, two other groups have used HU to model ageing in NSCs, both tested 
incubations of 1 to 16 hours and concentrations of 0.5µM, 8 µM, 20µM. Dong and 
colleagues report a small decrease in neurospheres as a consequence of 12-hour treatment 
with 8 µM HU while Daniele and colleagues report a decrease in cell number following 16-
hour treatment with 20µM HU. Though our study was initially designed based on these 
studies, we report no change in cell number during short incubations (3 or 8 hours) at 
matching concentrations and a considerable reduction in cell number following longer 
incubations even at much lower concentrations. As Dong and Daniele do not report the 
effects of cell number following 3 or 8-hour incubation time and do not test longer 
incubations, it is difficult to compare the toxicity across assays (Daniele et al., 2016; Dong 
et al., 2014). Interestingly, experiments on foreskin fibroblasts showed only a mild effect of 
prolonged treatment with 100µM HU on cell number relative to controls, suggesting 
different cell types may be less susceptible to HU than NSCs (Yeo et al., 2000).  Given our 
preliminary data showing similar variation in cellular markers irrespective of treatment 
duration, the lower doses but longer treatment periods were selected for both the 
proliferation and the differentiation assay to model the sub-toxic but chronic state of stress 
of aged cells in vivo in the absence of excessive cell loss. Though it is possible that higher 
concentrations may have induced more robust results, extensive cell loss, such as that seen 
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in response to the higher treatment concentrations, would not be representative of the in 
vivo ageing phenotype. Indeed,  though there are reports of neuronal loss in ageing, this 
appears to be only minimal in non-pathological circumstances (de Magalhães and Passos, 
2018; Dong et al., 2014; Price et al., 2001; Raz and Rodrigue, 2006).  
 
The last component of the ageing model was replicative senescence, we modelled this in 
vitro by using cells with higher passage numbers. Though the HPCs used throughout this 
thesis are immortalised and are usually considered to be able to replicate indefinitely, they, 
like many other cell lines, show slight alterations with increased passage such as a slower 
duplication rate. Several groups have shown differences in morphology, development, 
gene expression and survival between high and low passage cell in a variety of cell lines 
(Briske-Anderson et al., 1997; Chang-Liu and Woloschak, 1997; Chen et al., 2015; Yu et al., 
1997). In this chapter, we utilized this characteristic hypothesising that higher passage 
numbers would more closely resemble aged cells found in vivo. Therefore, we tested the 
survival, proliferative and differentiative abilities of passage 25 to passage 30 to assess 
whether higher passages could be used in future experiments. We show no obvious 
changes in cell number across passages and that cells at all passages expressed stemness 
and proliferation markers during the proliferation assay and markers for differentiation and 
reduced proliferation during the differentiation assay. As for OS, what is considered a high 
or low passage number varies considerably between cell lines as do its effects. For the cell 
line used here, experiments are usually carried out on cells at passage 16-20 (Anacker et 
al., 2013; Maruszak et al., 2014; Murphy et al., 2018). The pilot work outlined in section 
4.3.1.2 suggested higher passage cells are proliferating and differentiating as expected and 
that there may be differences across passages in the number immature neurons. Passage 
26 was selected as the passage number to be used as part of the ageing model as it showed 
similar properties in terms of proliferative and differentiative abilities to other higher 
passages but was faster to produce in terms of methodology.  
 
 4. An Alternative Multimodal Model to Induce Neural Stem Cell Ageing 
157 
 
 Cellular consequences of the ageing model 
After selecting viable treatment concentrations and durations, we assessed cellular 
readouts following each treatment, both individually and in combination, on ‘young’ 
passage 17 cells. The treatments discussed above, were combined to model several aspects 
of ageing and thereby replicate a more representative ageing environment. Surprisingly, 
we saw no effect on any of the cellular markers for proliferation, differentiation, apoptosis, 
DNA damage or oxidative response following individual or combination treatment except 
for treatment with 50µM HU only. 50µM HU in fact, caused a significant reduction in 
proliferation during the proliferation assay and an increase in DNA damage following the 
differentiation assay. These results are similar to those from Dong and Daniele showing HU 
dose-dependent increases in DNA damage as evidenced by increases in H2AX 
phosphorylation (Daniele et al., 2016; Dong et al., 2014). Our results however, differ from 
those of the two studies above in cell type and in HU treatment duration and concentration. 
In addition, we report this increase was accompanied by such strong toxicity and variability 
in cellular response, as evidenced by the large error bars, that further experiments would 
be necessary to assess whether these changes were simply driven by the resulting decline 
in cell density. Indeed, cells in culture are known to be strongly affected by cell density (Kim 
et al., 2017; Wilson et al., 2015). Besides the technical aspects, these results could also 
indicate hippocampal progenitor cells are less susceptible to these stressors. As reviewed 
by Wang and colleagues, different neuron cell types are affected by stress and damage in 
different ways. In particular, even within specific regions such as the hippocampus, each 
subfield experiences different susceptibilities. For example, dentate gyrus neurons were 
shown to be less susceptible to OS than CA1 neurons. These findings support the possibility 
that the cell type used here is more resistant than those used previously (Lee et al., 2015; 
Wang and Michaelis, 2010).  
 
Given the toxicity of higher concentrations however, the lack of DNA damage seen in the 
treatment conditions involving HU remains unexpected. Suggesting that either HU 
concentrations that are higher than 10µM but lower than 50µM are necessary for a robust 
but sub-lethal effect or that H2AX quantification ought to be improved. Some groups in 
fact, quantify H2AX positive foci rather than H2AX positive cells, it may therefore be 
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interesting, to repeat these experiments with higher resolution microscopy to assess if 
different methodology yields different results (Kuo and Yang, 2008). 
 
Similarly, quantification of cellular markers following combination treatment and higher 
passage number showed no change across experimental conditions. Interestingly, for some 
markers, higher passage numbers appeared to lead to increased variability in cellular 
markers. An explanation for this phenotype may be that increased passage causes a 
heterogeneous population of both damaged and healthy cells and that the proportion of 
each varies across biological replicates leading to the increased variability seen in the 
immunocytochemistry results. It is important to note the very high number of cells 
expressing nuclear NRF2 seen across all conditions, usually averaging around 90% of the 
total cell count. In unstressed conditions, NRF2 is typically anchored to the cytoplasm. Upon 
OS, NRF2 travels to the nucleus where it forms heterodimers with other transcription 
factors and initiates transcription of genes that code for proteins with cytoprotective 
effects (Bakunina et al., 2015). Therefore, this data suggests that though there is no change 
in NRF2 levels between conditions, all conditions show a high oxidative response. Thus, 
merely counting the number of cells positive for NRF2 may not be sufficient and instead, 
assessing the overall expression of NRF2 may be necessary. qPCR analysis of NRF2 mRNA 
levels however, showed no change across conditions suggesting the levels of NRF do indeed 
remain unchanged across treatment and passage number. To confirm this finding, it might 
be interesting to assess NRF2 translocation by cellular fractionation combined with western 
blots to determine whether there is indeed an increase in nuclear translocation in the 
stressed conditions. Currently, these results suggest that the lack of differences may 
instead be due to a ceiling effect in oxidative response; there is no visible difference 
between treatments because all groups are already undergoing the highest level of 
oxidative response. This hypothesis is in line with experts in the field of OS suggesting that 
cell culture imposes a constant state of OS on cells that is often ignored in studies (Halliwell, 
2003; Wright and Shay, 2002). OS in culture is heavily dependent on cell type, isolation and 
culturing techniques but is likely due to an imbalance between ROS and anti-oxidant 
responses. Briefly, in comparison to in vivo, cultured cells tend to be exposed to higher 
levels of oxygen which promotes ROS generation. In addition, cell culture media is 
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frequently deficient in adequate levels of antioxidants and the presence of free metal ions 
can act as a pro-oxidant. Though this is not the case for every cell culture model, these 
aspects can all contribute to unusually high levels of OS in control conditions which may 
mask any further onset of OS (Halliwell, 2003). Future studies should therefore consider 
and minimise the impact of these aspects when assessing OS in culture. 
 
Despite the lack of differences in the percentage positive cells for each marker, we report 
interesting alterations in neuronal morphology. Cells stained for MAP2 and DCX show a 
more rounded morphology with increasing passage number. This was present both in pilot 
work assessing the differentiation potential of cell from passage 25 to passage 30 as well 
as in finalised experiments validating the ageing model. This phenotype was driven by cell 
passage but appeared unaffected by treatment; both individual treatments and 
combination treatments on passage 17 cells in fact, showed no effect.  These findings are 
in line with those by Knoth who reported dendritic alterations both when comparing DCX 
staining in young or aged mice and when comparing DCX staining on human post-mortem 
hippocampal tissue of individuals from 1 day to 100 years of age. The authors suggest DCX 
positive cells with no dendrites, which are more common in aged human and murine 
tissues, are cells in a more undifferentiated state (Knoth et al., 2010). Interestingly, our 
results show this phenotype was present both in DCX and MAP2 positive cells. As MAP2 
expression occurs slightly later in the neuronal differentiation timeline, this data suggests 
that, if the rounded morphology is caused by a standstill in differentiation, this occurs after 
the cells begin to express MAP2. Furthermore, Knoth show these morphological alterations 
are accompanied by a large decline in DCX positive cells whereas our data suggests DCX 
and MAP2 expression remains stable across passages but the proportion of cells with an 
elongated morphology decreases whilst that with a rounded morphology increases. Older 
studies in rat tissues using 3,3′-Diaminobenzidine staining, also showed increases in soma 
area, perimeter and diameter of dorsal lateral geniculate nucleus neurons with age 
suggesting this age-related phenotype is not specific to the hippocampus alone (Villena et 
al., 1997). 
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We also report that the stunted morphology identified in higher passage numbers is 
characterised by increased cytoplasm width and cytoplasm width to length ratio as well as 
increased nuclear area and roundness. Importantly, nuclear and cellular enlargement are 
often reported as a recurring phenotype of senescence in a number of cell types ranging 
from fibroblasts to several cancer cell lines (Angello et al., 1989; Barascu et al., 2012; Sadaie 
et al., 2015; Sikora et al., 2016). This data therefore suggests HPCs that undergo repeated 
passaging exhibit phenotypes similar to those of senescent cells and may therefore be 
undergoing senescence. Despite this, as research into the senescent phenotypes of post-
mitotic cells such as neurons is only just beginning, these phenotypes are yet to be explored 
in neurons and therefore a consensus on senescent phenotypes of neuronal cells is yet to 
be determined. Overall however, the morphological alterations reported here are a good 
indication that the model established in this chapter induces some aspects of ageing. 
 Molecular consequences of the ageing model 
Finally, we evaluated whether the expression levels of the 9 candidate genes, identified in 
the previous chapter, varied following the ageing model. First, we assessed their expression 
following individual and combination treatment on ‘young’ passage 17 cells. This revealed 
that treatment during the proliferation or differentiation assay did not affect the 
expression level of our candidate genes. Next, we assessed the effect of combination 
treatment and increased passage number. We report variations due to passage number in 
the expression levels of several genes following both the proliferation and the 
differentiation assays.  
 
We show that FOXO3A expression was significantly lower in cells with a higher passage. 
This was the case for experiments harvested both after the proliferation assay and after 
the differentiation assay, suggesting this change occurs in proliferating and differentiating 
cells alike. FOXO3A is a key molecule in NSC homeostasis that is frequently linked to ageing 
research as it is known to regulate the transcription of genes associated to OS response, 
DNA damage and to the repression of apoptosis (Fluteau et al., 2015; Paik et al., 2009; 
Renault et al., 2009; Stefanetti et al., 2018).  FOXO3A has been linked to human longevity 
by several successful association studies: Willcox and colleagues initially tested 5 known 
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longevity genes for association in a sample of long-lived Japanese men and showed 
significant associations with 3 FOXO3A polymorphisms. This association was later 
confirmed by Flachsbart et al who replicated and extended Wilcox’s results by showing 
these variations affected females and males alike in a German population. In line with this, 
associations between FOXO3A and longevity were also confirmed in a Han Chinese cohort 
(Flachsbart et al., 2009; Li et al., 2009; Willcox et al., 2008b). 
 
Despite this, a link between its expression levels and ageing human brains is yet to be 
established Our results however, are in line with groups showing an age-dependent 
decrease in FOXO3A in mouse small-intestine cells and increased phosphorylation, and 
therefore inactivation, of FOXO3A in older mouse NSCs (Becker et al., 2018; Renault et al., 
2009). In addition, experiments assessing the effects of the knockout and downregulation 
of FOXO3A in both mouse NSCs and human dermal fibroblasts, have reported the cells 
exhibited senescence and aged phenotypes therefore suggesting FOXO3A is indeed a driver 
of cellular ageing (Kyoung Kim et al., 2005; Renault et al., 2009). Given the important role 
in OS and DNA damage response, a decrease in the expression of FOXO3A in older cells may 
be indicative of poorer defence mechanisms. Interestingly, Fluteau and colleagues showed 
that while there was no association between FOXO3A expression and age in human lateral 
temporal cortex tissue, there was a significant correlation between FOXO3A expression and 
H2AX expression further supporting a role for FOXO3A in DNA damage response (Fluteau 
et al., 2015). While it is surprising that our results did not show accompanying alterations 
in DNA damage or apoptosis marker expression, this may be due to the assay length; a 
longer assay may in fact have allowed enough time for the gene expression alterations to 
be reflected by cellular outcomes. 
 
We also report variation in the gene expression of mTOR pathway components due to 
passage number. mTOR, the key molecule within this signalling cascade, showed variation 
due to passage number following the differentiation assay but post-hoc analysis did not 
survive multiple correction testing suggesting a lack of power and possibly only a modest 
effect size. Though it is difficult to compare such data to previous findings, alterations in 
mTOR signalling are strongly associated to autophagy and stem cell maintenance and have 
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been repeatedly implicated in ageing.  In general, attenuation of mTOR signalling either via 
rapamycin treatment or genetic intervention was shown to extend lifespan in yeast, 
worms, flies, and rodents as reviewed by Johnson (Johnson et al., 2013).  
 
Interestingly, we also report higher passage number induced decreased expression of two 
negative regulators of the mTOR pathway; GRB10 and PTEN. As for FOXO3A, GRB10 
showed a decrease in expression following both assays, again suggesting the alteration is a 
persistent change in response to passage number that is irrespective of the cell’s 
differentiation state.  This is particularly interesting as GRB10 is a known regulator of stem 
cells as evidenced by experiments investigating its role in hematopoetic stem cell 
regulation (Yan et al., 2016). Though its role in NSCs remains to be elucidated, alterations 
in its expression levels are indicative of mTOR signalling alterations as it is responsible for 
its regulation via negative feedback mechanisms. PTEN, the other negative regulator of 
mTOR investigated here, showed a significant decrease in expression level when comparing 
treated higher passage cells to treated lower passage cells but not when comparing 
untreated cells across passages. Our data shows treatment affects older cells more severely 
than younger cells. This suggests older cells are less equipped to deal with adverse 
environments; younger cells may thus be more efficient at dealing with OS and DNA 
damage and at returning to a normal state whilst older cells may have longer lasting 
alterations due to insults which is why the alterations are only detected in in the treated 
older cells. In line with this, the gene expression alterations in PTEN were only detectable 
following the differentiation assay. Given the differences in the assay length between the 
proliferation and differentiation assay, this data suggests either that tBHP and HU affect 
NSC progeny more harshly than their undifferentiated counterparts or that the 
differentiation assay is a more representative of chronic stress. Were the latter to be true, 
this result suggests older cells are more susceptible to prolonged periods of stress i.e. the 
differentiation assay. Regardless, previous findings have shown PTEN overexpression is 
linked to exceptional longevity in mice which is in line with our data showing decreased 
levels of PTEN in older cells (Ortega-Molina et al., 2012). In addition, PTEN has been linked 
to anti-oxidant activity and to apoptosis via PIP3 dependent and independent mechanisms 
respectively. The degree of damage was suggested to be a decisive factor as to whether 
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PTEN induces apoptosis or anti-oxidative response (Chen et al., 2005; Wan et al., 2007).  
Given the presence of PTEN expression alterations following the differentiation assay it 
would be interesting to prolong the assay and assess cellular changes pertaining to 
apoptosis and OS at a later timepoint. In summary, though the alterations in mTOR 
expression levels remain elusive, the lowered levels of negative regulators of the mTOR 
pathway are suggestive of a dysregulated signalling cascade which is likely to contribute to 
the altered phenotypes seen in cells with higher passage numbers. 
 
NAMPT, the rate limiting enzyme essential for SIRT1 deacetylation activity showed very 
interesting alterations during the proliferation assay. We report higher expression levels of 
NAMPT in passage 26 cells when compared to passage 17 cells and a further increase in 
expression in treated passage 26 cells when compared to untreated passage 26 cells. 
Interestingly, there was no alteration in expression when comparing treated and untreated 
passage 17 cells.  This data shows that while treatment alone is not able to cause alterations 
in low passage number cells, there is a cumulative effect of treatment and passage number 
that further exacerbates the phenotype seen in higher passage numbers. A possible 
explanation for these results is that cells with higher passage number have poorer, or at 
least different, resources to combat the oxidative and replicative stress caused by 
treatment, which result in an exacerbation of their ‘aged’ genetic signature. As for PTEN, it 
remains to be established whether the increase in NAMPT is a negative consequence or 
simply a compensatory mechanism. NAMPT overexpression in fact, was shown to rescue 
NAD+ depletion and mitochondrial dysfunction that accompany senescence by several 
groups. NAMPT expression was found to be lower in mesenchymal stem cells obtained 
from aged rats than in those obtained from younger rats. Notably, the aged phenotype 
found in older mesenchymal stem cells could be induced by inhibiting NAMPT function 
while NAMPT overexpression caused its attenuation (Ma et al., 2017). A marked decline in 
NAMPT expression and activity was also shown to precede senescence in human vascular 
smooth muscle cells which was delayed by NAMPT overexpression (van der Veer et al., 
2007). In line with this, NAMPT ablation in mouse NSCs recapitulated ageing phenotypes 
(Stein and Imai, 2014). These reports suggest the increase in NAMPT seen in response to 
treatment and increased passage is likely a defence mechanism. Surprisingly, these 
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alterations were not accompanied by significant changes in Sirt1 expression. There was 
however, a trend in a similar direction to that of NAMPT suggesting SIRT1 expression may 
indeed be changing. Importantly, these alterations appear specific to the proliferation 
assay, suggesting either that increased NAMPT as a compensatory mechanism is specific to 
NSCs and not to differentiated cells or that the cells are unable to sustain increased NAMPT 
expression for an extended period of time such as the differentiation assay. 
 
Finally, to assess whether these alterations were a consequence of senescence and to 
complement the NRF2 expression data discussed in the previous section, the expression 
levels of p16 were also assessed. p16 is a cyclin-dependent kinase inhibitor which is 
upregulated in senescent cells and is often used as a marker for senescence (Daniele et al., 
2016). Though an interesting trend was shown, suggesting treatment but not passage 
number increases p16 expression this was not significant. This suggests that while these 
results may be indicative of ageing phenotypes they are likely not due to senescence. SA-
βgal quantification was attempted to confirm this hypothesis, but components of the 
protocol appeared toxic, making the assay unreliable in this cell line (data not shown). 
Similarly, telomere length quantification by qPCR was attempted as described by Cawthon, 
but the resulting data was untrustworthy due to persistent variability across both technical 
and biological replicates (Cawthon, 2009). Further work optimising senescence readouts in 
this cell line is therefore necessary to clarify the state of these cells.  
 Summary and future directions 
In summary, we identified viable concentrations for the chronic treatment of the HPCs with 
tBHP and HU. We also proved that cells with higher passage number retain all proliferative 
and differentiative abilities and that surprisingly, treatment and passage number do not 
affect the expression of cellular markers of neurogenesis except for possible alterations in 
DNA damage. Of note, we showed robust morphological alterations and interesting 
alterations in the expression levels of candidate nutrient-sensing genes in response to 
increased passage number. We initially aimed to establish a more robust and multimodal 
model of ageing. While increasing passage number showed robust morphological and 
molecular alterations, treatment did not obtain the same result. In addition, the 
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combination of both treatment and increased passage to obtain a multimodal ageing 
model also failed to show considerable differences from passage number alone. Though 
we still believe the development of multimodal ageing models would be beneficial for 
ageing research, our current data suggests the more robust experimental condition is 
simply increased passage. 
 
Future experiments assessing post-translational modifications as well as the localization of 
these candidate molecules and epigenetic status would provide further insights on the 
alterations occurring in response to stress. Some of the genes that appear unaltered in 
response to stress may simply be undergoing different types of modifications. In addition, 
repeating these experiments and assessing both gene expression and cellular marker 
expression at varying timepoints throughout differentiation may uncover changes that 
have gone undetected in these assays. Specifically, extending the assay and assessing the 
electrophysiological properties of the resulting neurons would allow us to gain insight on 
the functionality of neurons that underwent chronic stress during both NSC and 
differentiated states. An unchanged number of progenitors, neuroblasts and immature 
neurons is not necessarily indicative of unaffected neurogenesis, a process that is 
dependent on a variety of other factors (Kempermann et al., 2004b). The altered 
morphology reported above in fact, may cause poorer integration and therefore poorer 
functionality. Finally, knockout and overexpression experiments targeting the altered 
genes would establish their contribution to the ageing phenotype and aid in understanding 
whether these changes are compensatory mechanisms or detrimental consequences 
contributing NSCs decline. 
 Limitations 
Despite the interesting findings outlined above, this study had a number of limitations. 
Firstly, to induce sub-lethal chronic stress rather than acute stress, very low concentrations 
of the treatments had to be used to not bias the results with the use of cultures with 
extensive cell loss. As evidenced by the large variation in the treatment group using the 
higher dose of HU, similar treatment concentrations caused different levels of toxicity in 
different biological replicates suggesting other variables beyond our control affect 
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treatment susceptibility. It is therefore possible that ideal concentrations of tBHP and HU, 
that induce more robust OS, DNA damage and senescence but do not cause cell death, lie 
somewhere between those tested here.  Identifying these might reveal changes which 
remained undetected in this study. In line with this, media components such as albumin 
and sodium selenite designed to prevent OS in culture may be interfering with the damage 
response to both passage number and treatment. Finally, while increased passage number 
has been used previously to model ageing, there is a possibility that this inadvertently 
selects for specific cell types. 
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5 Impact of Lifestyle and Genetics on Cognition: An Epidemiological 
Study.  
5.1 Introduction 
 Lifestyle effects on healthspan and cognition 
As discussed in chapter 1, increasing healthspan and thereby compressing morbidity is a 
major goal of current biogerontology research. Prolonging life is not a sustainable goal if it 
is not accompanied by an equal increase in healthspan.  Currently, yet both lifespan and 
healthspan are increasing, healthspan is doing so at a slower rate. This has caused an 
increase in proportion of time spent in late-life morbidity which now consists of 16-20% of 
life (Oeppen and Vaupel, 2002). Though it is often debated whether one can reach end of 
life in a relatively healthy state, studies on centenarians have reported that those who live 
longer tend to do so with an accompanying reduction of time spent in late-life morbidity. 
These findings, together with work in animal models have shown it would indeed be 
possible to extend both life and healthspan if the underlying ageing mechanisms are 
identified (Fontana et al., 2010; Fontana and Partridge, 2015). 
 
The steep increase in life expectancy over the last decades suggests only a minor role for 
genetic changes (Burger et al., 2012). Instead, lifestyle factors such as exercise, diet, 
education and social status appear to have greater effects than initially predicted. The 
hereditability of lifespan in fact, lies somewhere between 12% and 25% (Kaplanis et al., 
2018; van den Berg et al., 2017) and only a few genetic loci have so far shown robust 
association with longevity (Joshi et al., 2017; Partridge et al., 2018). The effect of lifestyle 
on healthspan and longevity is further supported by lack of genetic differences between 
individuals from areas with very high life expectancy and their neighbours (Poulain et al., 
2014). This has prompted the field to try and elucidate exactly how lifestyle can have such 
strong effects (Partridge et al., 2018). A major hurdle in biogerontology research however, 
is the heterogeneity with which ageing presents itself. Ageing is usually accompanied by 
multimorbidity i.e. the presence of two or more chronic health conditions, but these vary 
considerably between individuals. Therefore, whilst preventing each morbidity from 
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occurring in the first place may be a viable treatment option, it is difficult to predict which 
specific health conditions each person will be affected by (Partridge et al., 2018). This 
problem could be overcome if suitable and early biomarkers are developed to assess the 
risk of each age-associated condition. In an attempt to understand the mechanisms behind 
one of the most debilitating age-related morbidities, we focus on the age-related decline 
in cognitive function. 
 
Diet and nutrition, as discussed in chapter 1  have been linked to longevity and cognition in 
a variety of animal models and human studies (Most et al., 2017). Together with this, 
exercise has been associated to improved cognitive abilities and a reduction in age-related 
decline in both animal models and human studies (Busse et al., 2009; Sujkowski et al., 2015; 
Vaynman et al., 2004; Vaynman and Gomez-Pinilla, 2006; Weuve et al., 2004). An increase 
in energy expenditure appears protective against cognitive decline. Interestingly, this is 
also the case in older adults (Mattson, 2012; Roig et al., 2013; Smith et al., 2010). In line 
with this, observational studies have shown aerobic fitness is associated with reduced brain 
tissue loss in ageing humans and increased physical activity is related to improved mental 
health and better performance on cognitive tasks (Chekroud et al., 2018; Colcombe et al., 
2003; Hogan et al., 2013). In addition, several meta-analyses have been carried out 
assessing this relationship and have found aerobic exercise to be protective for cognitive 
function in the elderly, protective against dementia risk and also to be associated to lower 
risk of developing depression (Blondell et al., 2014; Northey et al., 2018; Schuch et al., 
2018). 
 
Following these findings, several intervention studies have tried elucidating the effects of 
diet and exercise on aspects of human ageing; the Mediterranean diet was shown to be 
protective against cardiovascular disease and cancer, while a combination of diet and 
exercise showed positive effects on diabetes and microvascular complications (Estruch et 
al., 2018; Nathan et al., 2015; Toledo et al., 2015). However, despite mounting evidence of 
the importance of diet and exercise in terms of cognition there are only limited and often 
contradicting human intervention studies assessing this relationship (Martin et al., 2007; 
Williams et al., 2010; Witte et al., 2009). One such study, is the ongoing FINGER intervention 
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study which focuses on 7 modifiable factors (low education, midlife hypertension, midlife 
obesity, diabetes, physical inactivity, smoking and depression) that greatly increase the risk 
of Alzheimer’s disease. This double-blind randomised controlled trial recruited at-risk 
elderly individuals and assigned them a multidomain intervention including diet, exercise 
and cognitive training for two years. Results from this study showed an improvement in 
cognitive performance suggesting the combination of diet and exercise, as well as early 
intervention, is crucial for preventing age-related cognitive decline (Ngandu et al., 2015). 
 
Despite this encouraging study, the exact lifestyle interventions that would benefit ageing 
and age-related cognitive decline the most are still unclear.  In addition, dietary restriction, 
one of the most effective interventions, is notorious for its low compliancy rates suggesting 
lifestyle interventions as a whole may not be a realistic public health intervention (Moreira 
et al., 2011; Partridge et al., 2018). This, combined with the heterogeneity seen in ageing 
phenotypes and contradicting results from human interventions, suggests further research 
is needed to devise more targeted and effective interventions for specific subpopulations. 
To achieve this, it is necessary to understand what makes certain individuals more prone 
to certain age-related conditions and therefore more susceptible to certain lifestyle 
interventions. Though only a small proportion of longevity is hereditary, genetic 
polymorphisms may still have important functions in determining this susceptibility. 
 Gene environment interactions 
Since the Human Genome Project was completed at the start of the century, increasing 
emphasis has been put on genetic studies. Projects such as the 100 genome project aimed 
at understanding genetic variation between individuals have provided new and exciting 
avenues for understanding the links between genotype and phenotype (Durbin et al., 
2010). As more genomes are sequenced, our understanding of factors such as linkage 
disequilibrium and thereby the available techniques are undergoing steep improvements 
(Hinds et al., 2006; Reich et al., 2001).  
 
These advances have allowed for the development of precision medicine, a field aimed at 
tailoring interventions to each patient in an attempt to decrease the number of failing 
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treatments. Often this tailoring is based upon the patient’s genetic background and allows 
for a better targeting of both drugs and lifestyle interventions which is usually accompanied 
by decreased side effects and increased efficacy (Ginsburg and Phillips, 2018). Precision 
medicine has shown positive outcomes in several diseases such as certain types of cancer 
and cystic fibrosis and is currently being developed for a larger set of disorders such as 
dementias and ageing in general (Hampel et al., 2016; Reitz, 2016). It is indeed in 
pathologies such as ageing, where there is a lack of effective treatments and vast 
heterogeneity in between cases, where precision medicine could be most useful. 
Understanding which patients would benefit from specific interventions, whether these 
may be lifestyle-based, drug-based or a combination, would both improve the care given 
to patients and decrease the financial burden of healthcare caused by an ageing population 
(Wiener and Tilly, 2002). For such therapies to be developed however, the field must first 
identify which polymorphism make people more or less susceptible to faster age-related 
decline and to the lifestyle effects thereon. For this purpose, studies attempting to clarify 
gene environment interaction (GxE) in the context of age-related cognitive decline are a 
necessity. 
 CANTAB PAL© as a measure for hippocampal-dependent cognition 
Biogerontology research is impaired by a lack of effective biomarkers to monitor disease 
progression in humans. Cambridge Cognition have therefore developed a battery of 
neuropsychological tests which can be used as early biomarkers of cognitive decline 
(Barnett et al., 2015). Cambridge Neuropsychological Test Automated Battery (CANTAB) 
was also designed with the aim to bridge the translational gap between animals and 
humans, another key issue in biogerontology research (Dutta and Sengupta, 2016; Murphy 
et al., 2014). Many of the tasks in the battery are based on animal paradigms and are 
adapted for human use. Equally, human neuropsychological assessments used in clinics 
were adapted to be used through touch screen devices and translated for use in both 
rodent and non-human primate models. 
 
 The CANTAB paired associates learning task in particular, was developed to help detect the 
prodromal stages of mild cognitive impairment and Alzheimer’s disease. It is based on 
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episodic memory, which is the ability to store, learn and retrieve information about past 
experience. The spatial element of the task makes performance particularly dependent on 
the hippocampus and the entorhinal and transentorhinal cortex (Brown and Aggleton, 
2001). The importance of the hippocampus in such tasks was initially suggested by case 
studies of patients with damaged hippocampi who performed badly on object-location 
tasks (Smith and Milner, 1981). Following this, Parkinson and colleagues reported that 
rhesus monkeys with large ablative legions in the hippocampal formation also reported 
significant impairments in object-location association tasks (Parkinson et al., 1988). Since 
then, the hippocampus has been further implicated in rodent-adapted versions of CANTAB 
PAL© performance; after muscimol (a GABA agonist) injection in the hippocampus in both 
rats and mice showed severe impairments in PAL task performance (Kim et al., 2015; Talpos 
et al., 2009; Yoon et al., 2012).  Finally, functional MRI studies in humans showed the PAL 
task activates the hippocampus, interestingly, this occurred in a load-dependent manner 
whereby activation increased with PAL task difficulty (de Rover et al., 2011). Lesion studies 
have also confirmed PAL test performance is dependent on the functional integrity of the 
temporal lobe and specifically of the entorhinal cortex (Owen et al., 1995). 
 
The PAL task was designed to be used within cognitively impaired and cognitively healthy 
populations alike, a graded adjustment was incorporated to help compare extreme 
performances. This graded nature means the task is subdivided into several stages and 
adjustments are applied to the participant’s score if they do not reach the more difficult 
stages. The 6-pattern stage (the second hardest) has been extensively studied and showed 
a 100% sensitivity in distinguishing cases from controls in mild cognitive impairment and 
Alzheimer’s studies (Barnett et al., 2015; Chandler et al., 2008). The more difficult 8-pattern 
PAL stage which is usually used in cognitively healthy populations instead, has no consensus 
on what score constitutes healthy or unhealthy cognition but is a valuable tool in assessing 
cognitive decline in the absence of pathology (Lee et al., 2013).  In all stages, PAL is highly 
dependent on age owing to its reliance on episodic memory, making it a useful tool to study 
both healthy and pathology-driven cognitive ageing (Barnett et al., 2015; Lee et al., 2013; 
Soares et al., 2015). Finally, as discussed in section  3.1.1 the strong effect of age and 
dependence on hippocampal function combined with the emphasis on distinguishing 
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similar scenarios from one another highlights the possible involvement of pattern 
separation and therefore adult hippocampal neurogenesis in PAL tasks.  
 Aims of this chapter 
As discussed above, interventions are needed to extend healthspan alongside lifespan and 
according to current research the most promising of these involve lifestyle interventions. 
However, no lifestyle intervention in humans has proven as efficient as those carried out in 
animal models, suggesting human heterogeneity may be an important factor to consider 
(Mitchell et al., 2015). In this chapter, we aimed the following. 1) To assess the impact of 
lifestyle factors such as diet and exercise on hippocampus-dependent cognition. 2) To 
assess the effect of genetic polymorphisms on hippocampus-dependent cognition and their 
interaction with lifestyle factors 3) To investigate methylation changes occurring as a result 
of age and lifestyle with the purpose to validate the importance of epigenetic alterations 
discussed in chapter 1. See Figure 49 for the aims and hypothesis of this chapter.  
 
We focus on polymorphisms related to the 9 candidate genes selected from the cellular 
and molecular in vitro work in previous chapters: mTOR, GRB10, IGF2R, PTEN, FOXO3A, 
UCP2, SIRT1, NAMPT and ABTB1. As discussed in chapter 3, these 9 genes all belong to 
pathways that have been associated to ageing, NSCs and cognitive decline. However, there 
are no previous studies linking polymorphisms in these regions with age-related cognitive 
decline or lifestyle interactions, making this an exciting and novel avenue. 
With this study, we also hope to address the translational gap which has caused many 
interventions developed in animal and in vitro models to prove unsuccessful when 
translated to humans (Franco and Cedazo-Minguez, 2014; Mak et al., 2014; Medina and 
Avila, 2014). To this purpose, we validated these 9 candidate genes that were found to be 
associated to neural stem cell function in vitro (see chapter 3) for association to cognitive 
performance in a human cohort. The PAL task was selected as the cognitive task available 
in the cohort that was most closely related to hippocampal function and therefore likely to 
rely on neurogenesis and neural stem cell function. Making it a useful human-based 
cognitive task with which to validate our in vitro findings. 
 





Figure 49 -  Chapter 5 hypothesis.  We hypothesis that chronological ageing, lifestyle and genetics impact 
on cognitive performance. We also hypothesise that these effects are in part, mediated by epigenetic 
alterations. Therefore, we aim to assess the effect of diet and exercise (1), single nucleotide polymorphisms 
(SNP) (2) and methylation status (3) in relation to ageing and cognitive performance on the Paired 
Associates Learning (PAL) task. 
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5.2 Materials and methods 
 Programming software 
All data cleaning, quality control, variable calculations, data merging, statistics and 
graphical representations outlined in this chapter were carried out in the Rstudio software 
(version 1.0.153) (RStudio Team, 2016).  
 Data request to access the TwinsUK cohort 
The data used in this chapter was obtained by the Department of Twin Research at King’s 
College London, as part of the TwinsUK cohort recruitment (Moayyeri et al., 2013). This 
cohort is comprised of over 12000 monozygotic and dizygotic twins between the ages of 
16 and 95 with a wide range of demographic, cognitive, genetic and lifestyle data, making 
it an ideal cohort for this study. Data was requested through the data access request form 
available online at http://www.twinsuk.ac.uk/data-access/submission-procedure-2/ 
(accessed on 26th August 2018). To study the effect of genetic polymorphisms on 
hippocampus-related cognition, all available PAL result scores were requested along with 
the demographic and genotype information pertaining to the twins with available PAL 
scores. To investigate the effect of lifestyle on cognition, the most contiguous total energy 
intake, Healthy Eating Index (HEI) and physical activity measures to the PAL phenotype 
were also requested. Finally, DNA methylation data was requested to investigate any 
association between methylation intensity and performance on cognitive tasks. 
 CANTAB Paired Associates Learning Task 
CANTAB includes a variety of digital cognitive tasks developed by the University of 
Cambridge aimed at assessing human brain function. In this study, we used CANTAB’s 
Paired Associate Learning Task. The task is delivered on a touchscreen and has a duration 
of 8 minutes. It consists of 10 stages of increasing difficulty each comprised of 2 phases 
(acquisition and recall). During the acquisition phase 1,2,5,6, or, in the final stage, 8 
patterns are shown in one of the 6 or, in the final stage, 8 boxes displayed on the screen. 
Following this initial acquisition phase, the patterns are shown one at a time in the middle 
of the screen and the participant is asked to place the patterns in the correct box. This 
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phase is known as the recall phase. During this phase, if the correct location of the patterns 
is given, the participant is allowed to proceed to the next stage, after an incorrect answer, 
all patterns are displayed again and the participant is prompted to provide the patterns’ 
locations again. Screenshots from the task are shown in Figure 50. 
 
 
Figure 50 - CANTAB Paired Associates Learning task (PAL) Screenshot showing the acquisition and recall 
phases of the PAL task. The screenshots show the 6-boxstage. Participants are asked whether the image is in 
the correct box during the acquisition phase and asked to place the image in the correct box during the recall 
phase .Image from (Delotterie, 2014)  
The outcome measure is the numbers of errors made by the participant adjusted for trials 
required and stages completed. Each stage allows a maximum of 10 errors before the 
participant is prevented from progressing and their adjusted score is calculated. The 
adjustment is calculated by summing the number of patterns not attempted and 
subtracting this number divided by the number of boxes from it. The result is then 
multiplied by the total number of possible trials. This adjustment is necessary to compare 
all participants irrespective of which stage of the test they have reached.  
Results adjusted for the 6-pattern PAL, which only includes the first 9 stages, are usually 
used in cognitively-impaired populations, as this study was aimed at investigating cognition 
in a cognitively-healthy ageing population, the 8-pattern PAL adjustment was used. PAL 
scores of 2153 individuals were received from TwinsUK. Prior to analysis, the PAL data was 
inspected for normality, heteroscedasticity and for the presence of outliers via visual 
inspection of frequency distribution, residual vs fitted, quantile-quantile (Q-Q), scale-
location and residual vs leverage plots. 
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 Demographic information 
Demographic factors such as date of birth, sex (female or male), zygosity (monozygotic or 
dizygotic), Mini Mental State Examination (MMSE) results, education and National Adult 
Reading Test (NART© Hazel E. Nelson) results were also received.  TwinsUK is made up of 
predominantly white participants of European background. 
Education was measured via an 8-question questionnaire (see Table 29). Participants were 
asked to tick the box with the qualification type most similar to their highest level of 
qualification. 
Code Qualification 
1 No qualification 
2 NVQ1/SVQ1 
3 O-Level/GCSE/NVQ2/SVQ2/Scottish Intermediate 
4 Scottish higher, NVQ3, city and qulds, Pitman 
5 A Level, Scottish Advanced Higher 
6 Higher Vocational training (e.g. Diploma, NVQ4, SVQ4) 
7 University degree 
8 Postgraduate degree (e.g. Masters or PhD), NVQ5, SVQ5 
Table 29 - TwinsUK education questionnaire. Table reporting the method used to code education data 
throughout the TwinsUK cohort. The first column shows the numerical value given to the participant’s answer 
(second column). 
NART was carried out following the guidelines outlined by Nelson and Wilson (Nelson and 
Wilson, 1991). Briefly, English mother-tongue participants are given a list of 61 irregular 
and non-phonetic words (eg. “psalm”, “ache”, “depot” and asked to read each one out 
loud. Multiple responses are allowed as long as a final one is decided upon before 
proceeding to the next word. No time restriction is imposed and the participant is only 
given feedback as to the correct responses at the end of the task. The number of errors and 
correct responses is the summed to create the NART score.  NART score is sometimes used 
as a proxy for education. 
 
As multiple entries for both the education questionnaire and NART were available per 
participant, only the entries closest in time to the completion of the PAL task for each 
participant were used in this study. Despite this, some mismatch between questionnaire 
date of completion and PAL date was still present. Of the 1384 individuals with available 
education data, only 4 individuals answered the education questionnaire within 1 year of 
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undertaking PAL, while 643 answered the education questionnaire more than 1 year but 
less than 3 years before or after undertaking PAL and 737 answered the education 
questionnaire more than 3 years before or after undertaking the PAL task.  Of the 1784 
individuals with available NART data, 1708 underwent NART within 1 year or undergoing 
PAL, 0 individuals underwent the two tests within 3 years of each other and 76 individuals 
underwent NART more than 3 years before or after undergoing PAL. This is summarised in 
Table 30.   
 
 
Exact match to pal 
(<1 year) 
Close match to pal 
(>1 but < 3 years) 
Distant match to pal 
(>3 years) 
Education (n=1384) 4 643 737 
NART (n=1784) 1708 0 76 
Table 30 - Table summarising the number of participants with exact, close or distant matches of education 
or NART entries in comparison to Paired associates learning test. An exact match means the participant 
underwent the education questionnaire or the NART test less than a year before or after undergoing the PAL 
task, a close match means they underwent the tests more than a year but less than 3 years before or after 
the PAL task and a distant match means the tests were carried out more than 3 years before or after the PAL 
task. 
 
 Time difference and age calculations were carried out using the “lubridate” package in R 
(Grolemund and Wickham, 2011). Due to missing and mismatched education data, NART 
was used as a proxy for education.  
 Lifestyle factors 
To assess the effect of lifestyle on cognition, measures of nutritional habits and physical 
activity were requested from TwinsUK. 
5.2.5.1 Nutrition: Calorie intake and Healthy Eating Index 
Two measures of nutritional habits were available as part of this study: average daily calorie 
intake and Healthy Eating Index (HEI). Both were calculated from food frequency 
questionnaires (FFQ) collected following the EPIC-Norfolk guidelines (European Prospective 
Investigation of Cancer). The FFQ documented the participants eating habits over the 
previous year by assessing consumption of 290 foods (See appendix section 8.4.1.1). Jane 
Skinner at the University of East Anglia converted the FFQ data to nutritional information 
and estimated energy consumption in kcal, and Ruth C. E. Bowyer at King’s College London 
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was responsible for converting the data to HEI. HEI was constructed following the 
guidelines described by Guenther and colleagues with the exception of the use of the UK 
based database “Composition of Foods integrated database” rather than an American 
based database (Bowyer et al., 2018; Guenther et al., 2013). 
 
Briefly, food items are classified into “U.S. Department of Agriculture” subgroups (e.g. fruit, 
grains, dairy, etc.) (see Table 31) and then categorised into HEI components based on their 
predominant attributes (e.g. further subdivided into of lean and solid fat). Each subgroup 
has a maximum possible amount of HEI points that can be assigned to it, the FFQ data is 
first converted to equivalent cups or ounces from FFQ portion information and then to a 
measure of “nutritional component per 1000 kcal”. Based on this ratio, a certain proportion 
of the possible HEI points for that subgroup is assigned to the participant. Out of the 12 
subgroups, the first 9 are known as adequacy components which aim to quantify the 
amount of healthy foods consumed, the remaining 3 (refined grains, sodium and empty 
calories) were introduced to negatively weigh HEI when excessive amounts of non-healthy 
foods are consumed. (See Table 31) 
  






Standard for maximum 
score 
Standard for minimum 
score of zero 
Total fruit 5 
≥0.8 cup equiv. per 1,000 
kcal 
No Fruit 
Whole fruit 5 
≥0.4 cup equiv. per 1,000 
kcal 
No Whole Fruit 
Total vegetables 5 
≥1.1 cup equiv. per 1,000 
kcal 
No Vegetables 
Greens and beans 5 
≥ 0.2 cup equiv. per 1,000 
kcal 
No Dark Green Vegetables 
or Beans and Peas 
Whole grains 10 ≥1.5 oz equiv. per 1,000 kcal No Whole Grains 
Dairy 10 
≥1.3 cup equiv. per 1,000 
kcal 
No Dairy 
Total protein foods 5 ≥2.5 oz equiv. per 1,000 kcal No Protein Foods 
Seafood and plant 
proteins 
5 ≥0.8 oz equiv. per 1,000 kcal 
No Seafood or Plant 
Proteins 
Fatty acids 10 (PUFAs + MUFAs)/SFAs ≥2.5 (PUFAs + MUFAs)/SFAs ≤1.2 
Refined grains 10 ≤1.8 oz equiv. per 1,000 kcal ≥4.3 oz equiv. per 1,000 kcal 
Sodium 10 ≤1.1 gram per 1,000 kcal ≥2.0 grams per 1,000 kcal 
Empty calories 20 ≤19% of energy ≥50% of energy 
Table 31 - Food subgroups and relative scoring included in the Healthy Eating Index (HEI). Food items are 
classified into subgroups (Component) and a maximum number of points (Max points) or a proportion thereof 
is assigned to contribute to the overall HEI score. Bottom two rows represent detrimental food items, 
therefore higher scores are obtained with lower intakes. Adapted from (Guenther et al., 2013) 
 
 HEI score can range from 0-100 points with the maximum achievable score indicating a 
diet that fulfils all health thresholds. The index was designed so that in a large enough 
population, 50 would be the mean HEI score and 1 and 99 would be the 1st and 99th 
percentile. Within the TwinsUK cohort we observe a mean of 60.03, a 1st percentile of 37 
and a 99th percentile of 86 (Bowyer et al., 2018).  Results from three batches of FFQ 
collections were received, as for the education questionnaires, the FFQ results collected 
closest in time to the PAL task results were used for each individual. Out of the 1567 
individuals with available PAL and FFQ data, 437 individuals had PAL and FFQ data less than 
a year apart, 293 had a time interval of 1-3 years between the FFQ and PAL task and the 
remaining 800 had a time interval greater than 3 years. 
 




To investigate another aspect of lifestyle and its effects on cognition, physical activity data 
was collected via International Physical Activity Questionnaire (IPAQ) (Hagströmer et al., 
2006), see section 8.4.1.2 for the IPAQ questionnaire. 
 
IPAQ aims at assessing the types of physical activity done by the participants to estimate a 
total physical activity measure known as MET-minutes per week. The IPAQ short form 
questionnaire used here, consists of 7 questions about the previous 7 days, the questions 
are subdivided in 4 sections: vigorous physical activity (such as heavy lifting or fast cycling), 
moderate activity (such as carrying light loads or cycling at a regular pace), time spent 
walking and time spent sitting. For each of the 4 sections, the participant is asked to state 
the number of days a week as well as hours and minutes a day spent doing that specific 
type of physical activity. The participants are also able to indicate no time spent.  From this, 
MET minutes are calculated: MET minutes represent the amount of energy expended when 
carrying out physical activity.  1 MET minute equals the amount of energy expended at rest. 
Therefore 2 MET minutes is double the resting energy expenditure. 
 
Upon receiving the raw IPAQ data, MET minutes were calculated as per IPAQ guidelines, by 
first converting the time spent doing each form of activity to minutes and then multiplying 
that by a constant. The constant varied according to the form of activity: 3.3 for walking, 4 
for moderate and 8 for vigorous physical activity. Only activities of 10 or more minutes are 
included in the calculations of MET minutes. Once MET minutes were calculated 
participants were split into high, moderate and low physical activity following guidelines 
outlined on the IPAQ website (www.ipaq.ki.se) (accessed on 1.10.18). 
 
For a participant to be classified as high physical activity they must have had engaged in 
either of the following: 
a)  vigorous activity on at least 3 days achieving a minimum of 1500 MET minutes a 
week  
b) 7 or more days of any combination of vigorous or moderate activity achieving a 
minimum of 3000 MET minutes a week. 
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For a participant to be classified as moderate physical activity they must have had engaged 
in any of the following: 
a) 3 or more days of vigorous activity of at least 20 minutes a day 
b) 5 or more days of moderate activity and/or walking at least 30 minutes a day 
c) 5 more days of any combination of walking, moderate or vigorous activity achieving 
a minimum total physical activity of at least 600 MET minutes a week. 
For a participant to be classified as low physical activity they must not have met any of the 
criteria for the other two groups.  
 
Data cleaning was also carried out in accordance to IPAQ guidelines, this included removing 
participants with missing answers or with unreasonably high levels of activity, identifying 
possible human errors when completing the questionnaires and applying a truncation rule 
that converted all activity variables exceeding 180 minutes to equal 180 minutes. The 
truncation attempts to normalise the distribution of the activity levels and prevent 
misclassification of participants with very irregular exercise patterns into the “high activity” 
category. The data on time spent sitting was not used in this study. Of the participants with 
both IPAQ and PAL data, all those who declared a form of physical disability were explored 
to see whether the PAL task had been carried out prior to or following the disability onset. 
All those who underwent PAL before the onset of the disability, or underwent PAL less than 
a year following the disability’s onset were excluded as their physical activity levels would 
not be representative of their physical activity levels at the time of PAL. All those with a 
disability of unknown duration were also excluded from analysis. Only one physical activity 
measure per participant was available. Out of the 846 participants with eligible PAL and 
IPAQ data, 473 had undergone the task and IPAQ within a year of one another, 34 within 
1-3 years and 339 underwent the task and the IPAQ more than 3 years apart. 
 Genetic data 
Single Nucleotide Polymorphisms (SNP) array analysis is typically used for the interrogation 
of genetic loci to obtain an individual’s genotype. Oligonucelotide probes within the array 
hybridise with the fragmented DNA in the test sample and emit a fluorescent signal for 
each of the two alleles (e.g. allele A or allele B) at a given SNP. The signal abundance for 
each allele is then interpreted to identify the genotype as A, B or AB (i.e. homozygous for 
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A allele, homozygous for B allele or heterozygous). The signals emitted by the array are 
then normalised to a baseline to account for the overall brightness and to allow for 
comparisons between arrays, finally, several quality control (QC) steps carried out. 
 
In our study, we focused on the SNPs present in and around our 9 genes of interest (FoxO3, 
Sirt1, IGF2R, ABTB1, NAMPT, PTEN, UCP2, GRB10 and mTOR). Therefore, the genotype 
information for all SNPs within the gene boundaries and 300 kb up and downstream was 
requested. The UCSC Genome Reference GRCh37 (assembly date 2009) was used to design 
the coordinates matching our areas of interest. Table 32 shows the resulting coordinates 
for each of our genes of interest. 
 
Gene Coordinates 
FoxO3 chr6: 108881026 - 109005971 
Sirt1 chr10: 69644427 - 69678147 
Igf2r chr6: 160390131 - 160527583 
ABTB1 chr3: 127391781 - 127399769 
NAMPT chr7: 105888732 - 106225638 
PTEN chr10: 89623195 - 89728532 
UCP2 chr11: 73685716 - 73693889 
GRB10 chr7: 50657760 - 50861159 
mTOR chr1: 11166588 -11322608 
Table 32 - Table showing the gene coordinates for the genetic information request to TwinsUK.  The 
coordinates for each gene contain the gene as well as 300KB up and downstream of the gene boundaries. All 
SNPs within these coordinates were requested for this study. 
 
The genotyping was carried out by TwinsUK using a combination of Illumina arrays 
(HumanHap300, HumanHap610Q, 1M-Duo and 1.2MDuo 1M). The data for each array was 
normalised separately and then pooled. A visual inspection of 100 random shared SNPs 
across arrays was carried out to rule out any batch effects. Samples were excluded 
according to the following criteria: a sample call rate <98%, heterozygosity across all SNPs 
≥2 SD from the sample mean, evidence of non-European ancestry (assessed by principal 
component analysis with HapMap3 populations) and possibility of sample identity errors 
as informed by the identity by descent probabilities. TwinsUK also carried out QC to select 
which SNPs should be included in the final data. The exclusion criteria included a Hardy-
Weinberg p-value<10-6 (within unrelated individuals), a minor allele frequency (MAF) of 
<1% and a SNP call rate of <97% (SNPs with MAF ≥ 5%) or < 99% (for 1% ≤ MAF < 5%). 
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Upon receiving the data from TwinsUK, further QC was carried out. Due to our limited 
number of participants, MAF was restricted to 5% or more, and a minimum SNP call rate of 
95% within our subset was applied. The area surrounding the gene boundaries was also 
reduced from 300kb to 100kb up and downstream. Following this last step of QC there 
were 4315 eligible SNPs. The number of SNPs per gene is summarised in Table 33. 
 
Linkage disequilibrium (LD) was accounted for by creating tag SNPs with the Priority Pruner 
software. This software prunes SNPs by removing all those that are in LD with other SNPs 
in the dataset. As per convention, a SNPs with an r2 > 0.8 and within 250KB was determined 
to be in LD. Based on MAF, one of the SNPs in LD is retained and named a ‘tag SNPs’ while 
all other SNPs are pruned.  Following the creation of tag SNPs there were 482 eligible tag 
SNPs (see Table 33). 
 
Gene Raw SNPs Tag SNPs 
FoxO3 411 58 
Sirt1 377 18 
Igf2r 578 94 
ABTB1 328 41 
NAMPT 508 53 
PTEN 423 66 
UCP2 312 49 
GRB10 1033 90 
mTOR 345 13 
TOTAL 4315 482 
Table 33 - Pruning outcome.  Table showing the 9 candidate genes investigated in this study (Gene), the 
number of single nucleotide polymorphisms (SNPs) per gene before (Raw SNPs) and after (Tag SNPs) pruning. 
Pruning was carried out to account for linkage disequilibrium between nearby SNPs 
  
 Methylation data 
To assess whether DNA methylation of specific residues had an effect on PAL performance, 
DNA methylation intensity was requested. DNA methylation was measured using the 
Infinium HumanMethylation450 BeadChips and the results analysed in R. The signals were 
background corrected and those with a detection p value below 0.05 were set to missing. 
The BMIQ method (Teschendorff et al., 2013) was employed to carry out probe type 
correction and all probes with missing data were removed along with any probes mapping 
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to multiple locations of the genome. The resulting data were the methylation beta values, 
a measure of methylation intensity for a specific site, which can range from 0 to 1. 
 
Only 288 participants had available data on methylation intensity, therefore we restricted 
the analysis to only 1 candidate residue. However, as seen in Figure 52 only 73 participants 
had eligible PAL and methylation data, no analysis was carried out relating methylation 
intensity to cognitive performance. Instead, methylation intensity of the candidate residue 
and its association to lifestyle and age was investigated. 
 Descriptive statistics 
Due to the interdisciplinary nature of this study, combining genetics, cognition and lifestyle, 
the number of eligible participants varied greatly across the different analyses.  Figure 51 
and Figure 52 show the number of participants when each new variable is included in the 
analysis. There was a large reduction in eligible participants due to large quantities of 
missing data for each variable. Due to this, it was not possible to use the same participants 
in all the analyses. Separate descriptive analyses were thus carried out to describe the sub 
cohorts used in each analysis. 
 
Descriptive analysis of each of the sub cohorts is reported in Table 34.  For all sub cohorts 
including SNP data, descriptive analysis was carried out on the maximum number of people 
included in regressions involving SNP data. This number varied according to which SNP was 
being analysed due to the SNP call rate ranging from 95% to 100% (as explained in 5.2.6). 
The “PAL with no dementia” subgroup was used in the analysis investigating the effects of 
age on PAL score.  The “PAL, NART, SNPs” cohort was used in the analyses investigating the 
effects of SNPs on cognition. The “PAL, NART, SNPs, nutrition” and “PAL, NART, exercise” 
sub cohorts were used when investigating the interaction between SNP and lifestyle on 
cognition. The “methylation” sub cohort was used to assess whether methylation intensity 
of the ABTB1 methylation site cg03330058 varied with age. Finally, the “methylation, 
nutrition” and “methylation, exercise” sub cohorts were used to assess if there was an 
association between lifestyle and methylation of cg03330058. 
 




Figure 51 - Diagram showing the number of eligible participants with data for each variable combination in 
the study investigating Paired Associates Learning results (PAL), Single Nucleotide Polymorphisms (SNPs) 
and lifestyle (nutrition or exercise).  NART: National Adult Reading Scale. 
 
  




Figure 52 - Diagram showing the number of eligible participants with data for each variable combination 
when investigating ABTB1 residue cg03330058’s methylation intensity and its relation to Paired Associates 
Learning results (PAL), Single Nucleotide Polymorphisms (SNPs) and lifestyle (nutrition or exercise). NART: 
National Adult Reading Scale. 
 
  
Variables included and 
number of participants 
Females : males MZ : DZ 
Min age - Max age 
Mean (sd) 




55.11  14.9 




57.22  12.97 




57.77  12.73 
PAL, NART, SNPs, exercise 
(613) 
568:45 321:294 
22.52 – 91.82 




29.20 – 80.40 




29.20 – 80.90 




29.20 – 80.90 
56.74  8.11 
Table 34 - Descriptive statistics of cohort and subcohorts used in this chapter. Table showing the female to 
male ratio, Monozygotic (MZ) to Dizygotic (DZ) ratio and minimum, maximum and mean  sd age for each of 
the sub cohorts. Age in the last 3 rows is the participant’s age when the methylation array was carried out, in 
all other rows age equals to the participant’s age at PAL. 
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  General Estimating Equation model and statistics 
To account for relatedness within the cohort, Generalised Estimating Equations (GEE) were 
used instead of linear regressions. The R package “geepack” was used for all analysis 
(Halekoh et al., 2006). 
 
GEEs are a quasi-likelihood based statistical method that allow for clustering, they can be 
used to account for batch effects in large epidemiological studies, repeated measures 
within longitudinal studies or, as in this case, relatedness between individuals. In this study 
each twin pair, irrespective of zygosity, formed a cluster and their relatedness was 
therefore accounted for within the analysis. It is often debated whether monozygotic (MZ) 
twins should be treated differently owing to their identical genetic composition. One 
alternative is to use an average of the MZ twins’ data. As a form of sensitivity analysis, part 
of the analysis was therefore repeated using averages of MZ data rather than individual 
values.  
 
The assumptions when using GEE models include unrelated observations between clusters 
and adequately large sample size (usually around 50 clusters). There are no assumptions as 
to the normality of the data, though efficiency is improved when normally distributed data 
is used (Ghisletta and Spini, 2004). An exchangeable correlation structure was selected with 
the help of Quasi Information Criterion (QIC) and Correlation Information Criterion (CIC). 
The QIC is the quasi-likelihood counterpart of the Akaike information criterion. It is an 
estimator of the relative quality of a certain statistical model given the data it is based on. 
It is comprised of a trade-off between the goodness of fit of a model and a penalty for the 
model’s over-complexity. CIC is a modified version of the QIC which was shown to have 
substantially improved. Therefore, smaller QIC and CIC are indicative of a better-fitted 
correlation structure, which is essentially a measure of correlation between observations 
within clusters performance (Barnett et al., 2010; Gosho et al., 2011). For all analysis 
involving PAL, age at PAL, NART score and gender were included in the model as covariates. 
Benjamini-Hochberg multiple correction was applied at each stage of the analysis p and q 
values are reported. 




In this chapter, we aimed to investigate the effects of genetic polymorphisms and lifestyle 
habits on PAL performance in a healthy population. We focused (on the 9 candidate genes 
selected in the previous sections and on diet and physical activity as lifestyle measures. In 
addition, we assessed the epigenetic changes occurring in ABTB1 as a function of age.   
 Mini Mental State Examination as an exclusion criteria 
As a cognitively-healthy population was required for this study, MMSE results were used 
to exclude all participants with a known diagnosis of dementia. Dementia diagnosis was 
determined by an MMSE score of less than 27.   
 
To test whether dementia diagnosis affected PAL score, and thus whether it was indeed 
necessary to exclude those with MMSE < 27, Welch’s t-test was carried out to compare the 
mean PAL score of patients with and without a dementia diagnosis.  Welch’s t-test was 
chosen over the student’s t-test due to the different variance and sample size across 
groups. As seen in Figure 53, participants with an MMSE value below 27 made more 
mistakes (mean of 50.5) on the PAL task when compared to those with an MMSE score of 
27 or above (mean of 24.2); two-sample t(48.1)= 4.5, p = 4 x 10-5. All participants with 
MMSE scores below 27 were excluded from following analyses. 
 
 




Figure 53 - Effect of Mini Mental State Examination (MMSE) score on Paired associates Learning (PAL) 
performance. Graph showing the mean errors made in PAL by participants with a MMSE score higher than or 
equal to 27 (No dementia) and those with an MMSE score lower than 27 (diagnosis).  
 
 Covariate selection; effect of age, education and gender on PAL 
As PAL performance is known to be dependent on age, age was tested for correlation with 
PAL score within our cohort. Firstly, the frequency distribution plot for PAL values alone 
and for the resulting residuals showed a positive skew (Figure 54 panel 1 A and F 
respectively). In line with this, the residual vs fitted value plot did not show a random 
distribution around the residual value of 0 but instead showed a propensity for larger PAL 
values to have greater residuals also suggesting a non-normal distribution (Figure 54 panel 
1 B). In addition, the Q-Q plot did not result in a straight line suggesting different 
distributions between PAL and age values (Figure 54 panel 1 C). Furthermore, the scale-
location plots used to see whether residuals were spread equally along the range of the 
predictor did not show a horizontal trend, this suggested that the assumption of equal 
variance was not met (Figure 54 panel 1 D). Finally, residuals vs leverage plots were used 
to identify any influential outliers and 3 data points were identified, these however did not 
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exceed Cook’s distance, meaning they were unlikely to be influential to regression results 
(Figure 54 panel 1 E). 
 As the plots showed the data violated linear regression assumptions, a logarithmic 
transformation (Loge(PAL score +1)) was applied onto the PAL values. The resulting 
frequency distribution plots of both the PAL values and the residual now followed a normal 
distribution as did the residual vs fitted value plot (Figure 54 panel 2 A, F and B 
respecitvely). A straight line resulted from the Q-Q plot and a horizontal line with mostly 
equally spread values resulted from the scale-location plot (Figure 54 panel 2 C and D). 
Finally, the residuals vs leverage plot showed 2 possible outliers, though as before, they did 
not exceed Cook’s distance (Figure 54 panel 2 E). The logarithmic+1 transformation was 
therefore selected. For the remainder of this study, the reported PAL errors will be the 
transformed values.  
 




Figure 54 - Plots used to determine whether the data was normally distributed. Panel 1: Plots resulting from 
untransformed data. Panel 2: plots resulting from Log(PAL score +1) transformation. (A) Frequency plot of 
PAL values. (B) Residual vs fitted plot (C) Quantile-Quantile (Q-Q) plot. (D) Scale-location plot (E) residual vs 
leverage plot and (F) Frequency plot of the residuals of the correlation between Paired Associates Learning 
(PAL) and age. 
 5. Impact of Lifestyle and Genetics on Cognition: An Epidemiological Study 
192 
 
Figure 55 shows the distribution of the data in a scatterplot showing the correlation 
between PAL and age before and after the transformation.  A moderate correlation 
(Pearson’s, r =0.50, p < 0.00001) was observed between age and PAL score. Age was 
therefore selected as a covariate for the models outlined in this chapter. 
 
 
Figure 55 -Logarithmic transformation of Paired Associates Learning (PAL) variable. Graphs showing PAL 
errors against age in years before (left) and after logarithmic transformation (right). Each dot represents a 
participant. 
 PAL scores were also tested for correlation with education and gender to assess whether 
these would bias further analyses. PAL showed a weak but significant negative correlation 
with education (Spearman’s, r = -0.29, p < 0.00001), suggesting higher education leads to 
better performance on the PAL task.  As explained in section 5.2.4, NART data was available 
and was much completer and more accurate than the education data and was therefore 
tested for use as a proxy of education. As for education, NART showed a weak but 
significant correlation with PAL (Pearson’s, r = 0.10, p < 0.00001), suggesting worse 
performance on the NART task correlates with worse performance on PAL.  NART and 
education showed a moderate and significant negative correlation. (Spearman’s, r= -0.43, 
p < 0.00001) suggesting higher education leads to better performance on the NART task. 
Following these comparisons, NART was selected as an important covariate for all models 
involving PAL. The effect of gender on PAL was tested via Welch’s t-test and showed a non-
significant (p = 0.1) increase of 2.3% in PAL errors in the male subgroup compared to the 
female subgroup. Due to the limited number of male participants within our cohort 
1879:226 (F:M) and the varying number of participants in each model, gender was included 
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as a covariate to account for the possibility of an undetected effect of gender. The above 
correlations and t-test are displayed in Figure 56.  
 
 
Figure 56 - Effect of education, National Adult Reading Test score (NART) and gender on Paired Associates 
Learning (PAL) performance. Graphs showing boxplots of the correlation and t-test carried out to assess the 
association of education, NART score and gender on PAL and the association between NART and education. 
The graph titled Education shows the negative correlation between PAL and level of education (higher 
education displayed by higher numbers, see methods for details). NART and PAL shows the positive 
correlation between PAL errors and NART, NART score was split into bins for ease of visualization due to the 
large number of data points. NART and Education shows the negative correlation between NART score and 
level of education. Gender shows the mean and distribution of PAL errors in females (F) and males (M). Each 
dot represents a participant. Data treated as continuous but graphed as categorical for ease of visualization 
As lifestyle is known to change with age, associations between age and lifestyle were 
assessed. Interestingly, in this cohort age was not associated with calorie consumption (r 
=0.005, p = 0.8) or physical activity levels (r = 0.016, p= 0.6) as shown by Pearson’s and 
Spearman’s correlations respectively. Age showed a very weak but significant positive 
correlation with healthy eating (r = 0.08, p = 0.002) following the Pearson’s correlation test. 
Though this suggests older participants ate more healthily, the very low r value suggests 
this association may be an artefact. 
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 Association of cognition to lifestyle 
The first hypothesis tested in this study was whether diet and physical activity can affect 
PAL score, irrespective of genotype (aim 1 in section 5.1.4). Firstly, correlations were 
carried out and residuals were inspected for normality, heteroscedasticity and for the 
presence of outliers via visual inspection of frequency distribution, residual vs fitted, 
quantile-quantile (Q-Q), scale-location and residual vs leverage plots as described in section 
5.3.2, the plots showed the data did not require transformations (see appendix section 
8.4.2.1 for plots). 
 
GEE models were used to account for the relatedness of the individuals as explained in 
5.2.9. No significant associations were seen between healthy eating and PAL, calorie intake 
and PAL or physical activity and PAL, suggesting dietary or exercise habits alone are not 
predictive of PAL score. This is shown by the scatterplot and box plots in Figure 57. All 
variables were used as continuous values. Interestingly however, there was a significant 
interaction between physical activity and calorie intake (β = -0.0002, p = 0.0037), suggesting 
a different association between calorie intake on PAL according to the participant’s exercise 
level. This interaction is shown in Figure 57E where the intersecting lines show different 
slopes according to varying levels of activity. This result shows that for participants with 
low IPAQ, each Kcal consumed is predictive of a 0.0002 increase in PAL errors. For 
participants with moderate IPAQ levels, each Kcal consumed is predictive of a 0.00001 
decrease in PAL errors. Finally, participants with high IPAQ levels show a decrease of 0.0002 
PAL errors for each Kcal consumed. The interaction value, used in to calculate these slopes, 
is reported in Table 35. Following visual inspection of the scatterplot however, possible 
outliers were identified. As a form of sensitivity analysis, the interquartile range was used 
to set lower and upper limits to the Kcal variable. This excluded participants with calorie 
consumption greater than 3426, when the analysis was carried out on this new subset of 
participants the interaction effect was no longer significant (p = 0.07) but remained in the 
same direction. 
 
There was no significant interaction between physical activity and healthy eating Figure 
57D). The adjusted p values were obtained by carrying out Benjamini-Hochberg correction 
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to account for the 5 comparisons carried out in this analysis. See Table 35 for beta 
coefficients, confidence intervals, p and q values and number of people in each linear 
model. The final two rows report the interaction values rather than marginal values. 
 
 
Figure 57 - Lifestyle effects on Paired Associates Learning (PAL) performance. Scatter plots showing the 
absence of significant association between PAL errors and (A) healthy eating and (B) calorie intake. (C) Boxplot 
showing no association between varying levels of physical activity and PAL performance. (D) Scatterplots 
showing there is no interaction between physical activity and healthy eating on PAL performance while (E) 
shows increased calorie intake is associated to better PAL performance in the subgroup of participants who 
are highly active (blue line) but not in the subgroups of participants with low and moderate exercise (orange 
and green lines respectively).In A,B,C each dot represents a participant. In D and E dots represent participants 
with low physical activity levels, triangles those with moderate activity levels and squares those with high 










PAL ~ β coefficient L95 U95 p value n q value 
HEI 0.0004 -0.004 0.005 0.87 1165 0.87 
KCAL 0.00005 -0.00003 0.0001 0.21 1165 0.52 
IPAQ 0.03 -0.06 0.005 0.56 613 0.87 
IPAQ*HEI -0.002 -0.02 0.013 0.81 605 0.87 
IPAQ *KCAL -0.0002 -0.0004 -0.00001 0.0037 605 0.018 
Table 35 - Table showing the results of the linear models assessing the association between lifestyle and 
Paired Associates Learning (PAL) performance.  β coefficient, lower (L95) and upper (U95) confidence 
intervals, unadjusted p value, number of people (n) and adjusted p value (q value) following Benjamini-
Hochberg correction in each analysis. The first column reports which independent variable is tested for 
association with PAL errors: healthy eating index (HEI), calorie intake (Kcal), physical activity (IPAQ). The last 
two rows report the effect of the interaction between physical activity and healthy index (IPAQ*HEI) and 
between physical activity and calorie intake (IPAQ*Kcal) on PAL errors. Significant results in bold. “ * ” denotes 
interaction,  “ ~ ” denotes correlation 
 Identifying tagging SNPs to account for linkage disequilibrium 
Next, we investigated how genotype might affect PAL performance. To account for LD the 
Priority Pruner software was used to prune SNPs as explained in section 5.2.6. See appendix 
section 8.4.2.2 for a file containing all tagging and tagged genes. 
 
To visualize the results of the SNP selection process, Locus Zoom plots were created. For 
each of the 9 candidate genes, a Locus Zoom plot was created before pruning and one after 
pruning, all 18 graphs are displayed below (Figure 59  to Figure 66). The graphs titled raw 
SNPs are locus zoom plots of SNPs prior to pruning while those titled raw SNPs display SNPs 
after pruning. In each graph, the left y-axis shows the -log10 of the unadjusted p value 
obtained from the linear model testing the SNP for association to PAL score (as outlined in 
section 5.2.9). Dots closer to 0 represent least significant SNPs. A larger r2 is indicative of a 
stronger disequilibrium. The right y-axis shows the recombination rate displayed on the 
graphs by the blue line whose peaks represent areas of the genome with higher-than-
normal recombination rates. As can be seen in the ABTB1 graph prior to pruning, a high 
recombination rate essentially stops any LD past that point. As seen in the graphs below 
some of the SNPs in the tag SNP graph are in mild LD with each other but, as the r2 = 0.8 
cut-off was used, none of the remaining SNPs after pruning are in LD stronger than r2 =0.8.  
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Of note, in the graphs below are the high number of SNPs in ABTB1 and FOXO3 that were 
significantly associated to PAL errors as well as the absence of significant SNPs in mTOR. 
Furthermore, GRB10 showed near to no significant associations (except for rs189209677 
which showed some association) despite the high density of SNPs. SNPs in IGF2R NAMPT, 
PTEN and UCP2 showed little to no association to PAL errors. Interestingly, the SIRT1 graph 
showed only one SNP (rs497849) to be significantly associated to PAL errors. 
As the study was designed to include all SNPs within 100kb of the gene boundaries of each 
candidate gene, sometimes SNPs of interest appeared to overlap with other genes. This is 
seen clearly in the ABTB1 locus zoom where many significant SNPs are found within the 
MCM2 coding region and in the UCP2 locus zoom plot where some of the few significant 
SNPs appear to be in the coding region of the PAAF1 gene.  
  




Figure 58 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in ABTB1 Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner.  




Figure 59 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in SIRT1 Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 60 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in NAMPT Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 61 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in IGF2R Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 62 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in PTEN Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 63 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in FOXO3 Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 64 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in UCP2 Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 65 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in mTOR Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 




Figure 66 - Locus zoom plot of single nucleotide polymorphisms (SNPs) in GRB10 Locus zoom plots showing 
the p-values (on the left y-axis) of the association between each SNP (shown as a dot) to performance in the 
paired associates learning (PAL) task. Peaks in the recombination rate of DNA (right y-axis) are shown by the 
blue line. Peaks mean higher recombination rate and therefore lower linkage disequilibrium. The top plot 
shows the locus zoom plot of all SNPs within 100KBb up and downstream of the gene boundaries, the bottom 
graph shows only a selection of these that survived pruning to account for linkage disequilibrium. For ease of 
visualization, the most significant SNP is highlighted in purple and its RS number is reported on the graph, the 
adjacent SNPs are then colour coded to show the degree of linkage disequilibrium to that SNP as show by the 
legend in the top right corner. 
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 SNPs in the proximity of Sirt1 and ABTB1 are associated to higher PAL errors 
GEE linear models were used to investigate whether SNPs in the 9 candidate genes were 
associated to PAL errors. The 482 tag SNPs selected in the previous section were used and 
individual linear models were carried out for each SNP. As explained in section 5.2.9, each 
linear model included clusters to account for twin pairing and included age, gender and 
NART score as covariates owing to their effects on PAL performance as discussed in section 
5.3.2.The results were then corrected for multiple testing (482 comparisons) using the 
Benjamini-Hochberg correction. Table 36 reports the 5 most significantly associated SNPs 
to PAL errors along with the corresponding beta coefficients, confidence intervals, p and q 




SNP Tagged SNPs 
β 
coefficient 

































Table 36 - Results of the linear models testing SNPs for association to Paired Associates Learning errors. β 
coefficient, lower (L95) and upper (U95) confidence intervals, unadjusted p value, number of people (n) and 
adjusted p value (q value) following Benjamini-Hochberg correction are reported for each model. The 
candidate gene closest to the  single nucleotide polymorphism (SNP) being tested is reported in brackets in 
the first column. Tagged SNPs refer to the SNPs tagged by the SNP reported in the first column. 
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The association between SNPs rs497849 (a SNP in the proximity of SIRT1) and rs782431 (a 
SNP in the proximity of ABTB1) with PAL errors survived multiple testing correction, these 
graphical representations of these associations are shown in Figure 67. No other SNPs were 
in LD with rs497849 but 3 SNPs were in LD with rs782431: rs2630213, rs2720262 and 
rs782455, making them interesting candidates for effects on PAL. Of note, is the presence 
of a further 2 tag SNPs (rs6439080 and rs782448) related to ABTB1 appearing in the top 5 





Figure 67 - Paired associates learning (PAL) task errors and genotype. Boxplots showing the association 
between rs497849 (left) and rs782431 (right) genotype with PAL errors. Genotypes are displayed as 0: 
homozygous for the major allele (orange), 1: heterozygous (green) and 2: homozygous for the minor allele 
(blue). Each dot represents a participant.   
 
As the correct way to include MZ twins in epidemiological studies is often debated, 
sensitivity analysis was carried to see if different methods affected the results. The two 
other methods tested involved either averaging the MZ twins to form a single data point 
or including only one of the two MZ twins. These methods identified similar SNPs as when 
the analysis was carried out by using the chosen method detailed in section 5.2.9, which 
accounts for relatedness in MZ and DZ by using clusters within the GEE model. See appendix 
section 8.4.2.4 for the 5 most significant SNPs resulting from the other two methods.  
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 Physical activity levels are differentially associated to PAL performance 
according to SIRT1 genotype.  
The following analysis was carried out to investigate whether genotype affected the 
association between lifestyle habits and PAL errors. To do this, linear models testing the 
association between calorie intake, healthy eating and physical activity with PAL errors 
were carried out but the interaction with genotype was added into each model as well as 
the usual covariates (age, gender and NART score). All variables were continuous. 
There were no significant interactions between genotype and healthy eating or genotype 
and calorie intake (see appendix section 8.4.2.5). However, physical activity levels showed 
significant interactions with rs10997817 (a SNP in the proximity of SIRT1) genotype (β= 
0.30, p =0.0001), suggesting physical activity level may affect PAL performance differently 
according to genotype.  
 
This result shows that for participants who are homozygous for the major allele (genotype 
0), an increase in physical activity is predictive of a decrease of 0.054 in PAL errors. For 
those who are heterozygous (genotype 1) instead, increasing physical activity units were 
predictive of an average increase of 0.3 PAL errors. In contrast, participants who are 
homozygous for the minor allele (genotype 2) showed a large increase in PAL errors (0.56) 
with increased exercise. It is important to keep in mind that rs10997817 tags rs12220640 
and rs77797709, meaning any of these 3 SNPs could be responsible for the interaction with 
physical activity.  
 
The interaction coefficients of the 5 SNPS with the most significant interactions between 
physical activity and genotype are reported in Table 37 along with the confidence intervals, 
p and q values and number of people for each interaction. As before, Benjamini-Hochberg 
correction was used to create the q values (482 comparisons).  Though only one SNP 
















128+ 0.22 0.03 0.41 0.0007 613 0.171 
rs10997810 
(SIRT1) 
8+ 0.29 0.03 0.55 0.001 605 0.224 
rs4457643 
(SIRT1) 
43+ 0.39 -0.05 0.79 0.002 607 0.261 
rs6593185 
(GRB10) 
rs62447566 -0.19 -0.38 0.01 0.005 613 0.346 
Table 37 -  Results of linear models testing the interaction of genotype and physical activity levels on the 
association between physical activity and Paired Associates Learning task. β coefficient, lower (L95) and 
upper (U95) confidence intervals, unadjusted p value, number of people (n) and adjusted p value (q value) 
following Benjamini-Hochberg correction for each model are reported. The candidate gene closest to the SNP 
being tested is reported in brackets in the first column. Tagged SNPs refer to the SNPs tagged by the SNP 
reported in the first column, due to the high levels of LD in the SIRT genes, we do not report all tagged SNPS. 
See appendix section 8.4.2.2 for these SNPs.  
 
Interestingly, the rs10997817 SNP showed no association with PAL performance when 
physical activity was excluded from the model (see Table 38), suggesting any association is 
dependent on the interaction between physical activity and genotype. The graphical 
representation of these comparisons in shown in Figure 68. 
 
 Table 38 - Results of the linear model testing the association between rs10997817 and Paired Associates 
Learning (PAL) task .  β coefficient, lower (L95) and upper (U95) confidence intervals, unadjusted p value, 
number of people (n) and adjusted p value (q value) following Benjamini-Hochberg correction are reported. 
“ ~ ” denotes test for association.   
 
PAL ~ genotype β coefficient L95 U95 p value n q value 
rs10997817 
(SIRT1) 
-0.08 -0.18 0.03 0.15 1286 0.773 




Figure 68 - Interaction between physical activity (IPAQ) and genotype on Paired Associates Learning (PAL) 
errors   Left: Graph showing the effect of genotype on the association between physical activity (IPAQ on the 
x-axis) and PAL errors (y-axis). Right: Boxplot showing the lack of association between RS10997817 genotype 
with PAL errors. Genotypes are displayed as 0: homozygous for the major allele (orange), 1: heterozygous 
(green) and 2: homozygous for the minor allele (blue). Each dot represents a participant.  Data was analysed 
as categorical but represented as continuous for ease of visualization. 
 
 Effects of age and lifestyle on methylation status 
As both aging and lifestyle are likely to affect epigenetics, changes in methylation were also 
investigated. Due to the limited number of participants with available methylation data (n 
=288) however, the study was limited to assessing the methylation status of the 
cg03330058 residue. Assessing the methylation status of all sites in all 9 candidate genes, 
would have caused a loss of power due to a large number of multiple comparisons and only 
a small number of participants. Therefore, we approached a candidate approach and only 
investigated the cg03330058 in the ABTB1 gene which was previously highlighted by 
Horvath’s clock (Horvath, 2013). 
 
First, the methylation status of the residue was tested for association to gender. A Welch’s 
two sample t-test showed a significant (t(4)= 5, p = 0.007) increase of 4.4% in methylation 
status of cg03330058 in males compared to females. However only 4 of 2888 patients were 
male making this result unreliable. Next, methylation status was tested for association to 
age with a GEE linear model. Clusters were used to control for the relatedness of the 
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participants and gender was included as a covariate.  This showed a narrowly non-
significant (p= 0.067) negative association between cg03330058 methylation and age, 
suggesting that in a larger sample, methylation at this residue may be decreased in older 
people (see Table 39). Graphs showing the correlation between age and methylation 
intensity of cg03330058 and the difference in methylation intensity of cg03330058 in male 
and female participants are shown in Figure 69. 
 Table 39 Results of the linear model testing the association between methylation of the cg03330058 
residue and age β coefficient, lower (L95) and upper (U95) confidence intervals, unadjusted p value, number 
of people (n) and adjusted p value (q value) following Benjamini-Hochberg correction are reported. “ ~ ” test 
for association.   
 
 
Figure 69 -Impact of age and gender on cg03330058 methylation.  Scatter plot showing the correlation (p= 
0.067) between age (x-axis) and methylation intensity of the cg03330058 residue (y-axis). Box plot showing 
the mean and the distribution of the methylation intensity of values of the cg03330058 residue in male (M) 
and female (F) participants.  
  
To assess whether lifestyle affected methylation status, healthy eating, physical activity and 
calorie intake were regressed against methylation intensity. Age and gender were included 
as covariates and relatedness was controlled by clustering. This showed no association 
between any of the lifestyle measures and methylation intensity except for a possible weak 
association between healthy eating and methylation status. This association however, did 
 β coefficient L95 U95 p value n 
Methylation ~ Age -0.0009 -0.002 0.000006 0.0671 288 
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not survive multiple testing correction. See Table 40 for beta coefficients, confidence 
intervals, p and q values and number of people in each linear model. Graphical 
representations of these correlations are shown in Figure 70. 
 
Methylation ~ β coefficient L95 U95 p value n q value 
HEI -0.0005 -0.001 -0.00003 0.0385 267 0.116 
Kcal -0.0000008 -0.00001 0.000008 0.85 267 0.852 
IPAQ -0.007 -0.016 0.002 0.1264 146 0.190 
Table 40 - Results of the analysis testing the association between methylation and healthy eating (HEI), 
methylation and calorie intake (Kcal) and methylation and physical activity and methylation status (IPAQ). 
Reported are the β coefficient, lower (L95) and upper (U95) confidence intervals, unadjusted p value, number 
of people (n) and adjusted p value (q value) following Benjamini-Hochberg correction for each linear model. 
“ ~ ” denotes correlation.  
 
Figure 70 - Lifestyle effects on methylation. Scatterplots showing the association between healthy eating 
(HEI) and calorie intake (Kcal) with methylation intensity of the cg03330058 residue. Boxplot showing the 
association between varying levels of physical activity (IPAQ) and methylation intensity of cg03330058 
residue. In all graphs methylation intensity is on the y-axis.  
Due to the limited number of participants, there was a lack of power to carry out analyses 
testing the association between methylation status and cognition (n=64) or methylation 
and lifestyle (n=25). Data not shown.  
  




The data outlined in this chapter shows that while there is no significant effect on PAL 
performance of diet or exercise individually, an interaction of these two factors does 
impact PAL performance. In addition, this study reports interesting associations between 
genotype and hippocampal cognition and suggests possible epigenetic alterations as a 
function of age. 
 Preliminary data: Impact of dementia diagnosis on Paired Associates Learning 
performance 
This study aimed to assess the association between lifestyle, genetic and epigenetic factors 
to cognition in a healthy population. To ensure this cohort only contained healthy 
participants a selection based on MMSE score was explored. To validate this decision and 
to assess whether MMSE score affected PAL performance, a preliminary study comparing 
participants with or without a MMSE-based dementia diagnosis was carried out. 
 
We report worse performance on the PAL task by participants with a score lower than 27 
on the MMSE. A cut-off of 27 was selected, over the more lenient and sometimes-used cut-
off of 24, as TwinsUK is recruited as a healthy cohort and is formed largely by highly 
educated individuals. Therefore scores below 27 in the absence of dementia are not 
expected within this cohort (Kukull et al., 1994; O’Bryant et al., 2008). Our data suggests 
the possible presence of dementia (MMSE<27) negatively impacts PAL performance. This 
finding was not unexpected as associations between PAL performance and MMSE score 
have been reported before and as a decline in cognitive ability is likely to present itself as 
poorer performance in both the MMSE and the PAL task (Ito et al., 2010). It was interesting 
however, to witness this association in a healthy cohort.  
 
The effectiveness of MMSE as a diagnostic tool and correct cut-off is often debated as is 
the effect of age, education and IQ on MMSE score (Butler et al., 1996; Dykiert et al., 2016; 
O’Bryant et al., 2008). Due to the exclusion of all participants with definite dementia 
diagnosis from the TwinsUK cohort however, this cohort was not appropriate to study 
these effects or the impact of MMSE score on PAL performance (Moayyeri et al., 2013). 
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Regardless, it is interesting to note that the maximum errors were not higher in the 
subgroup of participants with possible dementia (Maximum PAL errors =130) than in those 
with no dementia (Maximum PAL errors = 138), suggesting it was not outliers causing the 
mean of PAL errors to increase in this subgroup but an overall increase in PAL errors 
throughout participants.  
 
Following this result, MMSE score was used to ensure a healthy population and to take into 
account any imminent dementia diagnoses. Though we believe this to be necessary to 
ensure no undiagnosed patients biased the data, it is possible this cut-off caused some 
older but healthy participants with borderline scores such as 26 to be mistakenly excluded. 
 Demographics effects on cognition: focus on age, education and gender 
The data reported in this section shows a clear correlation between PAL performance and 
age. As PAL relies on episodic memory (Barnett et al., 2015) and episodic memory is known 
to decline with age (Friedman, 2013), this finding is in line with the existing literature and 
previous studies within this cohort (Barnett et al., 2015; Lee et al., 2013; Steves et al., 2013). 
CANTAB reports a steady performance until the 5th decade when participants start showing 
deterioration this trend is also reflected in our data as is the considerable interindividual 
variation in the extent of deterioration (Barnett et al., 2015). Part of this variation is likely 
to be explained by other confounding factors such as level of education, gender, lifestyle 
and genotype. Interestingly, the finding that PAL performance, which is highly dependent 
on hippocampal function, worsens with age is suggestive of a possible involvement of 
neurogenesis, which is also known to be strongly affected by age (Mathews et al., 2017). 
 
To explain some of the interindividual variability, we assessed the effect of education on 
PAL performance; our results show increased education being associated to better 
performance. Though PAL is sometimes regarded as not being dependent on education, 
due to the use of pictures rather than words, several studies are now reporting an 
association between PAL performance and education, with more highly educated people 
making less errors (Blackwell et al., 2010; Lee et al., 2013). This was also supported by 
Bento-Torres and colleagues who found a similar association in a Brazilian cohort and 
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suggested early schooling as a preventative measure to fight age-related cognitive decline 
(Bento-Torres et al., 2017). This association is usually attributed to the cognitive reserve 
effect; people with higher IQs, education or participation in leisure activities show less 
severe signs of cognitive decline (both age and pathology related) despite the biological 
and histological deterioration of the brain. Cognitive reserve therefore refers to the ability 
of the individual to have a more flexible use of their cognitive resources allowing for better 
performance on tasks and a slower decline (Tucker and Stern, 2011). Knight and colleagues 
however, discuss that it may not be schooling itself that improves performance but rather 
that, people with lower cognitive abilities tend to collectively attain fewer educational 
qualifications, which might explain why higher educational levels appear to be associated 
to PAL performance (Knight et al., 2010). Another factor to take into account is that as the 
CANTAB PAL© is delivered on a touch screen, more educated people as well as younger 
people and those from higher socioeconomic background might have an advantage as they 
may be more accustomed to using such devices in their daily lives. The interaction between 
all these factors may contribute to the apparent effect of education on PAL.  
 
We also report an association between NART and PAL performance and a strong 
association between NART and educational level.  NART is usually used as a measure of 
intelligence but, as it relies on the participants reading irregular words, it is often associated 
to their educational levels (Kiely et al., 2011).  Some studies however, have shown NART 
levels to remain unchanged from the age of 11 suggesting an effect irrespective of 
education (Suzanne Barker-Collo et al., 2008). In this case the relationship seen here 
between NART and education further supports Knight’s notion that it may simply be the 
same participants, those with higher intelligence and therefore better NART scores, who 
perform better on PAL and opt for higher levels of education as opposed to an active effect 
of education level. 
 
Finally, we report a non-significant trend of increased errors in the male subgroup 
compared to the female subgroup. This is in line with others finding female participants 
tend to have better performances on PAL compared to their male counterparts, though the 
reason behind this remains unknown (Blackwell et al., 2010). Due to the much larger 
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proportion of females compared to males within our cohort, it is difficult to discern 
whether this trend is a true effect or an artefact due to the small amount of variation in the 
male subgroup. 
 Lifestyle effects on cognition 
This study aimed to assess the effect of lifestyle factors such as diet and exercise on 
cognitive performance. Our findings suggest no association between healthy eating and 
PAL performance. Though we hypothesised healthy eating impacted PAL performance, this 
result is supported by  Tangney and colleagues who also failed to see an association 
between HEI and cognitive performance in individuals aged over 65 (Tangney et al., 2011). 
The authors did see an association between better adherence to the Mediterranean diet 
and slower cognitive decline, suggesting there was an effect of diet on cognition which was 
not detected by HEI. This is also further supported by studies using the recommended food 
score as a measure of diet quality reporting participants with the best diet qualities 
undergoing slower age-related cognitive decline (Wengreen et al., 2009).  
 
 In contrast, a more recent study showed positive associations to cognitive performance 
for both Mediterranean diet scores and HEI. The authors attributed the different results to 
a more comprehensive FFQ food list and a younger cohort (Ye et al., 2013). Our study 
however, is based on an even more comprehensive food list (290 foods vs 264) and wider 
age range, suggesting further reasons for this discrepancy may exist. Part of the 
discrepancy may be attributable to the different cognitive tests being used. No previous 
studies, including the two mentioned above, have focussed on the effect of HEI on 
hippocampal-dependent tasks, making our result a novel finding in the field. The 
hippocampus however was recently implicated by an interesting study showing an 
association between hippocampal volume and long-term high HEI (Akbaraly et al., 2018). 
Whether this would also relate to hippocampal-dependent tasks remains to be validated 
and would be an interesting addition to our study. The lack of association between HEI and 
PAL may indicate that HEI does not affect hippocampal-dependent tasks and that different 
diet measures may be more appropriate. For example, the Mediterranean diet has been 
robustly associated to slower cognitive decline making it a good candidate to study age-
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related cognition (Féart et al., 2010; Scarmeas et al., 2009; Tangney et al., 2011; Valls-
Pedret et al., 2012; Ye et al., 2013). Furthermore, the high levels of polyphenol rich foods 
in the Mediterranean diet are suggestive of an important role for the hippocampus and 
neurogenesis in this association (Fernández-Fernández et al., 2012; Shukitt-Hale et al., 
2008; Valente et al., 2009; Valls-Pedret et al., 2012). 
 
Surprisingly we saw no association between calorie intake and PAL score, this is in contrast 
to animal literature showing a relationship between calorie restriction and cognitive 
function or longevity. As discussed in chapter 1, several animal models have shown 
decreased calories to extend lifespan and improve cognitive abilities (Halagappa et al., 
2007; Maalouf et al., 2009; Taormina and Mirisola, 2014). Recent experiments in rhesus 
monkeys suggested high translational potential for the benefits of calorie restriction in 
terms of longevity (Mattison et al., 2017). Interestingly, this group had previously failed to 
find significant associations between calorie restriction and longevity in rhesus monkeys. 
The authors suggested these results may be due to the standard lab diet already being 
healthier than normal, meaning calorie restriction did not cause considerable 
improvements (Mattison et al., 2012). These results highlight the importance of including 
other measures such as the HEI in dietary studies. 
 
Human studies have also shown an increase in the incidence of mild cognitive impairment 
in people with high caloric intake suggesting an important role for calorie intake in cognitive 
function (Geda et al., 2013). Interestingly, results from the CALERIE clinical trial have shown 
several age-related benefits for calorie restriction but have failed to show an association 
with cognitive performance (Martin et al., 2007; Redman et al., 2018). Both our data and 
that from the CALERIE trial however, support the absence of adverse effects of calorie 
restriction on cognition which has been suggested in previous studies (Green and Saenz, 
1995; Kemps and Tiggemann, 2005). To date, no studies have assessed the effect of calorie 
consumption on hippocampus-dependent tasks in a healthy population. 
 
The surprising lack of association between both HEI and calorie intake with PAL 
performance reported in this study may be explained by the noise introduced in the 
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analysis by the large time differences between PAL assessment and FFQs. However, it may 
also be reflective of the need to account for other lifestyle aspects such as exercise and 
social status (Partridge et al., 2018). To assess if different exercise habits affected these 
associations, we tested for interactions between physical activity and dietary measures. 
We report physical activity modulates the association between calorie consumption and 
PAL performance. Individuals who undergo low or moderate levels of physical activity show 
an increase in PAL errors with an increase in calorie consumption. For individuals with high 
physical activity levels instead, an increase in calorie consumption appears related to fewer 
PAL errors. This result shows low calorie intake is unfavourable in highly active individuals 
suggesting a mismatch between energy intake and energy expenditure may be detrimental. 
It is interesting to note how data from low and moderately active individuals instead, shows 
positive effect of reduced calorie intake on cognitive performance, as per the literature 
discussed above. The different associations between calorie consumption and cognitive 
performance according to exercise levels, show the importance of factoring in lifestyle as a 
whole in such analyses. These differences are likely attributable to more or less favourable 
overall metabolic states as discussed by Picard and Turnbull (Picard and Turnbull, 2013). 
Due to possible influential outliers within our data, it would be interesting to repeat this 
analysis in a different cohort to validate this finding. Finally, we report no interaction 
between physical activity levels and the association between HEI and PAL performance, 
supporting either the possibility of diet not affecting hippocampal-cognition or the notion 
that other dietary indices may be more appropriate. 
 
Interestingly we report no association between physical activity and PAL performance but 
show an interaction between exercise and diet. This result highlights the need to take into 
account all aspects of lifestyle and suggests this may be exceptionally important for 
hippocampus-related cognition (Lucassen et al., 2010). 
 
The lack of association between physical activity and PAL was surprising due to the ever-
increasing body of evidence showing a strong association between exercise and cognitive 
function (McNerney and Radvansky, 2015; Ngandu et al., 2015; Northey et al., 2018). The 
exact type of exercise and the pertaining mechanisms that are beneficial to human 
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cognition however have not yet been clarified (Kennedy et al., 2016; McNerney and 
Radvansky, 2015). Suggesting different types of exercise may have different outcomes on 
cognition. In addition, though animal studies suggest an important role for the 
hippocampus in exercise-associated cognitive benefits, no human study has focused 
specifically on hippocampal cognition but rather on related aspects such as depression and 
dementia onset (Blondell et al., 2014; Klempin et al., 2013; Schuch et al., 2018; van Praag 
et al., 2005). Our data suggests hippocampal cognition may not be as susceptible to 
exercise in humans as in animal models. Alternatively, it may be necessary to further 
subdivide the participants to distinguish those who are sedimentary from those with low 
levels of exercise and those with high exercise levels from those with excessively high 
exercise levels. Studies have in fact shown exercise benefits are already present in 
individuals with low to moderate exercise levels when compared to sedentary individuals 
(Sofi et al., 2011) and that extreme exercise ranges are associated to worse mental health 
(Chekroud et al., 2018). 
 SIRT1 and ABTB1 genotype effects on cognition 
Following the results highlighting the importance of lifestyle on cognition, we attempted 
to explain some of the remaining part of interindividual variation. We report a significant 
association between rs497849 genotype (a polymorphism in the proximity of the SIRT1 
gene) and PAL performance. Carriers of the minor allele “G” were more likely to perform 
worse on the PAL task than those carrying the major allele “T”. Accordingly, homozygous 
participants for this SNPs performed worse than those with a “TT” genotype but better 
than those with a “GG” genotype. This finding suggests an important role for SIRT1 in 
hippocampal cognition. As seen in Figure 59 however, this SNP is not located in the SIRT1 
coding region but further downstream closer to the HERC4 coding region in addition, the 
consequence of this mutation on SIRT1 one regulation remains unknown. Despite this, the 
rs497849 SNP is often used as a tag SNP in studies investigating SIRT1 as it is in strong LD 
with surrounding SNPs. Surprisingly and contrary to other studies, this SNP was not in LD 
with any other SNPs in our cohort. This may be due to the limited number of participants 
causing weaker r2 values which do not survive the LD threshold of r2 = 0.8. 
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Groups have reported associations between other SIRT1 polymorphisms and traits such as 
lung squamous cell carcinoma (Leng et al., 2013), body mass index (Zillikens et al., 2009), 
type 2 diabetes (Botden et al., 2012) and even cognitive performance (Kuningas et al., 
2007).  These links are supportive of a possible effect of SIRT1 on ageing, nutrition and 
cognition related phenotypes. Therefore, though no groups have reported direct 
associations of rs497849 to these specific traits before, our findings together with those 
mentioned above, support a promising role for SIRT1 in ageing.  
 
The other polymorphism with a significant association to PAL performance was rs782431 
which was included in our analysis due to its proximity to the ABTB1 gene. As above, the 
presence of the minor allele was predictive of increased errors in the PAL task. Accordingly, 
participants who were homozygous for the major allele showed lower PAL errors than their 
heterozygous and minor allele homozygous counterparts. This SNP was also in LD with three 
other SNPs (rs263021, rs2720262 and rs782455) suggesting any of these polymorphisms or 
combination could be affecting important molecular pathways relating to hippocampal 
cognition. The function of this gene, as discussed in chapter 3, remains largely unknown. It 
was however highlighted by unpublished work in our lab and Horvath’s clock as an 
important gene in ageing and as a possible new gene involved in insulin-sensitivity 
(Horvath, 2013; Miranda et al., 2014; Murphy et al., 2018). No studies have so far identified 
phenotypes associated to polymorphisms in this gene. Interestingly, the rs782431SNP 
appears to be within the MCM2 coding region. This finding is particularly interesting given 
MCM2’s function as DNA replication licensing factor and the use of MCM2 expression as a 
marker for slowly cycling NSCs in adult neurogenesis studies (Maslov et al., 2004; von 
Bohlen und Halbach, 2011). A polymorphism in this gene may therefore indicate alterations 
in NSC proliferation and NSC pool maintenance which would result in altered neurogenesis. 
Given the strong association between neurogenesis and hippocampus-dependent 
cognition, alterations in neurogenesis may be a possible explanation for the link seen 
between this SNP and PAL performance. Despite this, three of our top five most 
significantly associated SNPs were in proximity to ABTB1. This supports an important role 
for the gene in PAL performance rather than just an accidental proximity to the MCM2 
gene. As seen in Figure 71 in fact, the other SNPs are present further away from MCM2 
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with one (red dot in Figure 71) being within ABTB1’s coding region. As each of these SNPs 
tags several other SNPs (Table 36) it would be interesting to elucidate whether these 
effects are synergistic and by which mechanism ABTB1 affects cognition. 
  
 
Figure 71 - SNPs in the proximity of ABTB1. Diagram highlighting the location of three SNPs in proximity to 
ABTB1 that showed likely associations to PAL performance. The black line at the bottom indicates the 
chromosome position in megabases (Mb). The SNPs are shown as coloured dots and the genes coded for by 
each section of the chromosome are shown as coloured squares. Though all SNPs are within 100KB of ABTB1’s 
coding region, only rs782448 (red dot) is within ABTB1’s coding region, whilst rs782431 (purple dot) is within 
the MCM2 gene coding region and RS6439080 (green dot) is further upstream within TPRA1’s coding region. 
Each SNP shown also tags several other nearby SNPs.  
Surprisingly, though the locus-zoom plots (see Figure 63) showed some association 
between SNPs in the proximity of FOXO3A and PAL performance, none of the SNPs survived 
multiple correction. As FOXO3A-related polymorphisms are some of the few 
polymorphisms successfully associated to human longevity, we had expected to see 
associations to cognitive performance for these polymorphisms (Joshi et al., 2017; Nygaard 
et al., 2014; Willcox et al., 2008a). Previous studies however have reported that while 
FOXO3A genotype is predictive of improved longevity and healthspan it is not associated 
to an accompanying superior cognitive performance (Willcox et al., 2008a; Zeng et al., 
2015). Importantly, mTOR, a candidate gene in many ageing studies also showed no 
association to PAL performance suggesting it may not be involved in hippocampus 
dependent cognition (Harrison et al., 2009; Lamming et al., 2013). In line with this, several 
other candidate genes showed no association to cognitive performance despite previous 
studies reporting associations to other age-related declines. Indeed, genetic variations in 
mTOR and IGF2R have been associated to cancer (Xu et al. 2013; Shao et al. 2014; A. J. Yoon 
et al. 2012), those in GRB10 have been linked to increased risk of type II diabetes (Di Paola 
et al. 2010) and UCP2 polymorphisms have been correlated to physical ageing measures 
such as walking speed (Dato et al. 2014). As we employed an additive model to account for 
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the additive effect of the presence of the risk allele, it would be interesting to validate these 
findings by testing the association of haplotypes rather than individual SNPs.  
 Lifestyle and genotype interaction effects on cognition 
As existing literature and our previous findings highlighted the importance of lifestyle when 
assessing factors affecting cognition, we investigated the possibility of a modulatory effect 
of genotype on the association between lifestyle and cognitive performance. Our study 
failed to identify any polymorphisms that affected susceptibility of either calorie intake or 
healthy eating on cognitive performance. It however highlighted an interaction between 
rs10997817 and physical activity levels affecting the association of physical activity with 
cognitive performance. As expected, participants who were homozygous for the major 
allele appeared to make less mistakes on the PAL task if they exercised more supporting 
the positive association between cognitive performance and exercise found in several 
studies (Chekroud et al., 2018; Colcombe et al., 2003; Hogan et al., 2013). 
Surprisingly, those who were hetereozygous showed a minimal increase in PAL errors with 
increased exercise and those with the homozygous genotypes for the minor allele showed 
a strong increase in PAL errors with increased exercise. Besides Checkroud and colleagues 
finding an association between excessive exercise and poorer mental health, no other 
study has previously reported a negative effect of exercise on cognitive performance 
(Chekroud et al., 2018; Kennedy et al., 2016). To assess whether this was the case in our 
study, and whether participants with both risk alleles happened to undergo excessive 
amount of exercise and therefore have exceptionally detrimental outcomes on cognition, 
it would be interesting to repeat the study further subdividing the exercise categories to 
assess the effects of excessive exercise. Unfortunately, due to the low frequency of the 
minor allele larger cohorts are needed for such a study. Alternatively, this finding may 
simply highlight the importance of taking into account both genotype and lifestyle; the fact 
that most studies have highlighted a positive effect of exercise may be due to most 
participants having the major allele genotype. The minor allele may therefore be associated 
to poorer cognition but this association is usually harder to detect. 
 
In addition, the finding that the rs10997817 genotype is not on its own associated to PAL 
performance once again highlights the importance of a holistic approach to ageing 
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research.  Interestingly, other studies have selected SIRT1 polymorphisms to assess 
associations with longevity but have failed to find any links, our results suggest this may be 
due to factoring in aspects such as lifestyle (Flachsbart et al., 2005). One study however, 
found a significant association between rs10997870, a SNP in LD with rs866255, and 
suicidal behaviour in patients with bipolar syndrome, implicating the SIRT1 polymorphisms 
in mental health. The rs866255 polymorphism, was the SNP with the second most 
significant interaction with physical activity on PAL performance but did not survive 
multiple testing correction. It is also in LD with rs1467568 a SNP which was associated to 
BMI at baseline (Zillikens et al., 2009). If the association between rs866255 and PAL 
performance is not a false positive as FDR correction implies, this association combined 
with the findings above, suggests an important role for this area of SIRT1 in the interplay 
between genotype, cognition and lifestyle. Accordingly, as four of the five SNPs with most 
significant modulatory effects on the association between exercise and PAL performance 
are related to the SIRT1 gene, our findings support a role for this gene in this interplay. It is 
interesting to note that SIRT1 is known to have functions in energy metabolism in animal 
models making it a perfect candidate for convergent effects of both exercise and nutrition 
(Boily et al., 2008). Though dietary habits showed no interaction with SIRT1 genotype in 
our study, one could speculate that analyses assessing a three-way interaction between 
exercise, diet and genotype could identify interesting associations with respect to 
cognition. This analysis however, would require larger cohorts. 
 Lifestyle effects on ABTB1 methylation 
Following results highlighting an interesting role for in ABTB1 in hippocampal cognition, the 
methylation status of this gene was investigated. This gene and residue were selected due 
to exciting findings by the Horvath group highlighting this residue in the ABTB1 gene as one 
of the 353 methylation sites constituting the “Methylation clock”. The methylation clock is 
essentially a methylation signature that provides information on the biological, rather than 
chronological age of a tissue. Specifically, the cg03330058 residue in the ABTB1 gene has 
been highlighted, alongside other methylation sites, as undergoing a decrease in 
methylation intensity with age (Horvath, 2013). Therefore, we assessed the association of 
ABTB1 methylation, age and lifestyle within our cohort.  




We report a non-significant but interesting negative trend between cg03330058’s 
methylation intensity and age, this observation is line with Horvath’s clock data (Horvath, 
2013). Recently, in an effort to explain some of the heterogeneity of ageing, groups have 
focused on trying to distinguish what makes biological age differ from the chronological 
one. This has given rise to several human and animal methylation clocks aimed at 
understanding the methylation changes that occur in response to both chronological and 
biological age (Hannum et al., 2013; Levine et al., 2018). These are of great use in 
biogerontology research as they have strong correlations with both age of death, a 
measure of lifespan, and age-related disease onset and progression which can be used as 
a measure of healthspan (Horvath and Raj, 2018; Levine et al., 2018). Though our finding 
of a possible correlation between age and ABTB1 relates to those of Horvath’s, it is not 
supported by Hannum’s findings which do not highlight ABTB1 in the set of genes used to 
calculate the methylation clock (Hannum et al., 2013; Horvath, 2013).  
 
We also report an increase in methylation intensity in males compared to females, though 
this is based on only five male participants. This finding is not in line with previous findings 
by Horvath suggesting men tend to appear epigenetically older than their female 
counterparts. Horvath’s findings however, are based on the entire methylation clock and 
not exclusively on the cg03330058 residue like ours, suggesting there may be different 
gender effects on each residue. Regardless, given the very limited number of males and 
variation in the female subgroup, it is likely this result would change if more male 
participants were added to the analysis. 
 
We report no significant associations between lifestyle measures and methylation intensity 
of the cg03330058 residue besides a possible association with healthy eating, which does 
not survive multiple testing correction. Prior to Benjamini-Hochberg correction, our results 
show healthier eating is predictive of lower methylation intensity of the candidate residue. 
Should this finding to be confirmed, it would indicate an interesting association between 
healthier eating and an “epigenetically older” methylation status of this residue. As 
discussed in the chapter 1, diet is known to affect epigenetic status, however, to our 
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knowledge this is the first time it has been associated to methylation changes in the ABTB1 
gene. Interestingly, we did not see any associations with calorie consumption, suggesting 
the diet’s effects are likely due to specific, healthier nutrients being consumed rather than 
an effect of calorie reduction. To further understand and confirm this association, it would 
be interesting to look at the specific nutrients consumed by participants with varying 
amount of methylation intensities. In addition, for this to be relevant at an organismal level, 
it would be necessary to test if the association between healthy eating and methylation 
status is still present when all 353 CpG sites that form Horvath’s clock are taken into 
account. 
 
There was no correlation between physical activity levels and methylation status of the 
candidate residue, suggesting the reported effects of physical activity on epigenetics may 
act on other residues or on the overall methylation status rather than individual residues. 
Interestingly, the same study that reported an effect of physical activity on methylation, 
also reported an association with cognitive health (Marioni et al., 2015). Supporting this, 
studies have confirmed the validity of the methylation clocks in terms of cognitive ageing, 
finding associations between methylation status and the number of neurons, Alzheimer’s 
disease and neuropathology such as amyloid plaques (Horvath and Raj, 2018; Levine et al., 
2015; Lu et al., 2017).  Unfortunately, due to limited power in our cohort we were not able 
to test the association between methylation and cognitive performance, we believe this to 
be an interesting and necessary next step for this analysis. Alongside this, it would be 
interesting to test whether genotype is correlated to methylation status as studies are 
suggesting accelerated epigenetic ageing has hereditary components. Finally, testing the 
interaction between lifestyle, genotype and methylation status on cognitive performance 
would provide interesting answers within ageing research the ageing phenotype is likely a 
combination of all these factors.  
 
Though this study was limited by power, elucidating the effects of lifestyle on methylation 
status and the association between methylation and cognitive ageing is an interesting 
avenue. Epigenetic clocks have been suggested as useful tools in ageing research and age-
related healthcare as they can efficiently detect phenotypic age with minimal invasion 
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(Levine et al., 2018). Further research is needed to assess the validity of such clocks as a 
measure of age-related cognitive decline due to the differences between blood and brain 
methylation statuses (Walton et al., 2016). 
 Summary and future directions 
In summary, we report an interesting interaction between different aspects of lifestyle on 
their association to hippocampus dependent cognition. We also report an important 
function for both SIRT1 and ABTB1 polymorphisms in cognitive performance and highlight 
SIRT1 as a possible mediator of the effects of physical activity on cognition. Finally, we also 
suggest an age-relate association for ABTB1 methylation. Future studies validating these 
findings in independent longitudinal cohorts or cohorts comparing young and old 
participants are necessary to understand the impact of age on these associations. In 
addition, it will be interesting to assess the impact of genome-wide methylation status on 
PAL and other cognitive tasks and to relate this to lifestyle habits and genetic 
polymorphisms. Finally, future studies incorporating using the recently developed 
phenome-wide methodology, to compare genotype-to-phenotype via the use of electronic 
health records, may provide interesting information on the phenotypic relevance of these 
SNPs.   
 Limitations 
Despite interesting findings, this study has a number of limitations. Firstly, the variables 
pertaining to lifestyle are the result of self-report questionnaires which are known to suffer 
from errors and over reporting (Heesch et al., 2010; National Cancer Institute.; Rzewnicki 
et al., 2003). One study even suggested that older individuals may make more errors on the 
IPAQ (Heesch et al., 2010). In addition, as the population was not recruited for this 
particular study, the timings and nature of the measures may have impacted the results. 
For example, measures such as the Mediterranean diet score may have been more 
appropriate than HEI in this study and more consistent time differences in between 
questionnaires and the PAL task may have reduced noise.  
Additionally, the study was limited by missing data across participants, particularly the lack 
of data on education and the considerable reduction in power when assessing lifestyle as 
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opposed to genotype alone. This reduction in number of participants for example, 
prevented us from assessing a possible interplay between nutrition, exercise and genotype 
on cognition. Furthermore, in spite of the cohort being free of illness it may be more 
accurate to correct for medication, especially when thinking about the rising problem of 
polypharmacy in ageing populations (Guthrie et al., 2015). Also, while CANTAB PAL© 
provided an easy way to deliver a standardised cognitive task to a large number of 
participants, the use of technology may have hindered older people more than their 
younger counterparts. In addition, though the use of PAL was chosen to select for age-
related hippocampal cognition, a wider battery of tests may have provided better insights 
into ageing cognition as a whole. Furtheremore, it would be interesting to validate these 
findings on pattern separation tasks such as the Mnemonic Similarity Task developed by 
the Stark and colleagues (Stark et al., 2015). Authors have in fact suggested that while PAL 
is hippocampal dependent it might not be specifically dependent on neurogenesis (Déry et 
al., 2013). 
 
In terms of study design, as for any genetic study, the present one lacks power to detect 
associations with very rare variants. Also, the decision to test several genes and to include 
100kb up and downstream of the coding regions allowed us to find novel polymorphisms 
but also caused a loss of power due to the large number of multiple comparisons. Finally, 
though it was interesting to assess the effect of each SNP on cognition, it may be necessary 
to also assess the synergistic function of several SNPs or several genes as the interplay 
between lifestyle and cognition is likely to be affected by a number of related pathways. 
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6 General Conclusions 
6.1 Summary of key findings and future directions 
With this project, we aimed to evaluate the role of the mTOR, insulin and insulin-like 
signalling and sirtuin pathway in human NSC regulation and cognition. In particular, we 
evaluated the effect of ageing human serum, tert-Butyl hydroperoxide, hydroxyurea and 
increased passage number on NSC regulation and on the expression levels of candidate 
genes to mimic an aged systemic environment, oxidative stress, DNA damage and 
replicative senescence respectively.  We also investigated associations between genetic 
polymorphisms in candidate genes within these pathways and cognitive performance as 
well as the effects of lifestyle on this association. 
Firstly, we report that serum from human donors elicits alterations in NSC regulation that 
are associated to in vivo phenotypes such as cognitive performance and hippocampal 
volumes. In addition, we show that while gene expression alterations are not associated to 
the serum-donor’s age, the expression levels of nine candidate genes are strongly 
correlated to cellular phenotype. We hypothesise that this result is representative of 
biological ageing and that the lack of association to serum donor’s age is due to the 
discrepancies between chronological and biological age, a known characteristic of human 
ageing. Focusing on this and adopting an endophenotype approach we show that four of 
these nine genes (NAMPT, FOXO3A, mTOR and PTEN) show significant expression 
alterations in response to replicative senescence and that PTEN is also susceptible to 
treatment with tert-Butyl hydroperoxide and hydroxyurea. Importantly, we report that the 
molecular alterations following increased passage number are also accompanied by 
dramatic morphological alterations reminiscent of senescence. Finally, we report 
significant associations between genetic polymorphisms in two of the nine candidate genes 
identified by the endophenotype approach (ABTB1 and SIRT1) and cognitive performance 
in a human cohort. Our results also emphasise the effect of lifestyle in mediating this 
association.  
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Throughout this thesis we investigated nutrient-sensing pathways using a multidisciplinary 
approach. The collective interpretation of these findings not only provides support for a 
role of these pathways in human ageing but also highlights the advantages and limitations 
of each approach. In chapter 4, we aimed to establish a more controlled model of ageing 
that was less susceptible to human heterogeneity in comparison to the in vitro parabiosis 
model used in chapter 3. While passage number showed interesting alterations in both 
gene expression and morphology, pharmacological treatment showed little effect on both 
cellular and molecular aspects of the hippocampal progenitor cells. Therefore, our results 
suggest a more representative and robust ageing model might involve combining the use 
of serum and that of higher passage cells. However, given the importance of diet and 
exercise highlighted in chapter 5 and the human heterogeneity reported in chapter 3, such 
experiments would benefit from the use of serum from a human cohort with lifestyle 
information.  
As discussed in previous sections, future research can build upon these findings in several 
ways. Firstly, findings from the epidemiological study in the TwinsUK cohort could be 
mimicked in in vivo and in vitro models to identify the mechanisms affected by each 
polymorphism. Next, assessing expression levels of the candidate genes and resulting 
proteins in vivo would provide clearer information on the validity of the in vitro models and 
the discrepancies between the two approaches. In addition, further analysis of the effects 
of epigenetic alterations, such as methylation, on identified and novel genes will no doubt 
provide interesting information on the regulatory mechanism of these pathways. 
6.2 Considerations on methodological approach 
This study employed several noteworthy techniques. Firstly, the use of human serum, 
human cells and a human cohort enabled the investigation of ageing mechanisms in an 
entirely “human” context. As discussed throughout this thesis, the differences between 
humans and model organisms are becoming increasingly evident for several aspects of 
ageing. These are especially pronounced when evaluating the contribution of uniquely-
human aspects such as the inter-individual variability in response to genetic variation, diet 
and exercise. The work presented here is one of the very few studies investigating nutrient-
sensing pathways in NSC ageing in a human context. The use of an immortalised embryonic 
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cell line was selected over other human-based in vitro approaches such as induced 
pluripotent stem cells (iPSC) and induced neurons (iN). When compared to iPSCs, the HPC 
model faced similar drawbacks such as the “young” epigenetic and proteomic signatures 
but enabled a much more cost and time-efficient in vitro platform. In addition, a specific 
genetic composition was not necessary in this exploratory project making iPSCs 
unnecessary, given their methodological complexity. Though the use of iN would have 
overcome the rejuvenation drawbacks of iPSCs, the directed differentiation methodology 
would have hindered the assessment of NSC maintenance and differentiation, which was 
a key aspect of this research. To our knowledge, these other cellular models have not yet 
been employed in studies like the present one. Both iPSCs and iN however, would be 
extremely valuable platforms for future experiments combining findings from different 
chapters of this thesis. Both methods could be employed to assess the effect of an ageing 
environment and lifestyle in neurons with specific SNP combinations from individuals with 
accelerated or delayed cognitive decline. 
In addition, by using the systemic environment in chapter 3 and a combination of ageing 
characteristics in chapter 4, we modelled ageing in a more comprehensive manner than is 
usually done. Other studies in fact, tend to focus on a specific ageing aspect to determine 
its contribution to the overall ageing phenotype (Daniele et al., 2016; Le Belle et al., 2011; 
Walton et al., 2012). While this comes with obvious benefits for understanding the specific 
mechanisms responsible for each phenotype, it does not recapitulate the multifaceted 
nature of the ageing process. Authors have in fact described the variety a co-occurrence of 
processes involved in ageing and suggested approaches focused on understanding their 
interaction are necessary (López-Otín et al., 2013; Schubert et al., 2018). Though our 
models do not completely recapitulate all nine commonly accepted hallmarks of ageing 
they do aim towards this goal. Throughout this thesis in fact, we directly or indirectly assess 
five of these hallmarks, namely: deregulated nutrient-sensing pathways, mitochondrial 
dysfunction, cellular senescence and stem cell exhaustion. 
Furthermore, this thesis adopts a back-translation approach to usual studies involving 
epidemiological analysis. Normally, epidemiological studies are used to inform in vitro 
work. Instead, here we used results from our in vitro models to select the candidate genes 
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to be targeted by the epidemiological study. We believe this approach enables for the 
validation of in vitro work and at the same time allows for a more targeted approach to 
epidemiological research which is less susceptible to the statistical hindrance of multiple 
comparisons. As discussed throughout this thesis, validation of in vitro and in vivo work is 
essential to contest the replicability crisis currently affecting most of biomedical research 
(Begley and Ioannidis, 2015). As evidenced by our results, some genes that appeared to be 
essential regulators in both in vitro models, did not present with genotypic alterations 
associated to cognitive phenotypes in the epidemiological portion of this study. While an 
association between SNP and cognition is by no means the only proof for the involvement 
of a specific gene in NSC regulation. Such results do suggest further research is needed to 
elucidate the mechanisms responsible for the gene expression alterations in the in vitro 
models and both their impact and implications for human ageing. 
Finally, rapid advances in technology over the last two decades have enabled the collection 
and distribution of an overwhelming amount of data in a variety of disciplines. Much of this 
data however is not used to its full potential. Because of this, the analysis of pre-existing 
data has been suggested as a cost and time efficient way to address important scientific 
questions (Cheng and Phillips, 2014; Greenhoot and Dowsett, 2012). This increase in data 
availability however, has not yet been met by a shift in the research mentality where data 
collection is still regarded as a necessary part of most studies (Anderson et al., 2007). By 
using a pre-existing cohort, we hope to show how existing data can be shared across 
biomedical fields and incorporated to complement ongoing research. In line with this, large 
public cohorts are now being established to facilitate this kind of research (Khoury and 
Evans, 2015; Trehearne, 2016).  
6.3 Impact on biogerontology 
We believe the research outlined in this thesis contributes to advancing knowledge in the 
field of biogerontology. Of note, we confirm several genes identified by animal studies are 
involved in human ageing. We also provide evidence reinforcing the role for nutrient-
sensing-genes in ageing and in particular, highlight key molecules shared among several 
pathways. In addition, we emphasise the role of novel ageing molecules such as ABTB1 and 
suggest future research should focus on determining their biological function. Importantly, 
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we address the inter-individual variability often discussed in the field and show it is due, at 
least in part, to genetics and lifestyle. We also demonstrate that there are interesting 
interactions between lifestyle and nutrient-sensing gene genotype thereby providing 
further support for the development of precision medicine. We believe tailoring 
interventions to appropriate times and populations will improve the effectiveness of any 
intervention, be it pharmaceutical or environmental, and that studies such as the one 
outlined in this thesis will help achieve this goal. Importantly, our study can be used as a 
basis for future research into both pharmacological and environmental interventions due 
to the strong focus on both genetics and lifestyle.  
6.4 Conclusion 
In conclusion, using distinct methodologies, this thesis demonstrates an important role for 
nutrient-sensing pathways in both NSC regulation and cognitive ageing. In addition, it 
provides novel in vitro models of NSC ageing and delivers interesting candidates for future 
in vivo and in vitro studies aimed at developing pharmacological and lifestyle interventions 
to slow the ageing process and the concomitant development of age-related pathologies. 
Importantly, our study also emphasises the inter-individual variability of ageing and 
highlights the need for targeted therapies. 
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8.1 Chapter 2 appendix 
 CellInsight Parameters 
 







Object Area 30-290 
 
Table 41 - Table showing CellInsight parameters used to select cells via DAPI staining. Nuclei stains that 





Mask value: Ring/ 
Circle 
Ki67 (555 wavelength) 0.1 50 Circle = 0 
Ki67 (488 wavelength) 0.03 60 Circle = 0 
CC3 0.1 160 Circle = 1 
SOX2 0.02 40 Circle = 0 
Nestin 0.03 55 Ring = -1, 3 
H2ax 0.1 100 Circle = 0 
NRF2 0.08 50 Circle = 1 
 





Mask value: Ring/ 
Circle 
KI67 (555 wavelength) 0.1 60 Circle = 0 
Ki67 (488 wavelength) 0.06 60 Circle = 0 
CC3 0.1 20 Circle = 1 
MAP2 0.2 200 Ring = -1, 3 
DCX 0.1 40 Circle = 3 
H2AX 0.2 100 Circle = 0 
NRF2 0.08 20 Circle = 1 
 
Table 43 -  Table showing CellInsight parameters used throughout in vitro studies on differentiating cells.  
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8.2 Chapter 3 appendix 
 Correlation matrix of   PAL performance, cellular markers and hippocampal 
volumes 
 
Below is the correlation matrix used to analyse which correlations showed significant 
association.








Figure 72- Screenshot of correlation matrix used to summarise relevant correlations. The first column reports the first variable and columns 3-14 show the other variable 
being tested for association during each correlation. The second column indicates the corrections applied to each correlation: correlations involving Paired Associates Learning 
(PAL) were corrected for both age and education while all others were only corrected for age.
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 Non-significant associations between gene expression and cellular markers 
 
Tables reporting the p and R values for the non-significant correlations carried out in section 
943.3.3.3 
 
MASH r p value 
MASH and Ki67 0.10 0.58 
MASH and CC3% -0.342 0.075 
MASH and MAP2% 0.210 0.294 
MASH and DCX% -0.008 0.969 
MASH and cells/field 0.197 0.298 
 
ETV6 r p value 
ETV6 and Ki67 0.086 0.662 
ETV6 and CC3% 0.341 0.088 
ETV6 and MAP2% -0.201 0.336 
ETV6 and DCX% 0.357 0.074 
ETV6 and cells/field -0.316 0.101 
 
S6K r p value 
S6K and Ki67 -0.067 0.734 
S6K and CC3% -0.003 0.990 
S6K and MAP2% 0.181 0.386 
S6K and DCX% 0.028 0.892 
S6K and cells/field 0.173 0.379 
 
EIF4E r p value 
EIF4E and Ki67 -0.001 0.992 
EIF4E and CC3% 0.029 0.887 
EIF4E and MAP2% 0.265 0.200 
EIF4E and DCX% 0.073 0.725 
EIF4E and cells/field 0.207 0.291 
 
4EBP1 r p value 
4EBP1 and Ki67 0.236 0.228 
4EBP1 and CC3% 0.079 0.701 
4EBP1 and MAP2% -0.046 0.828 
4EBP1 and DCX% -0.221 0.279 
4EBP1 and cells/field -0.038 0.846 
 




IRS2 r p value 
IRS2 and Ki67 -0.0003 0.999 
IRS2 and CC3% 0.089 0.664 
IRS2 and MAP2% -0.113 0.592 
IRS2 and DCX% -0.052 0.801 
IRS2 and cells/field -0.341 0.076 
 
NRIP r p value 
NRIP and Ki67 -0.09 0.656 
NRIP and CC3% 0.002 0.991 
NRIP and MAP2% -0.104 0.622 
NRIP and DCX% 0.192 0.348 
NRIP and cells/field -0.190 0.333 
 
 
 Correlation of expression levels of related genes 
The expression levels of genes with direct or indirect effects on each other’s activity or 
expression were assessed for associations. Besides several interesting trends, the association 
of the expression levels of PTEN and GRB10 and those of mTOR and GRB10 showed significant 
negative and positive correlations respectively. In line with our results, GRB10 is believed to 
be under positive regulation by mTOR and PTEN is believed to negatively regulate mTOR 
activity. Though there was no significant association between PTEN and mTOR there is a clear 
trend towards a negative association providing further support for PTEN’s negative control of 
the mTOR pathway and, ultimately, of GRB10. 
 




Figure 73 – Correlations between related genes. Figure showing the relationship between expression levels of genes known to alter each other’s function or expression. 
Each dot represents the average expression levels of the genes in HPCOA07 cells after treatment with a single serum sample. Experiments were carried out in duplicates and 
correlation analysis was used to check for significant associations. Line of best fit indicates significant result PTEN and GRB10 expression levels were negatively correlated (p 
= 0.037, r = -0.36). mTOR and GRB10 expression levels instead, showed positive correlations (p= 0.007, r= 0.44)
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8.3 Chapter 4 appendix 
 Methods 
 
8.3.1.1 Machine learning methods and scripts 
The scripts used for carrying out machine learning on the Columbus software can be found at 
the following links:   
 
 MAP2 machine learning script: 
https://drive.google.com/open?id=1ZKycgPevBd1VF-OPXYAZvikF1hCXt1jr 
 
 DCX machine learning script: 
https://drive.google.com/open?id=1aoNKyHhUn0q3FthzuR0CWTSirKdjLxjB 
 
Below are the summaries of the scripts outlined in the links above.
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Map2 protocol parameters summary: 
 




DCX protocol parameters summary: 
 








Figure 74 - Proliferation assay: Percentage of SOX2 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations.  Graphs showing the resulting percentage of SOX2 positive 
cells following various treatments during the human progenitor cell proliferation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of SOX2 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of SOX2 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of SOX2 positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were fixed 
72 hours after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 















































































































































































Figure 75 - Proliferation assay: Percentage of nestin positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations.  Graphs showing the resulting percentage of nestin positive 
cells following various treatments during the human progenitor cell proliferation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of nestin positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of nestin positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of nestin positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were fixed 
72 hours after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 















































































































































































Figure 76 - Proliferation assay: Percentage of Ki67 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations.  Graphs showing the resulting percentage of Ki67 positive cells 
following various treatments during the human progenitor cell proliferation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of Ki67 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of Ki67 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of Ki67 positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were fixed 
72 hours after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 















































































































































































Figure 77 - Proliferation assay: Percentage of CC3 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations.  Graphs showing the resulting percentage of CC3 positive cells 
following various treatments during the human progenitor cell proliferation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of CC3 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of CC3 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of CC3 positive cells following shorter incubation periods 
with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were fixed 72 
hours after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 3 








































































































































































Figure 78 - Proliferation assay: Percentage of H2AX positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations.  Graphs showing the resulting percentage of H2AX positive 
cells following various treatments during the human progenitor cell proliferation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of H2AX positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of H2AX positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of H2AX positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were fixed 
72 hours after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 
















































































































































































Figure 79 - Differentiation assay: Percentage of DCX positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations Graphs showing the resulting percentage of DCX positive cells 
following various treatments during the human progenitor cell differentiation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of DCX positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of DCX positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of DCX positive cells following shorter incubation periods 
with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were not treated 
during the proliferation assay (72 hours). They were then either washed and treated at the 72 hour timepoint 
and left to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to differentiate 
in media only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 days after 
seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 technical 















































































































































































Figure 80- Differentiation assay: Percentage of MAP2 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations Graphs showing the resulting percentage of MAP2 positive cells 
following various treatments during the human progenitor cell differentiation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of MAP2 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of MAP2 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of MAP2 positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were not 
treated during the proliferation assay (72 hours). They were then either washed and treated at the 72 hour 
timepoint and left to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to 
differentiate in media only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 
days after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 















































































































































































Figure 81 - Differentiation assay: Percentage of Ki67 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations Graphs showing the resulting percentage of Ki67 positive cells 
following various treatments during the human progenitor cell differentiation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of Ki67 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of Ki67 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of Ki67 positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were not 
treated during the proliferation assay (72 hours). They were then either washed and treated at the 72 hour 
timepoint and left to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to 
differentiate in media only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 
days after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 















































































































































































Figure 82 - Differentiation assay: Percentage of CC3 positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations Graphs showing the resulting percentage of CC3 positive cells 
following various treatments during the human progenitor cell differentiation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of CC3 positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of CC3 positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of CC3 positive cells following shorter incubation periods 
with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were not treated 
during the proliferation assay (72 hours). They were then either washed and treated at the 72 hour timepoint 
and left to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to differentiate 
in media only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 days after 
seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 technical 









































































































































































Figure 83 - Differentiation assay: Percentage of H2AX positive cells with varying tert-Butyl hydroperoxide 
(tBHP) and hydroxyurea (HU) concentrations Graphs showing the resulting percentage of H2AX positive cells 
following various treatments during the human progenitor cell differentiation assay. The top row shows 
standard incubation periods of 48 hours. The left graph shows the percentage of H2AX positive cells with 
increasing tBHP concentrations (1µM, 10µM and 20 µM) compared to controls treated with media only.  The 
graph on the right shows the percentage of H2AX positive cells with increasing HU concentrations (10µM, 50 
µM, 100µM). The bottom row shows the percentage of H2AX positive cells following shorter incubation 
periods with HU; 8-hour incubation on the left and 3-hour incubation on the right. In all cases, cells were not 
treated during the proliferation assay (72 hours). They were then either washed and treated at the 72 hour 
timepoint and left to differentiate for a further 7 days or washed at the 72 hour timepoint and allowed to 
differentiate in media only conditions until treatment 8 or 3 hours prior to fixing. Cells were always fixed 9 
days after seeding. Standard deviation is reported as error bars. Each dot represents a technical replicate. 12 
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8.3.2.2 Morphology  alterations across  passages 
 
 
Figure 84 -  Morphology of DCX and MAP2 positive cells at different passage number. Differentiation assay 
results, cells at different passage numbers were incubated in either media only conditions or with 1µM tert-
Butyl hydroperoxide (tBHP) + 10µM hydroxyurea (HU) for 48 hours during the proliferation stage and for 7 
days during the differentiation stage. Passage numbers included 17 (p17) as a control and several higher 
passages ranging from passage 25 (p25) to passage 30 (p30). The proportion of cells with a more rounded 
morphology (stunted) and the proportion of cells with an elongated morphology for each group was 
quantified by machine learning. Treatment does not appear to have an effect on morphology but higher 
passage numbers appear to have a greater proportion of stunted cells than lower passage cells. 2 technical 
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8.3.2.3 Parameters used by machine learning scripts to distinguish between 
morphology types 
Using these scripts above, the following parameters were selected as important in 
distinguishing between the stunted and elongated morphologies. 
The Columbus software used linear classifiers to establish the class of each cell positive for 
either DCX or MAP2 staining. Briefly, this entails using a set of parameters and pertinent 
linear coefficients (detailed below) to inform on the most likely class (i.e. stunted or 
elongated). In both tables, the properties (1st column) are ordered by relevance to the 
model. The second column shows the linear coefficient for each property used to in the 




Properties (ordered by relevance) Linear coefficient 
Cytoplasm Ratio Width to Length 10.54928 
Nucleus Area [µm²] 0.010956 
Cytoplasm Width [µm] -0.10162 




Properties (ordered by relevance) Linear Coefficient 
Cytoplasm Roundness 3.354727 
Cytoplasm Ratio Width to Length 3.403816 
Nucleus Roundness 5.174257 
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8.4 Chapter 5 appendix 
 Methods 
8.4.1.1 Food Frequency Questionnaire 
Below are screenshots of the food frequency questionnaires used in the TwinsUK cohort. 
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8.4.1.2 IPAQ questionnaire 
Below if the questionnaire used to assess physical activity levels in the TwinsUK cohort. 
 




8.4.2.1 Assessing normality, heteroscedasticity and the presence of outliers 
in lifestyle variables 
Frequency distribution, residual vs fitted, quantile-quantile (Q-Q), scale-location and 
residual vs leverage plots of the residuals obtained from the correlation between Kcal and 
PAL (Figure 85), HEI and PAL (Figure 86) and IPAQ and PAL (Figure 87).  
 
Figure 85 - Frequency distribution, residual vs fitted, quantile-quantile (Q-Q), scale-location and residual 
vs leverage plots of the residuals obtained from the correlation between Kcal and Paired Associates 
Learning (PAL) 
 




Figure 86 - Frequency distribution, residual vs fitted, quantile-quantile (Q-Q), scale-location and residual 
vs leverage plots of the residuals obtained from the correlation between healthy eating and Paired 
Associates Learning (PAL) 
 
 
Figure 87 - Frequency distribution, residual vs fitted, quantile-quantile (Q-Q), scale-location and residual 
vs leverage plots of the residuals obtained from the correlation between physical activity and Paired 
Associates Learning (PAL) 
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8.4.2.2 Tag SNPs 
All raw and selected tag SNPs are reported in an excel file that can be found at: 
https://drive.google.com/open?id=1vjZzFTSciEYpeIvuPGpNqCl8Gv40S5uY 
 
8.4.2.3 Results of associations between 482 tag SNPs and paired associates 
learning 
All results from the association between the 482 tag SNPs and PAL can be found at: 
https://drive.google.com/open?id=1SU_Skzh6-a4Vw1ee-N33isxZD74uGxNg 
 
8.4.2.4 Sensitivity analysis to compare methodologies 
Below are the results of the analyses used as sensitivity analysis to select the cluster 
method to account for relatedness within our cohort.  Table 44 shows the 5 most significant 
SNPs when the analysis was carried out after averaging the values of each MZ twin pair and 
Table 45 shows the results of the analysis when only one of each MZ twin pair was used in 
the analysis. For both tables, the 2 significant SNPs highlighted by the analysis carried out 
in section 5.3.5 are in bold.  In both other methods, similar SNPs are highlighted suggesting 
all methods are valid, the cluster method was selected as it provided more power. 
 
SNP β coefficient L95 U95 p value n 
rs497849 (SIRT1) 0.18 0.10 0.26 0.00002 992 
rs2343401 (IGF2r) -0.14 -0.22 -0.06 0.0004 835 
rs782431 (ABTB1) 0.13 0.06 0.20 0.0005 984 
rs7358173 (PTEN) 0.13 0.06 0.21 0.0007 842 
rs9700237 (mTOR) -0.16 -0.25 -0.07 0.0008 663 
 
Table 44 - Table showing the results for the model testing SNPs for association to PAL errors after averaging 
of all datapoints of each Mz twin pair.  β coefficient, lower (L95) and upper (U95) confidence intervals, 
unadjusted p value, number of people (n) and adjusted p value (adjusted p) following Benjamini-Hochberg 
correction for each linear model are reported. The candidate gene closest to the SNP being tested is reported 
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SNP β coefficient L95 U95 p value n 
rs497849 (SIRT1) 0.16 0.08 0.25 0.000188 992 
rs782431 (ABTB1) 0.13 0.06 0.21 0.00054 984 
rs7072702 (PTEN) 0.13 0.05 0.21 0.000869 992 
rs2594290( mTOR) 0.23 0.09 0.37 0.001184 971 
rs2720231 (ABTB1) 0.12 0.05 0.20 0.001542 975 
 
Table 45 - Table showing the results for the model testing SNPs for association to PAL errors after one twin 
from each MZ twin pair. β coefficient, lower (L95) and upper (U95) confidence intervals, unadjusted p value, 
number of people (n) and adjusted p value (adjusted p) following Benjamini-Hochberg correction for each 
linear model are reported. The candidate gene closest to the SNP being tested is reported in brackets in the 
first column.  
 
8.4.2.5 No association between genotype and lifestyle factors 
As discussed in section 5.3.6, there were no significant interactions between genotype and 
healthy eating or genotype and calorie intake. Below are the 5 SNPs with the most 
significant interaction with healthy eating (Table 46) and calorie intake (Table 47) though 
as shown, none survived correction for multiple testing.  
 
SNP * HEI β coefficient p value n Adjusted p 
rs75033338 (GRB10) 0.02 0.00121 1158 0.582 
rs2044859 (GRB10) -0.01 0.00448 1161 0.617 
rs4947968 (GRB10) 0.01 0.00584 1161 0.617 
rs220722 (IGF2R) -0.02 0.01073 1165 0.617 
rs3120821 (mTOR) -0.01 0.01294 1114 0.617 
Table 46 - Table showing the interaction results between healthy eating and genotype on PAL score effect.  
β coefficient, unadjusted p value, number of people (n) and adjusted p value (adjusted p) following Benjamini-
Hochberg correction for the 5 most significant interactions are reported. The candidate gene closest to the 
SNP being tested is reported in brackets in the first column.  
 
SNP * KCAL β coefficient p value n Adjusted p 
rs61560478 (mTOR) -0.00023 0.00139 1138 0.492 
rs7635934 (ABTB1) 0.00021 0.00293 1165 0.492 
rs3758932 (UCP2) 0.00020 0.00515 1151 0.492 
rs10953493 (NAMPT) -0.00016 0.0065 1133 0.492 
rs3773155 (ABTB1) 0.00021 0.00738 1163 0.492 
Table 47 - Table showing the interaction results between calorie intake and genotype on PAL score effect.  
β coefficient, unadjusted p value, number of people (n) and adjusted p value (adjusted p) following Benjamini-
Hochberg correction for the 5 most significant interactions are reported. The candidate gene closest to the 
SNP being tested is reported in brackets in the first column 
 
